<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Aging Neurosci</journal-id><journal-id journal-id-type="iso-abbrev">Front Aging Neurosci</journal-id><journal-id journal-id-type="publisher-id">Front. Aging Neurosci.</journal-id><journal-title-group><journal-title>Frontiers in Aging Neuroscience</journal-title></journal-title-group><issn pub-type="epub">1663-4365</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5816049</article-id><article-id pub-id-type="doi">10.3389/fnagi.2018.00003</article-id><article-categories><subj-group subj-group-type="heading"><subject>Neuroscience</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Ethnopharmacological Approaches for Dementia Therapy and Significance of Natural Products and Herbal Drugs</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tewari</surname><given-names>Devesh</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/387306/overview"/></contrib><contrib contrib-type="author"><name><surname>Stankiewicz</surname><given-names>Adrian M.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/492271/overview"/></contrib><contrib contrib-type="author"><name><surname>Mocan</surname><given-names>Andrei</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/350779/overview"/></contrib><contrib contrib-type="author"><name><surname>Sah</surname><given-names>Archana N.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/464837/overview"/></contrib><contrib contrib-type="author"><name><surname>Tzvetkov</surname><given-names>Nikolay T.</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/516277/overview"/></contrib><contrib contrib-type="author"><name><surname>Huminiecki</surname><given-names>Lukasz</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Horba&#x00144;czuk</surname><given-names>Jaros&#x00142;aw O.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/458572/overview"/></contrib><contrib contrib-type="author"><name><surname>Atanasov</surname><given-names>Atanas G.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff6"><sup>6</sup></xref><xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/203955/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Department of Pharmaceutical Sciences, Faculty of Technology, Kumaun University</institution>, <addr-line>Nainital</addr-line>, <country>India</country></aff><aff id="aff2"><sup>2</sup><institution>Institute of Genetics and Animal Breeding of the Polish Academy of Sciences</institution>, <addr-line>Jastrzebiec</addr-line>, <country>Poland</country></aff><aff id="aff3"><sup>3</sup><institution>Department of Pharmaceutical Botany, Iuliu Ha&#x0021b;ieganu University of Medicine and Pharmacy</institution>, <addr-line>Cluj-Napoca</addr-line>, <country>Romania</country></aff><aff id="aff4"><sup>4</sup><institution>ICHAT and Institute for Life Sciences, University of Agricultural Sciences and Veterinary Medicine</institution>, <addr-line>Cluj-Napoca</addr-line>, <country>Romania</country></aff><aff id="aff5"><sup>5</sup><institution>Department of Molecular Biology and Biochemical Pharmacology, Institute of Molecular Biology Roumen Tsanev, Bulgarian Academy of Sciences</institution>, <addr-line>Sofia</addr-line>, <country>Bulgaria</country></aff><aff id="aff6"><sup>6</sup><institution>Department of Pharmacognosy, University of Vienna</institution>, <addr-line>Vienna</addr-line>, <country>Austria</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Athanasios Alexiou, Novel Global Community Educational Foundation (NGCEF), Hebersham, Australia</p></fn><fn fn-type="edited-by"><p>Reviewed by: Gjumrakch Aliev, GALLY International Biomedical Research, United States; Mohammad Hassan Baig, Yeungnam University, South Korea</p></fn><corresp id="fn001">*Correspondence: Atanas G. Atanasov <email xlink:type="simple">a.atanasov.mailbox@gmail.com</email></corresp><fn fn-type="other" id="fn002"><p>&#x02020;These authors have contributed equally to this study.</p></fn></author-notes><pub-date pub-type="epub"><day>12</day><month>2</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>10</volume><elocation-id>3</elocation-id><history><date date-type="received"><day>29</day><month>10</month><year>2017</year></date><date date-type="accepted"><day>08</day><month>1</month><year>2018</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2018 Tewari, Stankiewicz, Mocan, Sah, Tzvetkov, Huminiecki, Horba&#x00144;czuk and Atanasov.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Tewari, Stankiewicz, Mocan, Sah, Tzvetkov, Huminiecki, Horba&#x00144;czuk and Atanasov</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Dementia is a clinical syndrome wherein gradual decline of mental and cognitive capabilities of an afflicted person takes place. Dementia is associated with various risk factors and conditions such as insufficient cerebral blood supply, toxin exposure, mitochondrial dysfunction, oxidative damage, and often coexisting with some neurodegenerative disorders such as Alzheimer's disease (AD), Huntington's disease (HD), and Parkinson's disease (PD). Although there are well-established (semi-)synthetic drugs currently used for the management of AD and AD-associated dementia, most of them have several adverse effects. Thus, traditional medicine provides various plant-derived lead molecules that may be useful for further medical research. Herein we review the worldwide use of ethnomedicinal plants in dementia treatment. We have explored a number of recognized databases by using keywords and phrases such as &#x0201c;dementia&#x0201d;, &#x0201c;Alzheimer's,&#x0201d; &#x0201c;traditional medicine,&#x0201d; &#x0201c;ethnopharmacology,&#x0201d; &#x0201c;ethnobotany,&#x0201d; &#x0201c;herbs,&#x0201d; &#x0201c;medicinal plants&#x0201d; or other relevant terms, and summarized 90 medicinal plants that are traditionally used to treat dementia. Moreover, we highlight five medicinal plants or plant genera of prime importance and discuss the physiological effects, as well as the mechanism of action of their major bioactive compounds. Furthermore, the link between mitochondrial dysfunction and dementia is also discussed. We conclude that several drugs of plant origin may serve as promising therapeutics for the treatment of dementia, however, pivotal evidence for their therapeutic efficacy in advanced clinical studies is still lacking.</p></abstract><kwd-group><kwd>Alzheimer's disease</kwd><kwd>amyloid fibrils</kwd><kwd>&#x003b2;-amyloid</kwd><kwd>dementia</kwd><kwd>ethnopharmacology</kwd><kwd>herbal drugs</kwd></kwd-group><funding-group><award-group><funding-source id="cn001">Krajowy Naukowy Osrodek Wiodacy<named-content content-type="fundref-id">10.13039/501100008648</named-content></funding-source><award-id rid="cn001">05-1/KNOW2/2015</award-id></award-group></funding-group><counts><fig-count count="11"/><table-count count="3"/><equation-count count="0"/><ref-count count="283"/><page-count count="24"/><word-count count="17505"/></counts></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>Dementia is a clinical syndrome wherein gradual decline of mental and cognitive capabilities of an afflicted person takes place. As the disease progresses, the ability to function independently of an affected individual deteriorates due to memory loss (Burgess et al., <xref rid="B33" ref-type="bibr">2002</xref>; Damasio and Gabrowski, <xref rid="B56" ref-type="bibr">2004</xref>; Grand et al., <xref rid="B93" ref-type="bibr">2011</xref>). The causes of dementia can be either reversible or irreversible. The reversible causes include, for example, substance abuse, subdural hematoma, removable tumors, and central nervous system (CNS) infections (Tripathi and Vibha, <xref rid="B241" ref-type="bibr">2009</xref>). Some of the irreversible causes of dementia are neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), and Huntington's disease (HD) (Mehan et al., <xref rid="B160" ref-type="bibr">2012</xref>).</p><p>Thus, dementia is associated with multiple predisposing conditions and risk factors, among which aging is the greatest and most obvious one (Blennow et al., <xref rid="B28" ref-type="bibr">2006</xref>; Corrada et al., <xref rid="B52" ref-type="bibr">2010</xref>). The most widespread group of dementias is related to neurodegenerative disorders, including AD, PD, and HD, or amyotrophic lateral sclerosis (ALS). Another important group of dementias are vascular cognitive impairments. These pathologies often coexist with neurodegenerative dementias (Iadecola, <xref rid="B112" ref-type="bibr">2013</xref>). Vascular cognitive impairments arise due to various cerebrovascular pathologies, such as hypoperfusions or hemorrhages causing disruption of the blood-brain barrier (BBB) and neurovascular units, usually in hemispheric white matter (Iadecola, <xref rid="B112" ref-type="bibr">2013</xref>). Other diseases may also contribute to development of dementia. Such diseases include metabolic disorders, which participate in the pathology via dysregulation of energy management (Cai et al., <xref rid="B36" ref-type="bibr">2012</xref>), AIDS, which causes indirect damage to the brain through immune activated macrophages (Navia and Rostasy, <xref rid="B172" ref-type="bibr">2005</xref>), or even systemic infections (Lim et al., <xref rid="B145" ref-type="bibr">2015</xref>). Various environmental factors also increase the risk of developing dementia. For example toxins contained in abused substances (Ridley et al., <xref rid="B206" ref-type="bibr">2013</xref>), pesticides (Yan et al., <xref rid="B261" ref-type="bibr">2016</xref>), or air pollution (Rivas-Arancibia et al., <xref rid="B207" ref-type="bibr">2013</xref>; Power et al., <xref rid="B192" ref-type="bibr">2016</xref>) may cause oxidative stress and subsequent neuronal cell death. In addition to the above factors, the etiology of dementia includes a genetic component. The occurrence of dementia is connected with numerous gene polymorphisms and other mutations (Weksler et al., <xref rid="B256" ref-type="bibr">2013</xref>). For example, mutations in three deterministic autosomal dominant genes, i.e., presenilin 1 (PSEN1) on chromosome 14q, presenilin 2 (PSEN2) on 1q, and amyloid precursor protein (APP) on 21q, are associated with early-onset AD (EOAD) (Giri et al., <xref rid="B89" ref-type="bibr">2016</xref>). The apolipoprotein E (APOE) gene, located at locus 19q13.2, is the strongest genetic risk factor for sporadic lead-onset AD (LOAD) (Corder et al., <xref rid="B51" ref-type="bibr">1993</xref>; Giri et al., <xref rid="B89" ref-type="bibr">2016</xref>; Swerdlow et al., <xref rid="B233" ref-type="bibr">2017</xref>). There are three common APOE alleles, namely APOE &#x003b5;2, &#x003b5;3, and &#x003b5;4 alleles, among which the APOE &#x003b5;4 genotype is mainly associated with the higher risk of AD development (Mahley and Rall, <xref rid="B154" ref-type="bibr">2000</xref>; Giri et al., <xref rid="B89" ref-type="bibr">2016</xref>; Swerdlow et al., <xref rid="B233" ref-type="bibr">2017</xref>). The link between the APOE &#x003b5;4 genotype and development of AD pathology is complex (Giri et al., <xref rid="B89" ref-type="bibr">2016</xref>). Studies suggest that APOE &#x003b5;4 is associated with 3- up to 12-fold increased risk of LOAD and earlier onset of dementia in individuals with PSEN1 mutation, whereas APOE &#x003b5;2 decreases the risk of LOAD (Pastor et al., <xref rid="B186" ref-type="bibr">2003</xref>; Giri et al., <xref rid="B89" ref-type="bibr">2016</xref>). In addition, APOE &#x003b5;4 contributes to AD pathogenesis by A&#x003b2;-independent mechanisms involving neurovascular functions, synaptic plasticity, cholesterol homeostasis, and neuroinflammation (Giri et al., <xref rid="B89" ref-type="bibr">2016</xref>). Thus, the presence of APOE4 &#x003b5;4 allele is considered one of the risk factors for AD; more specifically, it is associated with increased risk of cerebral amyloid angiopathy and age-related cognitive decline during aging (Liu et al., <xref rid="B147" ref-type="bibr">2013</xref>).</p><p>Dementia is a highly prevalent syndrome. Despite its prevalence, some evidence suggest that only 10% (low-middle-income countries) to 50% (high-income countries) of all dementia cases are diagnosed (Prince et al., <xref rid="B194" ref-type="bibr">2016</xref>). In addition, the number of dementia cases will grow in consecutive years, as dementia mostly affects the elderly, and the number of people with advanced age is rising rapidly due to the global increase in life expectancy. Quaglio et al. (<xref rid="B197" ref-type="bibr">2016</xref>) approximate, that 1.5&#x02013;2% of the Europeans are currently affected by dementia. On a similar note, Prince et al. (<xref rid="B194" ref-type="bibr">2016</xref>) estimated that in 2015 around 47 million people globally suffered from dementia. This number may reach roughly 131 million in 2050 (Prince et al., <xref rid="B194" ref-type="bibr">2016</xref>). In the year 2021, one million people will be affected by dementia in the UK alone (Knapp et al., <xref rid="B136" ref-type="bibr">2007</xref>). The importance of developing novel dementia treatments was recognized by the G7 summit in December 2014. The forum participants recommended that dementia should be treated as a global priority with the main objective to introduce effective therapy by 2025 (Cummings et al., <xref rid="B54" ref-type="bibr">2016</xref>).</p><p>Dementia is a significant burden on society both by eliciting human suffering and financially. Dementia is the fifth most frequent cause of death in high-income countries (Dolgin, <xref rid="B66" ref-type="bibr">2016</xref>). Their caregivers were also negatively affected by the health conditions of the patients and showed moderately high levels of depressive symptoms (Schulz et al., <xref rid="B218" ref-type="bibr">2008</xref>). According to the World Alzheimer Report 2016 (Prince et al., <xref rid="B194" ref-type="bibr">2016</xref>), not only in the low-income countries, but also in the high-income countries people with dementia have poor access to healthcare due to its high cost and ineffective diagnostic systems. Dementia management is very expensive due to long-lasting and costly care that the patients receive (Hurd et al., <xref rid="B111" ref-type="bibr">2013</xref>). Various costs related to dementia, including health services, social services, unpaid careers, and others reach around &#x020ac;23 billion per year alone in the UK (Luengo-Fernandez et al., <xref rid="B152" ref-type="bibr">2010</xref>). This economic burden can be further illustrated by the fact that, in the UK, the current annual cost of dementia is higher than current annual costs of heart disease and cancer combined (Luengo-Fernandez et al., <xref rid="B152" ref-type="bibr">2010</xref>). Another prediction suggests that by 2050 dementia and Alzheimer's disease may cost the United States alone around USD 1 trillion (Dolgin, <xref rid="B66" ref-type="bibr">2016</xref>).</p><p>In this review, we present a global overview on the worldwide use of ethnomedicine for the management of dementia. Moreover, we also focus on five prominent plants traditionally used for dementia treatment and highlight the constituents, which may be responsible for plant's bioactivity.</p><p>Currently, there is no highly effective medicine that stops the progressive course of dementia (Abbott, <xref rid="B1" ref-type="bibr">2011</xref>). We propose that learning about the active substances produced by some plants and their mechanism of action may lead to the development of novel therapies for dementia. The natural products pool represents a continuous major source for drug discovery (Atanasov et al., <xref rid="B17" ref-type="bibr">2015</xref>). In this context, the present review could serve as a useful resource for the development of ethnomedicine-derived pharmaceuticals for the dementia therapy.</p></sec><sec id="s2"><title>Frequent forms of dementia</title><p>The most common types of dementia are AD-related dementia (approximately 50&#x02013;80% of all dementia cases) (Qiu et al., <xref rid="B196" ref-type="bibr">2009</xref>; Abbott, <xref rid="B1" ref-type="bibr">2011</xref>), vascular dementia (approximately 20&#x02013;30%) (Abbott, <xref rid="B1" ref-type="bibr">2011</xref>; Iadecola, <xref rid="B112" ref-type="bibr">2013</xref>), dementia with Lewy bodies (between 15 and 35% according to Zupancic et al., <xref rid="B283" ref-type="bibr">2011</xref>, or less than 5% according to Abbott, <xref rid="B1" ref-type="bibr">2011</xref>) and the frontotemporal dementia (FTD), which is the fourth most frequent form of presenile dementia (between 5 and 10%) (Abbott, <xref rid="B1" ref-type="bibr">2011</xref>; Table <xref ref-type="table" rid="T1">1</xref>).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Most common forms of dementia (according to Abbott, <xref rid="B1" ref-type="bibr">2011</xref>).</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Dementia form</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Neuropathology</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Symptoms</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Dementia cases (%)</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">AD-related dementia</td><td valign="top" align="left" rowspan="1" colspan="1">A&#x003b2; plaques, neurofibrillary tangles</td><td valign="top" align="left" rowspan="1" colspan="1">Memory deficits, depression, poor judgment or evidence of mental confusion</td><td valign="top" align="center" rowspan="1" colspan="1">50&#x02013;80</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Vascular dementia</td><td valign="top" align="left" rowspan="1" colspan="1">Decreased or interrupted blood flow to the brain, hypoperfusion, oxidative stress</td><td valign="top" align="left" rowspan="1" colspan="1">Similar to AD, but less affected memory</td><td valign="top" align="center" rowspan="1" colspan="1">20&#x02013;30</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Dementia with Lewy bodies</td><td valign="top" align="left" rowspan="1" colspan="1">&#x003b1;-Synuclein aggregates in neurons and glial cells (cortical Lewy bodies)</td><td valign="top" align="left" rowspan="1" colspan="1">Similar to AD and less to PD, hallucinations, tremors, impaired attention</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;5</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Frontotemporal dementia</td><td valign="top" align="left" rowspan="1" colspan="1">Accumulation of MAP tau, atrophy of frontal and temporal lobes</td><td valign="top" align="left" rowspan="1" colspan="1">Changes in social behavior, difficulties with language</td><td valign="top" align="center" rowspan="1" colspan="1">5&#x02013;10</td></tr></tbody></table></table-wrap><p>Common to these dysfunctions is a presence of abnormal accumulated proteins in the brains of patients. For example, in AD amyloid beta (A&#x003b2;) peptides aggregate into amyloid plaques (Hardy and Higgins, <xref rid="B97" ref-type="bibr">1992</xref>), while TDP-43 protein accumulates in the human brain during the course of FTD (Baloh, <xref rid="B20" ref-type="bibr">2011</xref>). Brains of FTD patients show gross atrophy of frontal and anterior temporal lobes (Brun, <xref rid="B32" ref-type="bibr">1987</xref>; McKhann et al., <xref rid="B159" ref-type="bibr">2001</xref>), and their histopathology reveals microvacuolar degeneration and loss of pyramidal neurons in the frontal and temporal cortex (Rabinovici and Miller, <xref rid="B198" ref-type="bibr">2010</xref>). Furthermore, pathologic accumulation of microtubule-associated protein (MAP) tau is a process also common for AD and FTD (Iqbal et al., <xref rid="B117" ref-type="bibr">2016</xref>). Abnormal hyperphosphorylation of tau protein leads to its aggregation into intraneuronal neurofibrillary tangles (Iqbal et al., <xref rid="B118" ref-type="bibr">2010</xref>). Vascular dementia is a heterogeneous group of brain disorders associated with a cognitive impairment that is attributed to multifactorial cerebrovascular pathologies, such as hypoperfusion, oxidative stress, and inflammation (Iadecola, <xref rid="B112" ref-type="bibr">2013</xref>). Dementia with Lewy bodies is characterized by the presence of &#x003b1;-synuclein aggregates in neurons and glial cells (Zupancic et al., <xref rid="B283" ref-type="bibr">2011</xref>), and also associated with cholinergic as well as glutamate transmission deficiencies (Zupancic et al., <xref rid="B283" ref-type="bibr">2011</xref>). It may also be concluded, that there is a great deal of overlap between the symptoms of different types of dementia (Abbott, <xref rid="B1" ref-type="bibr">2011</xref>).</p><p>Naturally, the pathology of these diseases is more complicated (Blennow et al., <xref rid="B28" ref-type="bibr">2006</xref>). Various markers of AD can be found in the brains of afflicted patients (Blennow et al., <xref rid="B28" ref-type="bibr">2006</xref>). These markers include, e.g., dysregulation of signaling of memory-related neurotransmitter acetylcholine (ACh) (Kihara and Shimohama, <xref rid="B129" ref-type="bibr">2004</xref>), vascular damage (Franzblau et al., <xref rid="B83" ref-type="bibr">2013</xref>), loss of neurons (Niikura et al., <xref rid="B176" ref-type="bibr">2006</xref>) and synapses (Shankar and Walsh, <xref rid="B222" ref-type="bibr">2009</xref>). Mitochondrial dysfunction is another pathology, which was recognized as an important early event in the AD progression and, therefore, may be considered as promising target for the treatment of AD and AD-related dementia (Kumar and Singh, <xref rid="B139" ref-type="bibr">2015</xref>). We briefly describe the mitochondrial dysfunction in the context of dementia in section Mitochondrial Dysfunction and Neurodegeneration.</p></sec><sec id="s3"><title>Mitochondrial dysfunction and neurodegeneration</title><p>Mitochondria are double membrane-enclosed organelles that are responsible to exert a broad range of cellular functions that include the most important adenosine triphosphate (ATP) production (energy conversion), but also involvement in several homeostatic processes, such as regulation of cell cycle and cell growth, calcium handling, and apoptosis-programmed cell death (van Horssen et al., <xref rid="B244" ref-type="bibr">2017</xref>). Moreover, mitochondria play a crucial role in many other essential metabolic processes (van Horssen et al., <xref rid="B244" ref-type="bibr">2017</xref>). Thus, mitochondrial diseases often have an associated metabolic component and, therefore, mitochondrial defects are predictable in energy-dependent disturbances, inflammation, and aging (Chan, <xref rid="B41" ref-type="bibr">2006</xref>; Banasch et al., <xref rid="B21" ref-type="bibr">2011</xref>). Hence, mitochondrial dysfunction is one of the key pathological features in various age-related neurodegenerative diseases including AD-associated dementia due to the pivotal role of mitochondria in neuronal cell survival or death (Moreira et al., <xref rid="B166" ref-type="bibr">2010</xref>). For example, it has been proposed that mitochondrial network remodeling plays a prominent role in neurodegeneration (Zhu et al., <xref rid="B281" ref-type="bibr">2013</xref>; Burte et al., <xref rid="B34" ref-type="bibr">2015</xref>). The mitochondrial cascade hypothesis proposed the mitochondrial dysfunction as a principal episode in AD pathology (Moreira et al., <xref rid="B166" ref-type="bibr">2010</xref>; Swerdlow et al., <xref rid="B232" ref-type="bibr">2010</xref>). Moreover, mitochondrial dysfunction, which is also described as an impairment of electron transport chain, is responsible to increase the production of reactive oxagen species (ROS) and change mitochondrial dynamics (Beal, <xref rid="B23" ref-type="bibr">2005</xref>; Lin and Beal, <xref rid="B146" ref-type="bibr">2006</xref>; Hung et al., <xref rid="B110" ref-type="bibr">2018</xref>). A recent study has shown the reciprocal relationship between ROS and mitochondrial dynamics during early stages of neurodegeneration (Hung et al., <xref rid="B110" ref-type="bibr">2018</xref>). It has also been found that the cause for mitochondria-mediated toxicity is the progressive accumulation of A&#x003b2; in mitochondria (Chen and Yan, <xref rid="B47" ref-type="bibr">2010</xref>). Recent studies provided the crucial role of mitochondrial dysfunction in regulating the ROS and intracellular calcium levels in neuronal cells (Aminzadeh et al., <xref rid="B11" ref-type="bibr">2018</xref>). In addition, Lee et al. investigated the relationship between the NAD-dependent deacetylase sirtuin-3 (SIRT3) protein and mitochondrial function using AD human brain samples, demonstrating that dysfunction of SIRT3 leads to mitochondrial and neuronal damage, and may improve the mitochondrial pathology and neurodegeneration in AD (Lee et al., <xref rid="B141" ref-type="bibr">2017</xref>). Therefore, mitochondrial dysfunction is considered as a cardinal pathological hallmark for neurodegenerative diseases including AD and AD-related dementia (Lin and Beal, <xref rid="B146" ref-type="bibr">2006</xref>; van Horssen et al., <xref rid="B244" ref-type="bibr">2017</xref>). Detailed information of mitochondrial activities that may be associated with dementia is presented in Figure <xref ref-type="fig" rid="F1">1</xref>.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Overview of mechanisms linking mitochondrial activity with dementia: (1) Mitochondria are crucially important for activating apoptosis (Wang and Youle, <xref rid="B250" ref-type="bibr">2009</xref>); (2) Mitochondria regulate calcium signaling pathway (Walsh et al., <xref rid="B246" ref-type="bibr">2009</xref>); (3) Oxidative phosphorylation occurs in electron transport chain of mitochondria; (4) Calcium signaling induces apoptosis (Hajnoczky et al., <xref rid="B96" ref-type="bibr">2003</xref>); (5) Calcium and neuroinflammatory signaling pathways interact with each other (Sama and Norris, <xref rid="B214" ref-type="bibr">2013</xref>); (6) Cell cycle requires calcium signaling (Berridge, <xref rid="B26" ref-type="bibr">1995</xref>); (7) Mitochondrial oxidative phosphorylation is one of the main sources of reactive oxygen species (Dai et al., <xref rid="B55" ref-type="bibr">2014</xref>); (8) Oxidative phosphorylation and reactive oxygen species regulate cell cycle (Antico Arciuch et al., <xref rid="B14" ref-type="bibr">2012</xref>); (9) Oxidative stress and neuroinflammation are highly interconnected processes (Gao et al., <xref rid="B85" ref-type="bibr">2014</xref>); (10) Neuronal apoptosis (LeBlanc, <xref rid="B140" ref-type="bibr">2005</xref>; Favaloro et al., <xref rid="B80" ref-type="bibr">2012</xref>); (11) Impaired calcium signaling (Berridge, <xref rid="B27" ref-type="bibr">2011</xref>; Nimmrich and Eckert, <xref rid="B177" ref-type="bibr">2013</xref>); (12) Changes in cell cycle (Raina et al., <xref rid="B199" ref-type="bibr">2000</xref>; Katsel et al., <xref rid="B127" ref-type="bibr">2013</xref>); (13) Presence of neuroinflammation (Pasqualetti et al., <xref rid="B185" ref-type="bibr">2015</xref>); (14) Increased oxidative stress (Bennett et al., <xref rid="B25" ref-type="bibr">2009</xref>; Kumar and Singh, <xref rid="B139" ref-type="bibr">2015</xref>); (15) Changes in mitochondrial morphology and functions (Spano et al., <xref rid="B226" ref-type="bibr">2015</xref>; Hung et al., <xref rid="B110" ref-type="bibr">2018</xref>).</p></caption><graphic xlink:href="fnagi-10-00003-g0001"/></fig><p>Summarizing the above, the oxidative stress and mitochondrial dysfunction are of high importance in the pathology and pathogenesis of AD and dementia. Therefore, natural antioxidants and mitochondria targeting molecules can be important strategies to treat elderly individuals with AD (Reddy and Reddy, <xref rid="B202" ref-type="bibr">2017</xref>). Several naturally occurring antioxidants, such as <italic>Ginkgo biloba</italic> (Gb) and curcumin, showed blocking effect on the age-dependent spatial cognitive behavior and also increased the A&#x003b2;-degrading enzymes in transgenic mouse models (Stackman et al., <xref rid="B227" ref-type="bibr">2003</xref>; Wang et al., <xref rid="B252" ref-type="bibr">2014</xref>). Moreover, several other antioxidants, including ferulic acid, &#x003b1;-lipoic acid, R-lipoic acid, vitamin E, vitamin C, melatonin, CoQ10, <italic>N</italic>-acetyl-L-cysteine, pyrrolyl-alpha-nitronyl nitroxide, and zeolite supplementation, also showed beneficial effects on AD in different transgenic mouse models (Reddy and Reddy, <xref rid="B202" ref-type="bibr">2017</xref>). Most of these naturally occurring compounds revealed reduction in A&#x003b2; levels, mitochondrial dysfunction, phosphorylated tau, and microglial activation, and also increased the synaptic activity (Reddy and Reddy, <xref rid="B202" ref-type="bibr">2017</xref>). Therefore, many of them are available as supplements or can be used as alternative treatment strategies that may help certain neurological conditions, such as PD, AD, some dementia types, and other clinical conditions.</p></sec><sec id="s4"><title>Current pharmaceutical treatments of dementia</title><sec><title>Approved (semi-)synthetic drugs</title><p>Several (semi-)synthetic drugs are available worldwide for the treatment of AD and some dementia types. The selective, reversible acetylcholinesterase (AChE) inhibitor donepezil, the non-selective butyrylcholinetserase (BuChE) and AChE inhibitor rivastigmine, as well as the <italic>N</italic>-methyl-D-aspartate (NMDA) receptor antagonist memantine are some of the most widely used therapeutics for AD-associated dementia (Blennow et al., <xref rid="B28" ref-type="bibr">2006</xref>; Winblad et al., <xref rid="B257" ref-type="bibr">2016</xref>). Some of these drugs, like the (semi-)synthetic drug rivastigmine, are also approved for treating other dementia types like PD-related dementia (Winblad et al., <xref rid="B257" ref-type="bibr">2016</xref>). Most prominent drugs approved for clinical use in AD and different forms of dementia are present in Table <xref ref-type="table" rid="T2">2</xref>. A combined donepezil&#x02013;memantine drug with the brand name Namzaric&#x000ae; was approved by the FDA in 2014 for the treatment of moderate-to-severe AD in people who are taking donepezil hydrochloride at the recommended clinically efficient dose of 10 mg/day (<ext-link ext-link-type="uri" xlink:href="http://www.alz.org">http://www.alz.org</ext-link> AD report). However, this combinative medicine may cause various side effects, including muscle problems, slow heartbeat and fainting, increased stomach acid levels, nausea, vomiting, and seizures. In addition, some findings suggest that abovementioned drugs do not provide therapeutic benefits for agitation present in patients with severe behavioral symptoms (Howard et al., <xref rid="B103" ref-type="bibr">2007</xref>; Fox et al., <xref rid="B82" ref-type="bibr">2012</xref>). Some neuroleptic/antipsychotic drugs, such as haloperidol, risperidone, and olanzapine, are currently being used to treat behavioral and psychological symptoms of dementia (BPSD), however, their use is controversial (Ballard and Howard, <xref rid="B19" ref-type="bibr">2006</xref>). Therefore, such drugs are not approved by FDA for the treatment of BPSD. Nevertheless, they are still often prescribed off-label as no better treatment for BPSD exists currently (Ibrahim et al., <xref rid="B114" ref-type="bibr">2012</xref>).</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Approved (semi-)synthetic drugs used for the treatment of dementia.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th valign="top" align="left" rowspan="1" colspan="1"><bold>Memantine</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Rivastigmine</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Donepezil</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Brand name</td><td valign="top" align="left" rowspan="1" colspan="1">Namenda&#x000ae; (USA)</td><td valign="top" align="left" rowspan="1" colspan="1">Exelon&#x000ae; (USA, Europe)</td><td valign="top" align="left" rowspan="1" colspan="1">Aricept&#x000ae; (USA, Europe)</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Axura&#x000ae; (Europe)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Ebixa&#x000ae; (Europe)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Memando&#x000ae; (Ger)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Chemical structure</td><td valign="top" align="left" rowspan="1" colspan="1"><inline-graphic xlink:href="fnagi-10-00003-i0001.jpg"/></td><td valign="top" align="left" rowspan="1" colspan="1"><inline-graphic xlink:href="fnagi-10-00003-i0002.jpg"/></td><td valign="top" align="left" rowspan="1" colspan="1"><inline-graphic xlink:href="fnagi-10-00003-i0003.jpg"/></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Indications</td><td valign="top" align="left" rowspan="1" colspan="1">Moderate-to-severe AD, AD-related dementia</td><td valign="top" align="left" rowspan="1" colspan="1">Mild-to-moderate AD, AD-related dementia</td><td valign="top" align="left" rowspan="1" colspan="1">Mild-to-moderate AD, early-to-mid AD dementia</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mode of action</td><td valign="top" align="left" rowspan="1" colspan="1">Non-competitive NMDA-receptor antagonist</td><td valign="top" align="left" rowspan="1" colspan="1">Slowly reversible, non-selective AChE and BuChE inhibitor</td><td valign="top" align="left" rowspan="1" colspan="1">Reversible, selective AChE inhibitor</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Side effects (<ext-link ext-link-type="uri" xlink:href="http://www.alz.org">http://www.alz.org</ext-link>)</td><td valign="top" align="left" rowspan="1" colspan="1">Confusion, dizziness, constipation, and headache</td><td valign="top" align="left" rowspan="1" colspan="1">Nausea, vomiting, loss of appetite, increased frequency of bowel movements</td><td valign="top" align="left" rowspan="1" colspan="1">Nausea, vomiting, loss of appetite, increased frequency of bowel movements</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Half-life (Blennow et al., <xref rid="B28" ref-type="bibr">2006</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">60&#x02013;100 h (long)</td><td valign="top" align="left" rowspan="1" colspan="1">1 h (very short)</td><td valign="top" align="left" rowspan="1" colspan="1">70 h (long)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Doses per day (Blennow et al., <xref rid="B28" ref-type="bibr">2006</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">One (first week)</td><td valign="top" align="left" rowspan="1" colspan="1">Two</td><td valign="top" align="left" rowspan="1" colspan="1">One</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Initial dose (Blennow et al., <xref rid="B28" ref-type="bibr">2006</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">5 mg/day</td><td valign="top" align="left" rowspan="1" colspan="1">3 mg/day (2 &#x000d7; 1.5 mg)</td><td valign="top" align="left" rowspan="1" colspan="1">5 mg/day</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Recommended clinically efficient dose (Blennow et al., <xref rid="B28" ref-type="bibr">2006</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">20 mg/day</td><td valign="top" align="left" rowspan="1" colspan="1">6&#x02013;12 mg/day</td><td valign="top" align="left" rowspan="1" colspan="1">10 mg/day</td></tr></tbody></table></table-wrap><p>The (semi-)synthetic drugs that are currently used for the treatment of dementia have an impact on several symptoms in different disease stages, but do not stop the progressive course of the disease (Tzvetkov and Antonov, <xref rid="B243" ref-type="bibr">2017</xref>). Therefore, the investigation of naturally occurring compounds with potential therapeutic properties for the treatment of different dementia forms is of great medical and socioeconomic importance.</p></sec><sec><title>Galantamine&#x02014;the only current drug of plant origin against dementia</title><p>Galantamine is an important drug of plant origin that is widely prescribed for the treatment of mild-to-moderate AD and AD-related dementia (Lilienfeld, <xref rid="B144" ref-type="bibr">2002</xref>). Efficacy of galantamine has been confirmed in several clinical trials (Olin and Schneider, <xref rid="B180" ref-type="bibr">2002</xref>). Galantamine, also known as galanthamine (for structure, see Figure <xref ref-type="fig" rid="F2">2</xref>), is an isoquinoline alkaloid produced by plants from <italic>Amaryllidaceae</italic> family. It was first discovered and isolated from bulbs of <italic>Galanthus nivalis</italic> (common snowdrop) by the Bulgarian chemist D. Paskov and his team in 1956 (Paskov, 1958). The original industrial phytopreparation of the pure galantamine extract (named Nivalin&#x000ae;) was prepared in late 1950s by the same research group (Chrusciel and Varagi&#x00107;, <xref rid="B50" ref-type="bibr">1966</xref>). Galantamine was first applied to treat poliomyelitis and later, for the treatment of neuropathic pain and as an anesthetic (Ng et al., <xref rid="B174" ref-type="bibr">2015</xref>). Today, galantamine is mainly obtained from <italic>Galanthus woronowi</italic> Losinsk and <italic>Galanthus alpines</italic> Sosn. (Caucasian snowdrop) daffodil bulbs and also synthesized artificially (Loy and Schneider, <xref rid="B151" ref-type="bibr">2006</xref>).</p><fig id="F2" position="float"><label>Figure 2</label><caption><p>Chemical structure and targeted mechanisms of galantamine (Gal) against AD and dementia. The major biological effects of Gal lead to significant neuroprotection via dual AChE inhibition and allosteric stimulation of nAChRs.</p></caption><graphic xlink:href="fnagi-10-00003-g0002"/></fig><p>Galantamine has a unique dual mode of action affecting the brain's cholinergic system (Figure <xref ref-type="fig" rid="F2">2</xref>). It is a reversible, competitive inhibitor of the AChE enzyme and an allosteric enhancer of the nicotinic acetylcholine receptor (nAChR) (Albuquerque et al., <xref rid="B10" ref-type="bibr">2001</xref>).</p><p>Galantamine also prevents mitochondrial dysfunction, as shown by its capability to rescue changes in mitochondrial membrane potential (MMP) and morphology induced by A&#x003b2;25/35 or hydrogen peroxide treatment (Ezoulin et al., <xref rid="B77" ref-type="bibr">2008</xref>; Liu et al., <xref rid="B148" ref-type="bibr">2010</xref>). Oxidative stress is caused by toxic reactive oxygen species (ROS), which are generated mainly during the electron transport in mitochondria. By protecting the mitochondria and inhibiting AChE activity galantamine decreases oxidative damage to cells and thus mediates neuroprotection (Tsvetkova et al., <xref rid="B242" ref-type="bibr">2013</xref>).</p><p>Furthermore, galantamine may interact with other brain-targeted drugs by decreasing activity of P-glycoprotein, a multi-drug resistance transporter present in brain's vascular endothelium (Namanja et al., <xref rid="B169" ref-type="bibr">2009</xref>). It is responsible for actively effluxing drugs back into the bloodstream, thus preventing them from crossing into the brain (Namanja et al., <xref rid="B169" ref-type="bibr">2009</xref>). Hence, galantamine may allow drugs that were co-administered with it to reach the brain more easily. Galantamine also enhances the protective effect of rofecoxib (an anti-inflammatory COX-2 inhibitor) and caffeic acid (a plant-derived phenol) against neurotoxicity-induced mitochondrial dysfunction, oxidative damage, and cognitive impairment in rats (Kumar et al., <xref rid="B138" ref-type="bibr">2011</xref>). Similarly, galantamine potentiates antioxidative activity of melatonin, a brain sleep hormone (Romero et al., <xref rid="B209" ref-type="bibr">2010</xref>). Combined galantamine and memantine treatment is also hypothesized to be a potential novel therapy for schizophrenia (Koola et al., <xref rid="B137" ref-type="bibr">2014</xref>).</p><p>Treatment with galantamine has shown to consistently delay the onset of different behavioral symptoms of dementia, such as anxiety, euphoria, depression, irritability, delusions, and unusual motor behavior (Monsch and Giannakopoulos, <xref rid="B165" ref-type="bibr">2004</xref>). A review by Loy and Schneider (<xref rid="B151" ref-type="bibr">2006</xref>) described in detail 10 clinical trials comprising the total of 6,805 demented patients, who were submitted to galantamine treatment. The results revealed that the galantamine is well-tolerated by the majority of patients. Some common side effects were observed in the treatment groups in a dose-dependent manner (Loy and Schneider, <xref rid="B151" ref-type="bibr">2006</xref>).</p><p>Because of its efficacy, the drug is recommended by Alzheimer's disease/dementia treatment guidelines of the USA and Europe (Doody et al., <xref rid="B69" ref-type="bibr">2001</xref>; Waldemar et al., <xref rid="B245" ref-type="bibr">2007</xref>). The drug is also approved for use in roughly 29 countries including Canada, in the European Union (except for The Netherlands, under the name Nivalin&#x000ae; in 2000), Japan, Korea, Mexico, Singapore, South Africa, Thailand, etc. The FDA approved galantamine in the United States under the brand name Razadyne&#x000ae; in 2001 for the treatment of AD and AD-related dementia. In summary, the plant-derived galantamine is a well-established medicine for dementia treatment, which acts via modulation of acetylcholine signaling and inhibition of oxidative damage.</p></sec></sec><sec id="s5"><title>General overview of the diversity of plants used in dementia treatment</title><p>Modern research on dementias showed that they are complex diseases with multiple molecular mechanisms involved in their pathogenesis. With this realization emerged the new paradigm for treating these pathologies: therapies for dementia should target multiple underling molecular targets, instead of concentrating on any single one. Correspondingly, plant and plant extracts are composed of many substances that are hypothesized to act on multiple molecular targets in an additive or even synergistic manner (Long et al., <xref rid="B149" ref-type="bibr">2015</xref>). Many herbal medicines are already being used for dementia treatment. Unfortunately, active ingredients of these herbs are poorly described. Similarly, we still know very little on how this myriad of substances interact with each other and with prescription medications (Zhou et al., <xref rid="B278" ref-type="bibr">2016b</xref>). The research on these topics will be essential for developing therapeutics, comprised of substances that amplify each other activity and which are devoid of harmful side effects.</p><p>In this work, we attempted to collect and document scattered information from various ethnopharmacological reports. We searched several web databases namely, ScienceDirect, Pubmed, Scopus, and Google Scholar using keywords such as &#x0201c;dementia,&#x0201d; &#x0201c;Alzheimer's,&#x0201d; &#x0201c;traditional medicine,&#x0201d; &#x0201c;ethnopharmacology,&#x0201d; and &#x0201c;ethnobotany.&#x0201d; Web hits from Google scholar were gathered through Boolean information retrieval method using plant name with &#x0201c;AND&#x0201d; operator (Pohl et al., <xref rid="B190" ref-type="bibr">2010</xref>) followed by &#x0201c;dementia&#x0201d; or &#x0201c;Alzheimer's.&#x0201d; An overview of the identified medicinal plants used for treating dementia or AD is presented in Table <xref ref-type="table" rid="T3">3</xref>.</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Overview of medicinal plants used to treat dementia worldwide.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Plant (Plant family)</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>References for the use of the plants for dementia treatment in ethnomedicine</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Number of google scholar hits for keyword &#x0201c;dementia&#x0201d;</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Number of google scholar hits for keyword &#x0201c;Alzheimer's&#x0201d;</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Acorus calamus</italic> L. (Acoraceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Howes and Houghton, <xref rid="B104" ref-type="bibr">2003</xref></td><td valign="top" align="center" rowspan="1" colspan="1">492</td><td valign="top" align="center" rowspan="1" colspan="1">730</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Aframomum melegueta</italic> (Roskoe) K. Schum. (Zingiberaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Fatumbi, <xref rid="B79" ref-type="bibr">1995</xref></td><td valign="top" align="center" rowspan="1" colspan="1">46</td><td valign="top" align="center" rowspan="1" colspan="1">104</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Agapanthus africanus</italic> (Agapanthaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Stafford et al., <xref rid="B228" ref-type="bibr">2008</xref></td><td valign="top" align="center" rowspan="1" colspan="1">06</td><td valign="top" align="center" rowspan="1" colspan="1">06</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Ammocharis coranica</italic> (Ker-Gawl.) Herb. (Amaryllidaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Stafford et al., <xref rid="B228" ref-type="bibr">2008</xref></td><td valign="top" align="center" rowspan="1" colspan="1">13</td><td valign="top" align="center" rowspan="1" colspan="1">26</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Ananas comosus</italic> (Bromeliaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Wolters, <xref rid="B258" ref-type="bibr">1994</xref>; Adams et al., <xref rid="B4" ref-type="bibr">2007</xref></td><td valign="top" align="center" rowspan="1" colspan="1">129</td><td valign="top" align="center" rowspan="1" colspan="1">414</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Angelica sinensis</italic> (Oliv.) Diels (Apiaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Mantle et al., <xref rid="B157" ref-type="bibr">2000</xref></td><td valign="top" align="center" rowspan="1" colspan="1">1,010</td><td valign="top" align="center" rowspan="1" colspan="1">1,660</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Angelica archangelica</italic> (Apiaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Ross, <xref rid="B210" ref-type="bibr">2001</xref>; Howes and Houghton, <xref rid="B104" ref-type="bibr">2003</xref></td><td valign="top" align="center" rowspan="1" colspan="1">196</td><td valign="top" align="center" rowspan="1" colspan="1">318</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Angelica</italic> species (Apiaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Perry and Howes, <xref rid="B188" ref-type="bibr">2011</xref></td><td valign="top" align="center" rowspan="1" colspan="1">4,670</td><td valign="top" align="center" rowspan="1" colspan="1">3,140</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Annona senegalensis</italic> Pers. (Annonaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Stafford et al., <xref rid="B228" ref-type="bibr">2008</xref></td><td valign="top" align="center" rowspan="1" colspan="1">139</td><td valign="top" align="center" rowspan="1" colspan="1">80</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Artemisia absinthium</italic> L. (Asteraceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Howes and Houghton, <xref rid="B104" ref-type="bibr">2003</xref>; Adams et al., <xref rid="B4" ref-type="bibr">2007</xref></td><td valign="top" align="center" rowspan="1" colspan="1">242</td><td valign="top" align="center" rowspan="1" colspan="1">439</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Asparagus africanus</italic> Lam. (Asparagaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Stafford et al., <xref rid="B228" ref-type="bibr">2008</xref></td><td valign="top" align="center" rowspan="1" colspan="1">26</td><td valign="top" align="center" rowspan="1" colspan="1">34</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Asparagus concinnus</italic> (Baker) Kies (Asparagaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Stafford et al., <xref rid="B228" ref-type="bibr">2008</xref></td><td valign="top" align="center" rowspan="1" colspan="1">01</td><td valign="top" align="center" rowspan="1" colspan="1">01</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Bacopa monnieri</italic> (L.) Wettst. (Plantaginaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Manyam, <xref rid="B158" ref-type="bibr">1999</xref></td><td valign="top" align="center" rowspan="1" colspan="1">1,370</td><td valign="top" align="center" rowspan="1" colspan="1">1,990</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Barbieria pinnata</italic> (Pers.) Baill. (Fabacea)</td><td valign="top" align="left" rowspan="1" colspan="1">Schultes, <xref rid="B216" ref-type="bibr">1993</xref>, <xref rid="B217" ref-type="bibr">1994</xref>; Adams et al., <xref rid="B4" ref-type="bibr">2007</xref></td><td valign="top" align="center" rowspan="1" colspan="1">04</td><td valign="top" align="center" rowspan="1" colspan="1">06</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Platycladus orientalis</italic> (L.) Franco (Syn. <italic>Biota orientalis</italic> (L.)Endl.) (Cupressaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Nishiyama et al., <xref rid="B179" ref-type="bibr">1995</xref>; Howes et al., <xref rid="B106" ref-type="bibr">2003</xref></td><td valign="top" align="center" rowspan="1" colspan="1">150</td><td valign="top" align="center" rowspan="1" colspan="1">236</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Boophone disticha</italic> (L.f.) Herb. (Amaryllidaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Stafford et al., <xref rid="B228" ref-type="bibr">2008</xref></td><td valign="top" align="center" rowspan="1" colspan="1">39</td><td valign="top" align="center" rowspan="1" colspan="1">78</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Brugmansia &#x000d7; candida</italic> Pers. (Solanaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Gonz&#x000e1;lez Ayala, <xref rid="B92" ref-type="bibr">1994</xref>; Adams et al., <xref rid="B4" ref-type="bibr">2007</xref></td><td valign="top" align="center" rowspan="1" colspan="1">12</td><td valign="top" align="center" rowspan="1" colspan="1">55</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Bupleurum</italic> species (Apiaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Perry and Howes, <xref rid="B188" ref-type="bibr">2011</xref></td><td valign="top" align="center" rowspan="1" colspan="1">518</td><td valign="top" align="center" rowspan="1" colspan="1">717</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Camellia sinensis</italic> Kuntze (Theaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Perry and Howes, <xref rid="B188" ref-type="bibr">2011</xref></td><td valign="top" align="center" rowspan="1" colspan="1">1,420</td><td valign="top" align="center" rowspan="1" colspan="1">3,910</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Cannabis sativa</italic> L. (Cannabaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Perry and Howes, <xref rid="B188" ref-type="bibr">2011</xref></td><td valign="top" align="center" rowspan="1" colspan="1">1,740</td><td valign="top" align="center" rowspan="1" colspan="1">3,260</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Carum carvi</italic> L. (Apiaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Adsersen et al., <xref rid="B5" ref-type="bibr">2006</xref></td><td valign="top" align="center" rowspan="1" colspan="1">163</td><td valign="top" align="center" rowspan="1" colspan="1">340</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Caryophyllus</italic> spp. (Caryophyllaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Tabernaemontanus, <xref rid="B234" ref-type="bibr">1987</xref>; Adams et al., <xref rid="B4" ref-type="bibr">2007</xref></td><td valign="top" align="center" rowspan="1" colspan="1">161</td><td valign="top" align="center" rowspan="1" colspan="1">292</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Cassia lucens</italic> Vog. (Fabaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Schultes, <xref rid="B216" ref-type="bibr">1993</xref>, <xref rid="B217" ref-type="bibr">1994</xref>; Adams et al., <xref rid="B4" ref-type="bibr">2007</xref></td><td valign="top" align="center" rowspan="1" colspan="1">28</td><td valign="top" align="center" rowspan="1" colspan="1">93</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Celastrus paniculatus</italic> Willd. (Celastraceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Howes and Houghton, <xref rid="B104" ref-type="bibr">2003</xref></td><td valign="top" align="center" rowspan="1" colspan="1">189</td><td valign="top" align="center" rowspan="1" colspan="1">274</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Centella asiatica</italic> (L.) Urb (Apiaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Stafford et al., <xref rid="B228" ref-type="bibr">2008</xref></td><td valign="top" align="center" rowspan="1" colspan="1">1,060</td><td valign="top" align="center" rowspan="1" colspan="1">1,970</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Dysphania ambrosioides</italic> (L.) Mosyakin&#x00026;Clemants (Amaranthaceae) {Syn. <italic>Chenopodium ambrosioides</italic> L.(Chenopodiaceae)}</td><td valign="top" align="left" rowspan="1" colspan="1">de Barradas, <xref rid="B61" ref-type="bibr">1957</xref>; CESA, <xref rid="B38" ref-type="bibr">1992</xref>, <xref rid="B39" ref-type="bibr">1993</xref>; Adams et al., <xref rid="B4" ref-type="bibr">2007</xref></td><td valign="top" align="center" rowspan="1" colspan="1">94</td><td valign="top" align="center" rowspan="1" colspan="1">154</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Clitoria ternatea</italic> L. (Fabaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Howes and Houghton, <xref rid="B104" ref-type="bibr">2003</xref></td><td valign="top" align="center" rowspan="1" colspan="1">185</td><td valign="top" align="center" rowspan="1" colspan="1">294</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Codonopsis pilulosa</italic> (Franch.) Nannf. (Campanulaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Howes and Houghton, <xref rid="B104" ref-type="bibr">2003</xref></td><td valign="top" align="center" rowspan="1" colspan="1">198</td><td valign="top" align="center" rowspan="1" colspan="1">245</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Coffea arabica</italic> L. (Rubiaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Perry and Howes, <xref rid="B188" ref-type="bibr">2011</xref></td><td valign="top" align="center" rowspan="1" colspan="1">484</td><td valign="top" align="center" rowspan="1" colspan="1">1,180</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Convallaria majalis</italic> L. (Convallariaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Tabernaemontanus, <xref rid="B234" ref-type="bibr">1987</xref>; Adams et al., <xref rid="B4" ref-type="bibr">2007</xref></td><td valign="top" align="center" rowspan="1" colspan="1">82</td><td valign="top" align="center" rowspan="1" colspan="1">95</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Coriandrum sativum</italic> L. (Apiaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Tabernaemontanus, <xref rid="B234" ref-type="bibr">1987</xref>; Adams et al., <xref rid="B4" ref-type="bibr">2007</xref></td><td valign="top" align="center" rowspan="1" colspan="1">310</td><td valign="top" align="center" rowspan="1" colspan="1">765</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Corydalis cava</italic> (L.) Schw. et K. (Papaveraceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Adsersen et al., <xref rid="B5" ref-type="bibr">2006</xref>; Adams et al., <xref rid="B4" ref-type="bibr">2007</xref></td><td valign="top" align="center" rowspan="1" colspan="1">65</td><td valign="top" align="center" rowspan="1" colspan="1">86</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Corydalis intermedia</italic> (L.) M'erat (Papaveraceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Adsersen et al., <xref rid="B5" ref-type="bibr">2006</xref>; Adams et al., <xref rid="B4" ref-type="bibr">2007</xref></td><td valign="top" align="center" rowspan="1" colspan="1">71</td><td valign="top" align="center" rowspan="1" colspan="1">141</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Corydalis solida</italic> (L.) Swartz ssp. <italic>laxa</italic> (Papaveraceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Adsersen et al., <xref rid="B5" ref-type="bibr">2006</xref>; Adams et al., <xref rid="B4" ref-type="bibr">2007</xref></td><td valign="top" align="center" rowspan="1" colspan="1">21</td><td valign="top" align="center" rowspan="1" colspan="1">30</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Corydalis solida</italic> (L.) Swartz ssp. <italic>slivenensis</italic> (Papaveraceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Adsersen et al., <xref rid="B5" ref-type="bibr">2006</xref>; Adams et al., <xref rid="B4" ref-type="bibr">2007</xref></td><td valign="top" align="center" rowspan="1" colspan="1">04</td><td valign="top" align="center" rowspan="1" colspan="1">04</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Crinum bulbispermum</italic> (Burm.f.) Milne-Redh. &#x00026; Schweick. (Amaryllidaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Stafford et al., <xref rid="B228" ref-type="bibr">2008</xref></td><td valign="top" align="center" rowspan="1" colspan="1">47</td><td valign="top" align="center" rowspan="1" colspan="1">97</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Crinum moorei</italic> Hook.f (Syn.<italic>Crinum imbricatum</italic> Baker) (Amaryllidaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Stafford et al., <xref rid="B228" ref-type="bibr">2008</xref></td><td valign="top" align="center" rowspan="1" colspan="1">20</td><td valign="top" align="center" rowspan="1" colspan="1">54</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Crinum macowanii</italic> Baker (Amaryllidaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Stafford et al., <xref rid="B228" ref-type="bibr">2008</xref></td><td valign="top" align="center" rowspan="1" colspan="1">41</td><td valign="top" align="center" rowspan="1" colspan="1">93</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Crocus sativus</italic> L. (Iridaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Perry and Howes, <xref rid="B188" ref-type="bibr">2011</xref></td><td valign="top" align="center" rowspan="1" colspan="1">678</td><td valign="top" align="center" rowspan="1" colspan="1">1,310</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Curcuma longa</italic> L. (Zingiberaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Howes and Houghton, <xref rid="B104" ref-type="bibr">2003</xref>; Perry and Howes, <xref rid="B188" ref-type="bibr">2011</xref></td><td valign="top" align="center" rowspan="1" colspan="1">2,130</td><td valign="top" align="center" rowspan="1" colspan="1">6,270</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Euphrasia nemorosa</italic> (Pers.) Wallr. (Scrophulariaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Adsersen et al., <xref rid="B5" ref-type="bibr">2006</xref></td><td valign="top" align="center" rowspan="1" colspan="1">09</td><td valign="top" align="center" rowspan="1" colspan="1">16</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Tetradium ruticarpum</italic> (A.Juss.) T.G.Hartley (Syn. <italic>Evodia rutaecarpa</italic> Hook.f.&#x00026;Thoms.) (Rutaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Mantle et al., <xref rid="B157" ref-type="bibr">2000</xref>; Howes and Perry, <xref rid="B105" ref-type="bibr">2011</xref></td><td valign="top" align="center" rowspan="1" colspan="1">366</td><td valign="top" align="center" rowspan="1" colspan="1">367</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Ferula gummosa</italic> Boiss. (Apiaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Tabernaemontanus, <xref rid="B234" ref-type="bibr">1987</xref>; Adams et al., <xref rid="B4" ref-type="bibr">2007</xref></td><td valign="top" align="center" rowspan="1" colspan="1">22</td><td valign="top" align="center" rowspan="1" colspan="1">32</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Galanthus woronowii</italic> Losinsk. (Amaryllidaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Perry and Howes, <xref rid="B188" ref-type="bibr">2011</xref></td><td valign="top" align="center" rowspan="1" colspan="1">155</td><td valign="top" align="center" rowspan="1" colspan="1">286</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Galanthus alpinus</italic> Sosn. (Syn. <italic>Galanthus caucasicus</italic>) (Amaryllidaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Perry and Howes, <xref rid="B188" ref-type="bibr">2011</xref></td><td valign="top" align="center" rowspan="1" colspan="1">27</td><td valign="top" align="center" rowspan="1" colspan="1">55</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Ginkgo biloba</italic> L. (Ginkgoaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Gurib-Fakim, <xref rid="B95" ref-type="bibr">2006</xref>; Perry and Howes, <xref rid="B188" ref-type="bibr">2011</xref></td><td valign="top" align="center" rowspan="1" colspan="1">14,000</td><td valign="top" align="center" rowspan="1" colspan="1">17,300</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Glycyrrhiza</italic> species (Leguminosae)</td><td valign="top" align="left" rowspan="1" colspan="1">Perry and Howes, <xref rid="B188" ref-type="bibr">2011</xref></td><td valign="top" align="center" rowspan="1" colspan="1">2,410</td><td valign="top" align="center" rowspan="1" colspan="1">4,050</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Huperzia serrate</italic> (Thunb.) Trevis. (Lycopodiaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Howes et al., <xref rid="B106" ref-type="bibr">2003</xref>; Adams et al., <xref rid="B4" ref-type="bibr">2007</xref>; Perry and Howes, <xref rid="B188" ref-type="bibr">2011</xref></td><td valign="top" align="center" rowspan="1" colspan="1">1,130</td><td valign="top" align="center" rowspan="1" colspan="1">1,710</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Hydrolea glabra</italic> Schum. and Thonn. (Hydrophilaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Fatumbi, <xref rid="B79" ref-type="bibr">1995</xref>; Adams et al., <xref rid="B4" ref-type="bibr">2007</xref></td><td valign="top" align="center" rowspan="1" colspan="1">01</td><td valign="top" align="center" rowspan="1" colspan="1">03</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Hypericum perforatum</italic> L. (Clusiaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Perry and Howes, <xref rid="B188" ref-type="bibr">2011</xref></td><td valign="top" align="center" rowspan="1" colspan="1">2,500</td><td valign="top" align="center" rowspan="1" colspan="1">3,180</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Lactuca sativa</italic> L. (Asteraceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Schweitzer de Palacios, <xref rid="B220" ref-type="bibr">1994</xref>; Adams et al., <xref rid="B4" ref-type="bibr">2007</xref></td><td valign="top" align="center" rowspan="1" colspan="1">287</td><td valign="top" align="center" rowspan="1" colspan="1">895</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Lannea schweinfurthii</italic> Engl. (Anacardiaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Stafford et al., <xref rid="B228" ref-type="bibr">2008</xref></td><td valign="top" align="center" rowspan="1" colspan="1">12</td><td valign="top" align="center" rowspan="1" colspan="1">22</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Lantana camara</italic> L. (Verbenaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">M&#x000fc;ller-Ebeling and R&#x000e4;tsch, <xref rid="B167" ref-type="bibr">1989</xref>; Adams et al., <xref rid="B4" ref-type="bibr">2007</xref></td><td valign="top" align="center" rowspan="1" colspan="1">97</td><td valign="top" align="center" rowspan="1" colspan="1">262</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Lavandula angustifolia</italic> Miller (Lamiaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Adsersen et al., <xref rid="B5" ref-type="bibr">2006</xref>; Perry and Howes, <xref rid="B188" ref-type="bibr">2011</xref></td><td valign="top" align="center" rowspan="1" colspan="1">800</td><td valign="top" align="center" rowspan="1" colspan="1">981</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Leucojum aestivum</italic> L. (Amaryllidaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Perry and Howes, <xref rid="B188" ref-type="bibr">2011</xref></td><td valign="top" align="center" rowspan="1" colspan="1">133</td><td valign="top" align="center" rowspan="1" colspan="1">447</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Lycoris radiata</italic> Herb. (Amaryllidaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Howes and Houghton, <xref rid="B104" ref-type="bibr">2003</xref></td><td valign="top" align="center" rowspan="1" colspan="1">227</td><td valign="top" align="center" rowspan="1" colspan="1">273</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Magnolia officinalis</italic> Rehder and Wilson (Magnoliaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Howes and Houghton, <xref rid="B104" ref-type="bibr">2003</xref></td><td valign="top" align="center" rowspan="1" colspan="1">389</td><td valign="top" align="center" rowspan="1" colspan="1">715</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Matricaria recutita</italic> L. (Asteraceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Tabernaemontanus, <xref rid="B234" ref-type="bibr">1987</xref>; Adams et al., <xref rid="B4" ref-type="bibr">2007</xref></td><td valign="top" align="center" rowspan="1" colspan="1">575</td><td valign="top" align="center" rowspan="1" colspan="1">1,150</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Medicago sativa</italic> L. (Fabaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Finkler, <xref rid="B81" ref-type="bibr">1985</xref>; Adams et al., <xref rid="B4" ref-type="bibr">2007</xref></td><td valign="top" align="center" rowspan="1" colspan="1">390</td><td valign="top" align="center" rowspan="1" colspan="1">1,180</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Melissa officinalis</italic> L. (Lamiaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Lonicerus, <xref rid="B150" ref-type="bibr">1679</xref>; Mills, <xref rid="B162" ref-type="bibr">1991</xref>; Perry et al., <xref rid="B189" ref-type="bibr">1998</xref>; Mantle et al., <xref rid="B157" ref-type="bibr">2000</xref>; Adsersen et al., <xref rid="B5" ref-type="bibr">2006</xref>; Adams et al., <xref rid="B4" ref-type="bibr">2007</xref>; Perry and Howes, <xref rid="B188" ref-type="bibr">2011</xref></td><td valign="top" align="center" rowspan="1" colspan="1">1,140</td><td valign="top" align="center" rowspan="1" colspan="1">1,920</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Mentha spicata</italic> L. (Lamiaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Adsersen et al., <xref rid="B5" ref-type="bibr">2006</xref></td><td valign="top" align="center" rowspan="1" colspan="1">223</td><td valign="top" align="center" rowspan="1" colspan="1">537</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Narcissus</italic> spp. (Amaryllidaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Perry and Howes, <xref rid="B188" ref-type="bibr">2011</xref></td><td valign="top" align="center" rowspan="1" colspan="1">1,480</td><td valign="top" align="center" rowspan="1" colspan="1">745</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Nicotiana</italic> species (Solanaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Perry and Howes, <xref rid="B188" ref-type="bibr">2011</xref></td><td valign="top" align="center" rowspan="1" colspan="1">900</td><td valign="top" align="center" rowspan="1" colspan="1">3,060</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Ocimum basilicum</italic> L. (Lamiaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Fuchs, <xref rid="B84" ref-type="bibr">1543</xref>; Sfikas, <xref rid="B221" ref-type="bibr">1980</xref>; Adams et al., <xref rid="B4" ref-type="bibr">2007</xref></td><td valign="top" align="center" rowspan="1" colspan="1">407</td><td valign="top" align="center" rowspan="1" colspan="1">997</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Origanum majorana</italic> Moench (Lamiaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Fuchs, <xref rid="B84" ref-type="bibr">1543</xref>; Adams et al., <xref rid="B4" ref-type="bibr">2007</xref></td><td valign="top" align="center" rowspan="1" colspan="1">675</td><td valign="top" align="center" rowspan="1" colspan="1">1,550</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Origanum vulgare</italic> L. (Lamiaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Adsersen et al., <xref rid="B5" ref-type="bibr">2006</xref></td><td valign="top" align="center" rowspan="1" colspan="1">358</td><td valign="top" align="center" rowspan="1" colspan="1">978</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Paeonia &#x000d7; suffruticosa</italic> Andrews (Paeoniaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Mantle et al., <xref rid="B157" ref-type="bibr">2000</xref></td><td valign="top" align="center" rowspan="1" colspan="1">189</td><td valign="top" align="center" rowspan="1" colspan="1">345</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Panax ginseng</italic> C.A.Mey. (Araliaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Perry and Howes, <xref rid="B188" ref-type="bibr">2011</xref></td><td valign="top" align="center" rowspan="1" colspan="1">4,790</td><td valign="top" align="center" rowspan="1" colspan="1">6,950</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Paullinia cupana</italic> Kunth ex. H. B. K (Sapindaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Taylor, <xref rid="B237" ref-type="bibr">1998</xref>; Adams et al., <xref rid="B4" ref-type="bibr">2007</xref></td><td valign="top" align="center" rowspan="1" colspan="1">248</td><td valign="top" align="center" rowspan="1" colspan="1">515</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Petroselinum crispum</italic> (Mil.) Nym.exA.W.Hill. (Apiaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Adsersen et al., <xref rid="B5" ref-type="bibr">2006</xref></td><td valign="top" align="center" rowspan="1" colspan="1">308</td><td valign="top" align="center" rowspan="1" colspan="1">562</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Physostigma venenosa</italic> Balf.f. (Leguminosae)</td><td valign="top" align="left" rowspan="1" colspan="1">Mantle et al., <xref rid="B157" ref-type="bibr">2000</xref></td><td valign="top" align="center" rowspan="1" colspan="1">08</td><td valign="top" align="center" rowspan="1" colspan="1">11</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Pimpinella anisum</italic> L. (Apiaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Adsersen et al., <xref rid="B5" ref-type="bibr">2006</xref></td><td valign="top" align="center" rowspan="1" colspan="1">214</td><td valign="top" align="center" rowspan="1" colspan="1">493</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Piper methysticum</italic> G.Forst. (Piperaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Perry and Howes, <xref rid="B188" ref-type="bibr">2011</xref></td><td valign="top" align="center" rowspan="1" colspan="1">768</td><td valign="top" align="center" rowspan="1" colspan="1">953</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Polygala tenuifolia</italic> Willd. (Polygalaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Duke and Ayensu, <xref rid="B72" ref-type="bibr">1985</xref>; Chang et al., <xref rid="B43" ref-type="bibr">1986</xref>; Howes and Houghton, <xref rid="B104" ref-type="bibr">2003</xref></td><td valign="top" align="center" rowspan="1" colspan="1">549</td><td valign="top" align="center" rowspan="1" colspan="1">679</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Pteroselinum vulgare</italic> (Mill.) Nym. and A.W. Hill (Apiaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Adams et al., <xref rid="B4" ref-type="bibr">2007</xref></td><td valign="top" align="center" rowspan="1" colspan="1">82</td><td valign="top" align="center" rowspan="1" colspan="1">221</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Rosmarinus officinalis</italic> L. (Lamiaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Price and Price, <xref rid="B193" ref-type="bibr">1995</xref>; Chevallier, <xref rid="B48" ref-type="bibr">1996</xref>; Perry et al., <xref rid="B189" ref-type="bibr">1998</xref>; Mantle et al., <xref rid="B157" ref-type="bibr">2000</xref>; Adams et al., <xref rid="B4" ref-type="bibr">2007</xref></td><td valign="top" align="center" rowspan="1" colspan="1">1,140</td><td valign="top" align="center" rowspan="1" colspan="1">2,440</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Rosmarinus officinalis</italic> L. (Lamiaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Adsersen et al., <xref rid="B5" ref-type="bibr">2006</xref></td><td valign="top" align="center" rowspan="1" colspan="1">1,140</td><td valign="top" align="center" rowspan="1" colspan="1">2,440</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Ruta graveolens</italic> L. (Rutaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Adsersen et al., <xref rid="B5" ref-type="bibr">2006</xref></td><td valign="top" align="center" rowspan="1" colspan="1">351</td><td valign="top" align="center" rowspan="1" colspan="1">420</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Salvia lavandulifolia</italic> Vahl. (Lamiaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Perry and Howes, <xref rid="B188" ref-type="bibr">2011</xref></td><td valign="top" align="center" rowspan="1" colspan="1">103</td><td valign="top" align="center" rowspan="1" colspan="1">190</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Salvia miltiorrhiza</italic> Bung. (Lamiaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Howes and Houghton, <xref rid="B104" ref-type="bibr">2003</xref></td><td valign="top" align="center" rowspan="1" colspan="1">1,430</td><td valign="top" align="center" rowspan="1" colspan="1">2,090</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Salvia officinalis</italic> L. (Lamiaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Sfikas 1980; Tabernaemontanus, <xref rid="B234" ref-type="bibr">1987</xref>; Akhondzadeh et al., <xref rid="B7" ref-type="bibr">2003</xref>; Howes et al., <xref rid="B106" ref-type="bibr">2003</xref>; Savelev et al., <xref rid="B215" ref-type="bibr">2004</xref>; Adams et al., <xref rid="B4" ref-type="bibr">2007</xref></td><td valign="top" align="center" rowspan="1" colspan="1">1,610</td><td valign="top" align="center" rowspan="1" colspan="1">2,960</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Scadoxus multiflorus</italic> (Martyn) Raf. (Amaryllidaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Stafford et al., <xref rid="B228" ref-type="bibr">2008</xref></td><td valign="top" align="center" rowspan="1" colspan="1">06</td><td valign="top" align="center" rowspan="1" colspan="1">31</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Syzygium aromaticum</italic> (L.) Merrill and Perry (Myrtaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Tabernaemontanus, <xref rid="B234" ref-type="bibr">1987</xref>; Adams et al., <xref rid="B4" ref-type="bibr">2007</xref></td><td valign="top" align="center" rowspan="1" colspan="1">248</td><td valign="top" align="center" rowspan="1" colspan="1">647</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Tagetes lucida</italic> Cav. (Asteraceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Ortiz de Montellano, <xref rid="B181" ref-type="bibr">1990</xref>; Adams et al., <xref rid="B4" ref-type="bibr">2007</xref></td><td valign="top" align="center" rowspan="1" colspan="1">25</td><td valign="top" align="center" rowspan="1" colspan="1">54</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Terminalia chebula</italic> Retz. (Combretaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Misra, <xref rid="B164" ref-type="bibr">1998</xref>; Manyam, <xref rid="B158" ref-type="bibr">1999</xref>; Howes and Houghton, <xref rid="B104" ref-type="bibr">2003</xref></td><td valign="top" align="center" rowspan="1" colspan="1">545</td><td valign="top" align="center" rowspan="1" colspan="1">938</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Theobroma cacao</italic> L. (Sterculiaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Roeder, <xref rid="B208" ref-type="bibr">1988</xref>; Adams et al., <xref rid="B4" ref-type="bibr">2007</xref></td><td valign="top" align="center" rowspan="1" colspan="1">535</td><td valign="top" align="center" rowspan="1" colspan="1">1,400</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Thymus vulgaris</italic> L. (Lamiaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Adsersen et al., <xref rid="B5" ref-type="bibr">2006</xref></td><td valign="top" align="center" rowspan="1" colspan="1">1,440</td><td valign="top" align="center" rowspan="1" colspan="1">2,760</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Valeriana officinalis</italic> L. (Valerianaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Perry and Howes, <xref rid="B188" ref-type="bibr">2011</xref></td><td valign="top" align="center" rowspan="1" colspan="1">973</td><td valign="top" align="center" rowspan="1" colspan="1">1,340</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Vinca minor</italic> L. (Apocynaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Perry and Howes, <xref rid="B188" ref-type="bibr">2011</xref></td><td valign="top" align="center" rowspan="1" colspan="1">1,520</td><td valign="top" align="center" rowspan="1" colspan="1">2,070</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>Vitis vinifera</italic> L. (Vitaceae)</td><td valign="top" align="left" rowspan="1" colspan="1">Perry and Howes, <xref rid="B188" ref-type="bibr">2011</xref></td><td valign="top" align="center" rowspan="1" colspan="1">994</td><td valign="top" align="center" rowspan="1" colspan="1">3,010</td></tr></tbody></table></table-wrap></sec><sec id="s6"><title>Selected prominent medicinal plants and plant genera used for the treatment of dementia</title><p>After the extensive web-search for medicinal plants used for dementia treatment in various regions worldwide, the following five plants or plant genera described below were selected for detailed discussion according to the highest observed number of web hits.</p><sec><title><italic>Ginkgo biloba</italic> L.</title><p>Ginkgo is among the most unique plants on earth and belongs to world's oldest tree species (IARC Working Group, <xref rid="B113" ref-type="bibr">2016</xref>). It is a living fossil which gross morphology did not change for around 200 million years (Guan et al., <xref rid="B94" ref-type="bibr">2016</xref>). Gingko is the last living member of the <italic>Ginkgoaceae</italic> family, which appeared during the Mesozoic era. Gb was cultivated in ancient China due to its diverse medicinal properties. Extracts from this plant were utilized for the treatment of various ailments and symptoms viz. poor circulation, fatigue, vertigo, and tinnitus (Sun et al., <xref rid="B231" ref-type="bibr">2013</xref>). Gingko extract is available on market in some countries (e.g., China) as a herbal supplement named Gingium. It is intended for use in certain age-related cognitive disorders including memory impairment and it alleviates the symptoms of dementias and AD (Zhou et al., <xref rid="B277" ref-type="bibr">2016a</xref>). There are two main categories of chemical phytoconstituents likely responsible for the neuro-therapeutic potential of Gingko: terpene lactones (ginkgolides and bilobalide) and flavonoids (flavonols and flavone glycosides) (Figure <xref ref-type="fig" rid="F3">3</xref>; Solfrizzi and Panza, <xref rid="B224" ref-type="bibr">2015</xref>; IARC Working Group, <xref rid="B113" ref-type="bibr">2016</xref>).</p><fig id="F3" position="float"><label>Figure 3</label><caption><p>Most prominent phytochemical constituents found in <italic>Gingko biloba</italic> (Gb).</p></caption><graphic xlink:href="fnagi-10-00003-g0003"/></fig><p>The triterpene ginkgolides A, B, and C are unique to Gb (Solfrizzi and Panza, <xref rid="B224" ref-type="bibr">2015</xref>). However, there are some other constituents such as the ginkgotoxin (found in Gb seeds) and the phenolic type lipid bilobol (found in Gb fruits) that possess some specific biological effects (IARC Working Group, <xref rid="B113" ref-type="bibr">2016</xref>). For example, ginkgotoxin exhibit neurotoxic activity (induce the epileptic seizures) (IARC Working Group, <xref rid="B113" ref-type="bibr">2016</xref>), whereas bilobol and its derivatives show cytotoxic and antibacterial activity (Tanaka et al., <xref rid="B236" ref-type="bibr">2011</xref>).</p><p>Ginkgo leaf extract was first developed for therapeutic purposes in Germany in 1965 (Isah, <xref rid="B119" ref-type="bibr">2015</xref>). The first commercially available extract was registered in France in 1974 under the name EGb761; it contains about 24% flavonoids and 6% terpene lactones (Isah, <xref rid="B119" ref-type="bibr">2015</xref>). The standardized Gb extract (EGb761) belongs to the most widely tested in clinical trials herbal medications worldwide for cognitive impairment, AD, and AD-related dementia (Solfrizzi and Panza, <xref rid="B224" ref-type="bibr">2015</xref>). EGb761 affects a multitude of mechanisms associated with proper brain functions (Zhou et al., <xref rid="B277" ref-type="bibr">2016a</xref>; Figure <xref ref-type="fig" rid="F4">4</xref>).</p><fig id="F4" position="float"><label>Figure 4</label><caption><p>Neuroprotective effects of <italic>Gingko biloba</italic> L.</p></caption><graphic xlink:href="fnagi-10-00003-g0004"/></fig><p>It was reported to mediate neuroprotection by modulating circulating glucocorticoid levels, as well as A&#x003b2; aggregation, ion homeostasis and growth factors synthesis (Amri et al., <xref rid="B12" ref-type="bibr">1996</xref>; Ahlemeyer and Krieglstein, <xref rid="B6" ref-type="bibr">2003</xref>). These processes are likely involved in regulation of oxidative stress (Butterfield et al., <xref rid="B35" ref-type="bibr">2013</xref>; Ruttkay-Nedecky et al., <xref rid="B211" ref-type="bibr">2013</xref>; D&#x000e1;vila et al., <xref rid="B60" ref-type="bibr">2016</xref>; Alam et al., <xref rid="B9" ref-type="bibr">2017</xref>; G&#x000f3;mez-S&#x000e1;mano et al., <xref rid="B91" ref-type="bibr">2017</xref>) which is in agreement with various reports showing antioxidative activity of Gb extract (Bridi et al., <xref rid="B30" ref-type="bibr">2001</xref>; Chandrasekaran et al., <xref rid="B42" ref-type="bibr">2003</xref>). Moreover, the influence of Ginkgo constituents on mitochondrial function is well recognized. Multiple <italic>in vitro</italic> studies show that Ginkgo constituents protect MMP from various toxicants and oxidative stress (Eckert et al., <xref rid="B73" ref-type="bibr">2005</xref>; Abdel-Kader et al., <xref rid="B2" ref-type="bibr">2007</xref>; Wang and Wang, <xref rid="B249" ref-type="bibr">2016</xref>). Gingko extract affects many aspects of mitochondrial morphology such as fission (Zhou et al., <xref rid="B279" ref-type="bibr">2017</xref>), swelling (Schwarzkopf et al., <xref rid="B219" ref-type="bibr">2013</xref>), and coupling (Rhein et al., <xref rid="B204" ref-type="bibr">2010</xref>). Gingko extract also interacts with mitochondrial electron transport chain (Abdel-Kader et al., <xref rid="B2" ref-type="bibr">2007</xref>). Interestingly, it was found that improvement of the oxidative phosphorylation efficiency was more pronounced in cells overexpressing APP than in control cells (Rhein et al., <xref rid="B204" ref-type="bibr">2010</xref>). This suggests that Ginkgo extract may be effective specifically in AD therapy. The extract also protected rodent neurons and glial cells against cerebral ischemia/reperfusion or scopolamine-induced toxicity (Chandrasekaran et al., <xref rid="B42" ref-type="bibr">2003</xref>; Domor&#x000e1;kov&#x000e1; et al., <xref rid="B67" ref-type="bibr">2006</xref>; Paganelli et al., <xref rid="B183" ref-type="bibr">2006</xref>; Jahanshahi et al., <xref rid="B122" ref-type="bibr">2012</xref>, <xref rid="B121" ref-type="bibr">2013</xref>). Moreover, EGb761 enhanced the functional integrity and protected cerebral microvascular endothelial cells cultured <italic>in vitro</italic> from damage (Yan et al., <xref rid="B262" ref-type="bibr">2008</xref>; Wan et al., <xref rid="B248" ref-type="bibr">2014</xref>). These effects may be related to a known antiplatelet activity of Gingko extract (Kim et al., <xref rid="B130" ref-type="bibr">2011</xref>). Antiplatelet agents are proposed as a possible therapeutics for vascular syndromes (Geeganage et al., <xref rid="B87" ref-type="bibr">2010</xref>; Heim et al., <xref rid="B99" ref-type="bibr">2017</xref>). Thus, EGb761 may counteract dysfunction of neurovascular unit, which is one of the pathologies associated with AD (Farkas and Luiten, <xref rid="B78" ref-type="bibr">2001</xref>; Zlokovic, <xref rid="B282" ref-type="bibr">2011</xref>).</p><p>The use of Ginkgo for the treatment of several cerebral dysfunctions connected to neurodegenerative dementia and brain aging has a long history (Abdou et al., <xref rid="B3" ref-type="bibr">2016</xref>). Studies performed on several animal models suggest that Gingko extract may enhance the cognitive and behavioral functions in aged individuals and Parkinson's disease patients (Kim et al., <xref rid="B132" ref-type="bibr">2004</xref>; Takuma et al., <xref rid="B235" ref-type="bibr">2007</xref>; Ribeiro et al., <xref rid="B205" ref-type="bibr">2016</xref>). Apart from the animal studies, several clinical trials also reported the lack of significant adverse effects and effectiveness of EGb 761 in the therapy of AD and vascular dementia (Kanowski et al., <xref rid="B126" ref-type="bibr">1996</xref>; Napryeyenko et al., <xref rid="B170" ref-type="bibr">2009</xref>; Ihl et al., <xref rid="B115" ref-type="bibr">2012</xref>). Although the gingko extract seems to be beneficial for the treatment of cognitive impairments, further studies are required to assess its possible interaction with other drugs. Such studies may translate to better efficacy and safety of gingko extract therapy. Few important interactions between Ginkgo constituents and drugs are currently known (Izzo, <xref rid="B120" ref-type="bibr">2012</xref>). Nevertheless, there are reports of single patients, which suffered serious neurological side effects after administering Ginkgo herb along with risperidone, valproic acid/phenytoin or trazodone (Izzo, <xref rid="B120" ref-type="bibr">2012</xref>). In summary, Ginkgo extract shows neuroprotective effect, which may be underlined by its antioxidative and/or antiplatelet activities. Clinical studies confirm the effectiveness of Ginkgo extract for dementia treatment. Thus, we speculate that some Ginkgo-based drugs may reach the market in near future.</p></sec><sec><title><italic>Panax ginseng</italic> C.A. Meyer (ginseng)</title><p>Ginseng is broadly used as an additive for dietary supplements or medicines. It serves as an adaptogen, which is a substance promoting homeostasis and protecting against various biological stressors. The dried root of this plant was used in the traditional medicine mainly in China and Korea (Yun, <xref rid="B272" ref-type="bibr">2001</xref>). There are several species of <italic>Panax</italic> including <italic>P. ginseng</italic> (Oriental ginseng), <italic>P. japonicus</italic> (Japanese ginseng), <italic>P. quinquefolius</italic> (American ginseng), <italic>P. trifolius, P. notoginseng</italic> (Burkill), and <italic>P. major</italic> (Ngan et al., <xref rid="B175" ref-type="bibr">1999</xref>). <italic>Panax ginseng</italic> CA Meyer is the most frequently used and extensively researched species of ginseng (Lee et al., <xref rid="B142" ref-type="bibr">2005</xref>). The species is widely distributed in the northeastern part of China. The plant has been used in traditional Chinese medicine for a more than 2000 years as a tonic for fatigue, weakness and aging (Wang et al., <xref rid="B254" ref-type="bibr">2010</xref>). Some constituents of this plant, such as ginsenosides Rg1 and Rg3 (Figure <xref ref-type="fig" rid="F5">5</xref>) and ginseng polysaccharides, have been investigated for their therapeutic potential (Yin et al., <xref rid="B270" ref-type="bibr">2013</xref>; Song et al., <xref rid="B225" ref-type="bibr">2017</xref>; Sun et al., <xref rid="B229" ref-type="bibr">2017</xref>). The neuroprotective effect of ginseng is mainly attributed to the 20(<italic>S</italic>)-ginsenoside Rg3 (Figure <xref ref-type="fig" rid="F5">5</xref>), which has a steroidal backbone structure with carbohydrate part and aliphatic side chain (Yang et al., <xref rid="B266" ref-type="bibr">2009</xref>). Rg3 is generated by heating the roots at high temperature (Popovich and Kitts, <xref rid="B191" ref-type="bibr">2004</xref>; Sun et al., <xref rid="B230" ref-type="bibr">2010</xref>).</p><fig id="F5" position="float"><label>Figure 5</label><caption><p>Phytochemical constituents of ginseng.</p></caption><graphic xlink:href="fnagi-10-00003-g0005"/></fig><p>A significant reduction of the amyloid-&#x003b2;40 and amyloid-&#x003b2;42 levels was reported after the ginsenoside Rg3 treatment in the brains of transgenic mice (Tg2576 line), as well as in cultured cells (Chen et al., <xref rid="B46" ref-type="bibr">2006</xref>). Ginsenoside Rg3 also protects against glutamate-induced neurotoxicity in cultured cortical neurons (Kim et al., <xref rid="B134" ref-type="bibr">1998</xref>). Similarly, another ginseng constituent ginsenoside Rg1 (GRg1) suppressed A&#x003b2;-induced neurotoxicity, likely through p38 pathway activation in neuroblastoma cells (Li et al., <xref rid="B143" ref-type="bibr">2012</xref>). Ginsenosides also regulate nicotinic acetylcholine receptor channel activity (Nah, <xref rid="B168" ref-type="bibr">2014</xref>). As acetylcholine signaling mediates learning and memory, modulation of acetylcholine receptor activity may be involved in the compound effectiveness against dementia (Bartus et al., <xref rid="B22" ref-type="bibr">1982</xref>; Giacobini, <xref rid="B88" ref-type="bibr">2004</xref>). The ginseng extract specifically enriched with ginsenoside Rg3 rescues scopolamine-induced memory impairment possibly through modulation of the AChE activity and the NF-&#x003ba;B signaling pathway in the hippocampus of mice (Kim et al., <xref rid="B131" ref-type="bibr">2016</xref>). NF-&#x003ba;B is a protein complex, which regulates neuroinflammation and is activated by ROS (Kaur et al., <xref rid="B128" ref-type="bibr">2015</xref>). On a similar note, GRg1 reduces the A&#x003b2;-associated generation of ROS and cell death (Wang and Du, <xref rid="B253" ref-type="bibr">2009</xref>). Correspondingly, many publications show protective effect of ginseng constituents on brain mitochondrial activity under multiple toxic conditions, including ischemia (Ye et al., <xref rid="B268" ref-type="bibr">2011</xref>), calcium treatment (Tian et al., <xref rid="B240" ref-type="bibr">2009</xref>; Zhou et al., <xref rid="B275" ref-type="bibr">2014</xref>), hydrogen peroxide treatment (Tian et al., <xref rid="B240" ref-type="bibr">2009</xref>), and even incubation of cells with A&#x003b2; <italic>in vitro</italic> (Ma et al., <xref rid="B153" ref-type="bibr">2014</xref>).</p><p>A recent meta-analysis of randomized clinical trials showed inconsistent effect of ginseng on AD (Wang et al., <xref rid="B255" ref-type="bibr">2016</xref>). Generally, the trials suffered from small sample size and poor design, including lack of placebo groups (Wang et al., <xref rid="B255" ref-type="bibr">2016</xref>). Thus, there is a need of larger trials to determine the efficacy of ginseng in AD.</p><p>In summary, ginseng constituents are suggested to modulate a number of dementia-related mechanisms, such as amyloid-&#x003b2; metabolism, oxidative stress, neuroinflammation, and acetylcholine signaling. Unfortunately, the effect of gingseng on dementia patients remains poorly understood despite some efforts.</p></sec><sec><title>Curcuminoids from genus curcuma</title><p>The genus Curcuma (commonly termed as Turmeric) comprises around 80 species and is considered as one of the biggest genera of the <italic>Zingiberaceae</italic> family (Sirirugsa et al., <xref rid="B223" ref-type="bibr">2007</xref>). Curcumin and its curcuminoid analogs, demethoxycurcumin and bisdemethoxycurcumin, are responsible for the typically yellow color of turmeric (Chin et al., <xref rid="B49" ref-type="bibr">2013</xref>). However, the main bioactive phytoconstituent of Curcuma genus is curcumin (Figure <xref ref-type="fig" rid="F6">6</xref>).</p><fig id="F6" position="float"><label>Figure 6</label><caption><p>Chemical structures of curcuminoids.</p></caption><graphic xlink:href="fnagi-10-00003-g0006"/></fig><p>It is an approved natural food colorant (E100) and can be easily obtained from turmeric through solvent extraction and crystallization (Chin et al., <xref rid="B49" ref-type="bibr">2013</xref>). Furthermore, curcumin is widely used in traditional Indian medicine for the treatment of anorexia, hepatic diseases, cold, cough, and other disorders (Chin et al., <xref rid="B49" ref-type="bibr">2013</xref>; Huminiecki et al., <xref rid="B109" ref-type="bibr">2017</xref>). Nowadays, <italic>in vivo</italic> studies suggest that curcumin has potential neuroprotective properties including antioxidant, anti-neuroinflammatory, antiproliferative, anti-amyloidogenic, and neuro-regulative effects (Chin et al., <xref rid="B49" ref-type="bibr">2013</xref>). A large epidemiological Indo-US Cross National Dementia study showed that the peasant Indian population has a low prevalence of AD and AD-associated dementia compared to the US population, and that may be linked to the high curcumin consumption in the Indian population (Chin et al., <xref rid="B49" ref-type="bibr">2013</xref>), although such correlation does not necessarily imply causative connection.</p><p>Curcumin is comprised of two feruloyl moieties with 3-methoxy-4-hydroxy substituents (Figure <xref ref-type="fig" rid="F7">7A</xref>; Sahne et al., <xref rid="B213" ref-type="bibr">2017</xref>). Both side units are linked together by an unsaturated seven-carbon spacer that includes a &#x003b2;-diketo function so that the molecule of curcumin is almost symmetric. Depending on pH of the environment, curcumin can exist in two possible tautomeric forms: enol and diketo (Sahne et al., <xref rid="B213" ref-type="bibr">2017</xref>). The keto form is predominant in acidic and neutral media (pH &#x02264; 7.4) as well as in solid state, while in non-polar and basic milieu (pH &#x02265; 8.0) the enol form is occurring (Sahne et al., <xref rid="B213" ref-type="bibr">2017</xref>). Moreover, the enol form co-exists in two equivalent tautomers that undergo intramolecular hydrogen transfer (Figure <xref ref-type="fig" rid="F7">7B</xref>; Anjomshoa et al., <xref rid="B13" ref-type="bibr">2016</xref>). Under physiological conditions (pH ~7.4) curcumin can reach its 1,3-keto-enol equilibrium state. Some of the most important antioxidant properties of curcumin and its ability to scavenge ROS are associated with the stability and the antioxidative capability of the methoxy phenolic type groups that are present. The structural features of curcumin including its tautomeric forms and pharmacophores are present in Figure <xref ref-type="fig" rid="F7">7</xref>.</p><fig id="F7" position="float"><label>Figure 7</label><caption><p>Tautomerism of curcumin: <bold>(A)</bold> Diketo and 1,3-keto-enol equilibrium form of curcumin with its biologically relevant structural units. <bold>(B)</bold> Hydrogen transfer in the most stable enol form.</p></caption><graphic xlink:href="fnagi-10-00003-g0007"/></fig><p>Curcumin suppresses tumor necrosis factor (TNF) activity, formation of A&#x003b2; plaques and protects brain cells from noxious agents (Belkacemi et al., <xref rid="B24" ref-type="bibr">2011</xref>). In recent years, the natural polyphenols are being implemented in the treatment of different neurological disorders (Pathak et al., <xref rid="B187" ref-type="bibr">2013</xref>; H&#x000fc;gel and Jackson, <xref rid="B108" ref-type="bibr">2015</xref>).</p><p>Curcumin-enriched diet enhances memory and hippocampal neurogenesis in aged rats (Dong et al., <xref rid="B68" ref-type="bibr">2012</xref>). This effect may be mediated by curcumin-induced modulation of expression of genes involved in cell growth and synaptic plasticity (Dong et al., <xref rid="B68" ref-type="bibr">2012</xref>). Neuroprotective properties of curcumin are often attributed to its anti-inflammatory, antioxidant and lipophilic potential (Mishra and Palanivelu, <xref rid="B163" ref-type="bibr">2008</xref>). For example, enhanced hippocampal expression of pro-inflammatory proteins TNF-&#x003b1; and IL-1 beta, which was caused by intracerebroventricular infusion of A&#x003b2;42 peptide solution, was at least partially normalized by infusion with curcumin-loaded lipid-core nanocapsules (but not free curcumin) (Hoppe et al., <xref rid="B101" ref-type="bibr">2013a</xref>). Similarly, in neuroblastoma cells, curcumin suppressed the radiation-induced increase in activity of the pro-neuroinflammatory complex NF-&#x003ba;B (Aravindan et al., <xref rid="B15" ref-type="bibr">2008</xref>). Activity of the neuroinflammation- and oxidative damage-related proteins NF-&#x003ba;B, Nrf2, and Sirt1 was also regulated in presence of curcumin in human neuroblastoma cells (Doggui et al., <xref rid="B65" ref-type="bibr">2013</xref>). Curcumin treatment reduces ROS level in neuroblastoma cell lines treated with the noxious agent acrolein and in rat primary neurons with induced Ab42 hyper-expression (Ye and Zhang, <xref rid="B267" ref-type="bibr">2012</xref>; Doggui et al., <xref rid="B65" ref-type="bibr">2013</xref>). Curcumin protects mitochondria from noxious factors such as oxidative stress and rotenone (inhibitor of electron transport chain) <italic>in vitro</italic> (Daverey and Agrawal, <xref rid="B59" ref-type="bibr">2016</xref>; Ramkumar et al., <xref rid="B200" ref-type="bibr">2017</xref>). It also alleviates the age-associated loss of mitochondrial and oxidative activity in rodent brains (Dkhar and Sharma, <xref rid="B64" ref-type="bibr">2010</xref>; Eckert et al., <xref rid="B74" ref-type="bibr">2013</xref>; Rastogi et al., <xref rid="B201" ref-type="bibr">2014</xref>). Curcumin also was shown to stimulate Sirt1 and Bcl-2 expression and to decrease brain cell death in experimental stroke (Miao et al., <xref rid="B161" ref-type="bibr">2016</xref>). Reports also show that curcumin increases cell viability at low dosages (Ye and Zhang, <xref rid="B267" ref-type="bibr">2012</xref>) and binds A&#x003b2; peptides, thus preventing them from aggregation into A&#x003b2; plaques (Yanagisawa et al., <xref rid="B264" ref-type="bibr">2011</xref>). Due to its lipophillic properties, the curcumin can cross the BBB, bind to the plaques and decrease the &#x003b2;-amyloid plaques in AD by inducing phagocytosis of A&#x003b2; (Mishra and Palanivelu, <xref rid="B163" ref-type="bibr">2008</xref>). Some of the curcumin derived pyrazoles and isoxazoles also bind to A&#x003b2;42 (Figure <xref ref-type="fig" rid="F8">8</xref>; Narlawar et al., <xref rid="B171" ref-type="bibr">2008</xref>).</p><fig id="F8" position="float"><label>Figure 8</label><caption><p>Neuroprotective effects of curcumin.</p></caption><graphic xlink:href="fnagi-10-00003-g0008"/></fig><p>Curcumin treatment decreases A&#x003b2;40/42 and PSEN1 protein and mRNA levels in APP-overexpressing neuroblastoma cells (Xiong et al., <xref rid="B259" ref-type="bibr">2011</xref>). Curcumin derivatives also increased the uptake of A&#x003b2; by macrophages, which were isolated from blood of AD patients and cultivated <italic>in vitro</italic> (Zhang et al., <xref rid="B274" ref-type="bibr">2006</xref>). This is a relevant information, because peripheral macrophages are known to infiltrate brains of AD patients and participate in clearance of amyloid plaques (Gate et al., <xref rid="B86" ref-type="bibr">2010</xref>). Moreover, in human neuroblastoma cells curcumin inhibits A&#x003b2;-induced tau phosphorylation likely via PTEN/Akt/GSK-3&#x003b2; pathway (Huang et al., <xref rid="B107" ref-type="bibr">2014</xref>). Other researchers report, that Akt/GSK-3&#x003b2; and ERK pathways mediate the protective effect of curcumin on A&#x003b2; induced memory impairments (Hoppe et al., <xref rid="B102" ref-type="bibr">2013b</xref>; Zhang et al., <xref rid="B273" ref-type="bibr">2015</xref>). Curcumin treatment also improved hippocampal-dependent memory of A&#x003b2;-infused rats (Hoppe et al., <xref rid="B102" ref-type="bibr">2013b</xref>).</p><p>A systematic review by Brondino et al. showed, that the few clinical trials studying the effect of curcumin on AD yielded inconclusive results (Brondino et al., <xref rid="B31" ref-type="bibr">2014</xref>). Although curcumin was found to be safe during short-term use, future clinical studies need to determine its long-term safety and efficacy on human subjects (Brondino et al., <xref rid="B31" ref-type="bibr">2014</xref>). Since the systematic review arrival, another clinical study was published on the topic, showing improvement of working memory and mood after curcumin treatment in a fairly small group of elderly participants (Cox et al., <xref rid="B53" ref-type="bibr">2015</xref>). There is also a study showing correlation between consumption of curcumin-containing spice&#x02014;curry&#x02014;with cognitive performance in elderly (Ng et al., <xref rid="B173" ref-type="bibr">2006</xref>). This finding should be taken with a grain of salt in context of curcumin-dementia research, as curcumin concentration in curry is fairly low (Tayyem et al., <xref rid="B238" ref-type="bibr">2006</xref>) and the extent of biologically available curcumin ingested with curry is disputed. Co-administration of curcumin and donepezil (reversible cholinesterase inhibitor) had synergistic effect on cognition and oxidative stress (Akinyemi et al., <xref rid="B8" ref-type="bibr">2017</xref>). Combined donepezil/curcumin therapeutic also showed good BBB permeability (Yan et al., <xref rid="B263" ref-type="bibr">2017</xref>). Concluding, curcumin protects brain cells against damage induced by oxidative stress and A&#x003b2; pathology. These properties may underlie beneficial effects of curcumin for treatment of dementia symptoms, as seen in animal model studies. The data suggest, that curcumin may be a promising candidate for novel dementia medication, but conclusive clinical research that could verify this hypothesis is still lacking. Moreover, to date, researchers analyzed the efficacy of curcumin exclusively against AD-associated dementia, leaving out other dementias.</p></sec><sec><title><italic>Glycyrrhiza</italic> genus</title><p>Genus <italic>Glycyrrhiza</italic>, also known as licorice (liquorice), is a member of Fabaceae family and consists of about 30 species. Most of the plants of this genus are perennial herbs native to Mediterranean region, Asia, Southern Russia, and Iran (Asl and Hosseinzadeh, <xref rid="B16" ref-type="bibr">2008</xref>). The <italic>Glycyrrhiza</italic> species are cultivated all throughout Europe and Asia (Blumenthal et al., <xref rid="B29" ref-type="bibr">2000</xref>; Asl and Hosseinzadeh, <xref rid="B16" ref-type="bibr">2008</xref>). The licorice roots and rhizomes are used worldwide as natural sweetener and a herbal medicine mainly for the therapy of autoimmune hepatitis C, jaundice, peptic ulcer, and skin diseases such as atopic dermatitis and inflammation-induced hyperpigmentation (Asl and Hosseinzadeh, <xref rid="B16" ref-type="bibr">2008</xref>; Callender et al., <xref rid="B37" ref-type="bibr">2011</xref>; Tewari et al., <xref rid="B239" ref-type="bibr">2017</xref>); further studies suggest that licorice roots may also have pharmacologically useful properties such as anticancer, antioxidative, anti-inflammatory, antiviral, antimicrobial, hepato- and cardioprotectitve effects (Asl and Hosseinzadeh, <xref rid="B16" ref-type="bibr">2008</xref>; Waltenberger et al., <xref rid="B247" ref-type="bibr">2016</xref>). The main bioactive phytoconstituents of <italic>Glycyrrhiza glabra</italic> (liquorice) root are the sweet-tasting triterpene saponin glycyrrhizin (glycyrrhizic acid) and the phenolic type compound isoliquiritigenin (Figure <xref ref-type="fig" rid="F9">9</xref>). Other important constituents also include several isoflavonoid derivatives such as shinpterocarpin, glabrone, glabridin, galbrene, lico-isoflavones A and B (Asl and Hosseinzadeh, <xref rid="B16" ref-type="bibr">2008</xref>).</p><fig id="F9" position="float"><label>Figure 9</label><caption><p>Chemical structures of the major phytoconstituents of <italic>Glycyrrhiza glabra</italic>.</p></caption><graphic xlink:href="fnagi-10-00003-g0009"/></fig><p>Due to their antioxidative properties, several species of <italic>Glycyrrhiza</italic> were investigated for possible therapeutic effects as neuroprotectants against neurodegenerative disorders such as PD, AD, and dementia. For example, extract from <italic>Glycyrrhiza inflata</italic> prevents tau misfolding <italic>in vitro</italic> (Chang et al., <xref rid="B44" ref-type="bibr">2016</xref>). Thus, the extract of this plant may be effective against various taupathies and AD. <italic>G. inflata</italic> extract decreased oxidative stress in cell models of spinocerebellar ataxia type 3 (SCA3), also known as Machado-Joseph disease (MJD), by upregulating the activity of PPARGC1A and the NFE2L2-ARE pathway (Chen et al., <xref rid="B45" ref-type="bibr">2014</xref>). Glycyrrhizin prevents cytotoxicity, ROS generation and downregulation of glutathione (GSH), which are elicited by 1-methyl-4-phenylpyridinium (MPP<sup>+</sup>) (Yim et al., <xref rid="B269" ref-type="bibr">2007</xref>). MPP+ is a neurotoxic substance acting via interference with the mitochondrial oxidative phosphorylation (Yim et al., <xref rid="B269" ref-type="bibr">2007</xref>). The GSH downregulation is noteworthy, because it is a crucial element of the antioxidative system of the brain (Dringen, <xref rid="B71" ref-type="bibr">2000</xref>). Increased oxidative stress in dementia is attributed to dwindled levels of GSH (Yim et al., <xref rid="B269" ref-type="bibr">2007</xref>; Saharan and Mandal, <xref rid="B212" ref-type="bibr">2014</xref>). Similarly, <italic>G. inflata</italic> extract was shown to inhibit oxidative stress <italic>in vitro</italic> (Chang et al., <xref rid="B44" ref-type="bibr">2016</xref>). The brain cells are susceptible to the oxidative stress. The effect of licorice extract on the oxidative stress may be connected to the beneficial effect of isoliquiritigenin on mitochondrial function (Yang et al., <xref rid="B265" ref-type="bibr">2012</xref>). Licorice may reduce the damage to the brain cells, improve the neuronal function and prevent the memory impairment by diminishing oxidative stress associated with several dementia types (Ju et al., <xref rid="B124" ref-type="bibr">1989</xref>; Dhingra et al., <xref rid="B63" ref-type="bibr">2004</xref>).</p><p>Figure <xref ref-type="fig" rid="F10">10</xref> summarizes the valuable effects of licorice root extract that may be useful for the treatment of dementia and/or AD-related dementia. Some authors suggest that memory-enhancing activity of the licorice root extract may be connected to its anti-inflammatory effect (Yokota et al., <xref rid="B271" ref-type="bibr">1998</xref>; Dhingra et al., <xref rid="B63" ref-type="bibr">2004</xref>). This data is in agreement with the known tight relationship between inflammation and oxidative stress (Dandekar et al., <xref rid="B57" ref-type="bibr">2015</xref>). <italic>Glycyrrhiza</italic> is used in various polyherbal formulations. One of such formulations used in traditional Japanese Kampo medicine is yokukansan, which is composed of seven different plants including <italic>Glycyrrhiza uralensis</italic> Fisher. <italic>Glycyrrhiza</italic> extract antagonizes &#x003b1;2A adrenoceptors (Ikarashi and Mizoguchi, <xref rid="B116" ref-type="bibr">2016</xref>). Several phytoconstituents of <italic>Glycyrrhiza</italic>: glycyrrhizin, glycycoumarin, liquiritin and isoliquiritigenin show neuroprotective effects when applied as a component of the yokukansan (Ikarashi and Mizoguchi, <xref rid="B116" ref-type="bibr">2016</xref>). Isoliquiritigenin inhibited the activity of the NMDA receptors (Ikarashi and Mizoguchi, <xref rid="B116" ref-type="bibr">2016</xref>). Noteworthy, memantine, an important synthetic drug against dementia, also shows antagonism for NMDA receptors (Danysz and Parsons, <xref rid="B58" ref-type="bibr">2003</xref>). Moreover, the neuroprotective effect of glycycoumarin may be due to its ability to suppress the pro-apoptotic activity of caspase-3 (Kanno et al., <xref rid="B125" ref-type="bibr">2015</xref>; Ikarashi and Mizoguchi, <xref rid="B116" ref-type="bibr">2016</xref>).</p><fig id="F10" position="float"><label>Figure 10</label><caption><p>A simplified representation of the neuroprotective effects of licorice for dementia treatment.</p></caption><graphic xlink:href="fnagi-10-00003-g0010"/></fig><p>Extract from another <italic>Glycyrrhiza</italic> species&#x02014;<italic>Glycyrrhiza glabra&#x02014;</italic>improved the learning ability of mice after 7 days of oral administration (Parle et al., <xref rid="B184" ref-type="bibr">2004</xref>). However, another study reported the paradoxical sedative properties of the extract (Hikino, <xref rid="B100" ref-type="bibr">1985</xref>). This shows that the <italic>G. glabra</italic> extract is useful for the improvement of the learning ability but its dose should be established carefully to prevent the sedative effects. A glycyrrhizin salt, diammonium-glycyrrhizinate, prevented the mitochondrial and cognitive dysfunctions induced by A&#x003b2;42 in mice (Zhu et al., <xref rid="B280" ref-type="bibr">2012</xref>). Although not yet proven in context of brain function, licorice constituents have a potential to interact with other drugs because of its modulating activity of P450 proteins, which belong to the main regulators of xenobiotic metabolism (Qiao et al., <xref rid="B195" ref-type="bibr">2014</xref>). In summary, glycyrrhiza extracts show anti-inflammatory and antioxidative properties and modulate glutamate signaling and apoptosis. Similarly to above described herbal medicines curcumin and ginseng, despite animal model-based evidence for glycyrrhiza effectiveness in regulating cognitive deficits, there are currently no studies on effectiveness of this plant for dementia therapy in patients.</p></sec><sec><title><italic>Camellia sinensis</italic> Kuntze</title><p><italic>Camellia sinensis</italic> Kuntze (green tea) brew is one of the most extensively consumed beverages in the world (Goenka et al., <xref rid="B90" ref-type="bibr">2013</xref>). Several beneficial effects of green tea consumption are reported for various conditions like obesity, diabetes, inflammation, coronary artery disease, stroke and some malignancies (de Mejia et al., <xref rid="B62" ref-type="bibr">2009</xref>; Chacko et al., <xref rid="B40" ref-type="bibr">2010</xref>). Consumption of green tea-related compounds [e.g., (-)-epigallocatechin-3-gallate] improves cognitive functions and prevents memory impairment in animals and humans (Rezai-Zadeh et al., <xref rid="B203" ref-type="bibr">2008</xref>; de Mejia et al., <xref rid="B62" ref-type="bibr">2009</xref>; Mandel et al., <xref rid="B156" ref-type="bibr">2011</xref>).</p><p>Around one-third out of 4,000 bioactive compounds of <italic>C. sinensis</italic> are polyphenols (Mahmood et al., <xref rid="B155" ref-type="bibr">2010</xref>). The gene expression and activity of the membrane metalloendopeptidase (MME) were enhanced by green tea extract. Several MME are capable of degrading A&#x003b2; peptides (Wang et al., <xref rid="B251" ref-type="bibr">2006</xref>). Pretreatment by infusion with extract of green tea leaves into the left hippocampus of a rat prevented cognitive impairments and superoxide dismutase activity changes, and corrected deregulated activity of pro-inflammatory enzyme COX and AChE, which were induced by injecting AlCl<sub>3</sub> into the same brain area (Jelenkovic et al., <xref rid="B123" ref-type="bibr">2014</xref>). When injected i.p. L-theanine, one of the amino acid components of <italic>C. sinensis</italic>, protects against memory impairment and cell death caused by ischemia (Egashira et al., <xref rid="B75" ref-type="bibr">2007</xref>, <xref rid="B76" ref-type="bibr">2008</xref>). Interestingly, chronic ingestion of L-theanine in rats also caused improvement in cognitive functions (Yamada et al., <xref rid="B260" ref-type="bibr">2008</xref>) and decreased oxidation levels in the brain of the rats (Nishida et al., <xref rid="B178" ref-type="bibr">2008</xref>). Similarly, in transgenic mouse AD model, the green tea constituent epigallocatechin-3-gallate normalized the dysregulated ROS production, as well as mitochondrial respiration and MMP (Dragicevic et al., <xref rid="B70" ref-type="bibr">2011</xref>). Generally, L-theanine is an <italic>N</italic>-amino-ethylated analog of the proteinogenic neurotransmitter L-glutamic acid and its precursor L-glutamine (Figure <xref ref-type="fig" rid="F11">11</xref>). L-theanine protects against A&#x003b2;42-induced memory deficits and death of cortical and hippocampal cells, possibly by suppressing the ERK/p38 and NF-&#x003ba;B signaling pathways and reducing the oxidative damage (Kim et al., <xref rid="B133" ref-type="bibr">2009</xref>).</p><fig id="F11" position="float"><label>Figure 11</label><caption><p>Chemical structures of the nootropic drug L-Theanine and its proteinogenic amino acid analogs.</p></caption><graphic xlink:href="fnagi-10-00003-g0011"/></fig><p>Daily consumption of green tea is hypothesized to reduce the risk of AD and age-related dementia (Ayoub and Melzig, <xref rid="B18" ref-type="bibr">2006</xref>). In some clinical studies, L-theanine improved the cognitive functions and mood in combination with caffeine in healthy human subjects (Haskell et al., <xref rid="B98" ref-type="bibr">2008</xref>; Owen et al., <xref rid="B182" ref-type="bibr">2008</xref>). On the other hand, the results of studies on the effects of L-theanine alone on mood are inconclusive (Kimura et al., <xref rid="B135" ref-type="bibr">2007</xref>; Haskell et al., <xref rid="B98" ref-type="bibr">2008</xref>). Green tea catechins can regulate activity of P-glycoprotein (Zhou et al., <xref rid="B276" ref-type="bibr">2004</xref>), which may influence brain availability of co-administered substances. Summarizing, green tea extract shows antiapoptotic and antioxidative activities and may even directly inhibit A&#x003b2; plaque formation. Moreover, several human studies provide credibility to the hypothesis that green tea constituents may be effective for modulation of human cognition and perhaps in dementia treatment.</p></sec></sec><sec sec-type="conclusions" id="s7"><title>Conclusions</title><p>In this work, we discuss that a large number of plants have been used for dementia treatment worldwide. The mechanisms of action of the reviewed five prominent representative plants generally involve anti-inflammatory, antioxidative, and antiapoptotic activity that are mainly associated with the neuroprotective effects of these plants or their bioactive constituents. Some of such naturally occurring compounds exhibit promising potential as alternative therapeutic strategies. For example, curcumin showed remarkable synergetic effects on cognition and oxidative stress, as well as good BBB permeability, when co-administrated with the approved reversible ChE inhibitor donepezil. Moreover, such combined donepezil/curcumin application may be useful for treatment of dementia symptoms, as seen in animal model studies. Furthermore, combined supplement treatment with some mitochondrial antioxidants, such as &#x003b1;-lipoic acid and acetyl-L-carnitine has been shown to reduce both physical and mental weariness or even to restore memory function in age-related diseases, including AD and different types of dementia, as provided in transgenic mouse model of AD. However, there are still many unknowns in this research area that need to be clarified by planning future studies. The scientific community needs more comprehensive research focused on identifying active ingredients of plants and investigating their mechanism of action. Such research will facilitate clinical studies evaluating the potential of the featured herbal products in dementia treatment. We conclude that further research on plants used in different ethnomedicinal practices and the traditional medicine could lead to the development of novel therapeutics for dementia and, therefore, is of a very high interest.</p></sec><sec id="s8"><title>Author contributions</title><p>DT, AMS, and AA have written the first draft of the manuscript. AM, ANS, LH, JH, and NT revised and improved the first draft. All authors have seen and agreed on the finally submitted version of the manuscript.</p><sec><title>Conflict of interest statement</title><p>Author NT was employed by NTZ Lab ltd. The other authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></sec></body><back><ack><p>The authors acknowledge the support by the Polish KNOW (Leading National Research Centre) Scientific Consortium &#x0201c;Healthy Animal&#x02014;Safe Food,&#x0201d; decision of Ministry of Science and Higher Education No. 05-1/KNOW2/2015.</p></ack><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abbott</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>Dementia: a problem for our age</article-title>. <source>Nature</source>
<volume>475</volume>, <fpage>S2</fpage>&#x02013;<lpage>S4</lpage>. <pub-id pub-id-type="doi">10.1038/475S2a</pub-id><?supplied-pmid 21760579?><pub-id pub-id-type="pmid">21760579</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdel-Kader</surname><given-names>R.</given-names></name><name><surname>Hauptmann</surname><given-names>S.</given-names></name><name><surname>Keil</surname><given-names>U.</given-names></name><name><surname>Scherping</surname><given-names>I.</given-names></name><name><surname>Leuner</surname><given-names>K.</given-names></name><name><surname>Eckert</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>Stabilization of mitochondrial function by <italic>Ginkgo biloba</italic> extract (EGb 761)</article-title>. <source>Pharmacol. Res.</source>
<volume>56</volume>, <fpage>493</fpage>&#x02013;<lpage>502</lpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2007.09.011</pub-id><?supplied-pmid 17977008?><pub-id pub-id-type="pmid">17977008</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdou</surname><given-names>H. M.</given-names></name><name><surname>Yousef</surname><given-names>M. I.</given-names></name><name><surname>El Mekkawy</surname><given-names>D. A.</given-names></name><name><surname>Al-Shami</surname><given-names>A. S.</given-names></name></person-group> (<year>2016</year>). <article-title>Prophylactic neuroprotective efficiency of co-administration of <italic>Ginkgo biloba</italic> and Trifolium pretense against sodium arsenite-induced neurotoxicity and dementia in different regions of brain and spinal cord of rats</article-title>. <source>Food Chem. Toxicol.</source>
<volume>94</volume>, <fpage>112</fpage>&#x02013;<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1016/j.fct.2016.05.015</pub-id><?supplied-pmid 27234133?><pub-id pub-id-type="pmid">27234133</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>M.</given-names></name><name><surname>Gm&#x000fc;nder</surname><given-names>F.</given-names></name><name><surname>Hamburger</surname><given-names>M.</given-names></name></person-group> (<year>2007</year>). <article-title>Plants traditionally used in age related brain disorders&#x02014;a survey of ethnobotanical literature</article-title>. <source>J. Ethnopharmacol.</source>
<volume>113</volume>, <fpage>363</fpage>&#x02013;<lpage>381</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2007.07.016</pub-id><?supplied-pmid 17720341?><pub-id pub-id-type="pmid">17720341</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adsersen</surname><given-names>A.</given-names></name><name><surname>Gauguin</surname><given-names>B.</given-names></name><name><surname>Gudiksen</surname><given-names>L.</given-names></name><name><surname>J&#x000e4;ger</surname><given-names>A. K.</given-names></name></person-group> (<year>2006</year>). <article-title>Screening of plants used in Danish folk medicine to treat memory dysfunction for acetylcholinesterase inhibitory activity</article-title>. <source>J. Ethnopharmacol.</source>
<volume>104</volume>, <fpage>418</fpage>&#x02013;<lpage>422</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2005.09.032</pub-id><?supplied-pmid 16280217?><pub-id pub-id-type="pmid">16280217</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahlemeyer</surname><given-names>B.</given-names></name><name><surname>Krieglstein</surname><given-names>J.</given-names></name></person-group> (<year>2003</year>). <article-title>Neuroprotective effects of <italic>Ginkgo biloba</italic> extract</article-title>. <source>Cell. Mol. Life Sci. C.</source>
<volume>60</volume>, <fpage>1779</fpage>&#x02013;<lpage>1792</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-003-3080-1</pub-id><?supplied-pmid 14523543?><pub-id pub-id-type="pmid">14523543</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akhondzadeh</surname><given-names>S.</given-names></name><name><surname>Noroozian</surname><given-names>M.</given-names></name><name><surname>Mohammadi</surname><given-names>M.</given-names></name><name><surname>Ohadinia</surname><given-names>S.</given-names></name><name><surname>Jamshidi</surname><given-names>A. H.</given-names></name><name><surname>Khani</surname><given-names>M.</given-names></name></person-group> (<year>2003</year>). <article-title>Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial</article-title>. <source>J. Clin. Pharm. Ther.</source>
<volume>28</volume>, <fpage>53</fpage>&#x02013;<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2710.2003.00463.x</pub-id><?supplied-pmid 12605619?><pub-id pub-id-type="pmid">12605619</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akinyemi</surname><given-names>A. J.</given-names></name><name><surname>Oboh</surname><given-names>G.</given-names></name><name><surname>Oyeleye</surname><given-names>S. I.</given-names></name><name><surname>Ogunsuyi</surname><given-names>O.</given-names></name></person-group> (<year>2017</year>). <article-title>Anti-amnestic effect of curcumin in combination with donepezil, an anticholinesterase drug: involvement of cholinergic system</article-title>. <source>Neurotox. Res.</source>
<volume>31</volume>, <fpage>560</fpage>&#x02013;<lpage>569</lpage>. <pub-id pub-id-type="doi">10.1007/s12640-017-9701-5</pub-id><?supplied-pmid 28102474?><pub-id pub-id-type="pmid">28102474</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alam</surname><given-names>M. M.</given-names></name><name><surname>Okazaki</surname><given-names>K.</given-names></name><name><surname>Nguyen</surname><given-names>L. T. T.</given-names></name><name><surname>Ota</surname><given-names>N.</given-names></name><name><surname>Kitamura</surname><given-names>H.</given-names></name><name><surname>Murakami</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Glucocorticoid receptor signaling represses the antioxidant response by inhibiting histone acetylation mediated by the transcriptional activator NRF2</article-title>. <source>J. Biol. Chem.</source>
<volume>292</volume>, <fpage>7519</fpage>&#x02013;<lpage>7530</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M116.773960</pub-id><?supplied-pmid 28314773?><pub-id pub-id-type="pmid">28314773</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albuquerque</surname><given-names>E. X.</given-names></name><name><surname>Santos</surname><given-names>M. D.</given-names></name><name><surname>Alkondon</surname><given-names>M.</given-names></name><name><surname>Pereira</surname><given-names>E. F.</given-names></name><name><surname>Maelicke</surname><given-names>A.</given-names></name></person-group> (<year>2001</year>). <article-title>Modulation of nicotinic receptor activity in the central nervous system: a novel approach to the treatment of Alzheimer disease</article-title>. <source>Alzheimer Dis. Assoc. Disord.</source>
<volume>15</volume>(<issue>Suppl. 1</issue>), <fpage>S19</fpage>&#x02013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1097/00002093-200108001-00004</pub-id><?supplied-pmid 11669505?><pub-id pub-id-type="pmid">11669505</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aminzadeh</surname><given-names>M.</given-names></name><name><surname>Roghani</surname><given-names>M.</given-names></name><name><surname>Sarfallah</surname><given-names>A.</given-names></name><name><surname>Riazi</surname><given-names>G. H.</given-names></name></person-group> (<year>2018</year>). <article-title>TRPM2 dependence of ROS-induced NLRP3 activation in Alzheimer's disease</article-title>. <source>Int. Immunopharmacol.</source>
<volume>54</volume>, <fpage>78</fpage>&#x02013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2017.10.024</pub-id><?supplied-pmid 29107864?><pub-id pub-id-type="pmid">29107864</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amri</surname><given-names>H.</given-names></name><name><surname>Ogwuegbu</surname><given-names>S. O.</given-names></name><name><surname>Boujrad</surname><given-names>N.</given-names></name><name><surname>Drieu</surname><given-names>K.</given-names></name><name><surname>Papadopoulos</surname><given-names>V.</given-names></name></person-group> (<year>1996</year>). <article-title><italic>In vivo</italic> regulation of peripheral-type benzodiazepine receptor and glucocorticoid synthesis by <italic>Ginkgo biloba</italic> extract EGb 761 and isolated ginkgolides</article-title>. <source>Endocrinology</source>
<volume>137</volume>, <fpage>5707</fpage>&#x02013;<lpage>5718</lpage>. <pub-id pub-id-type="doi">10.1210/endo.137.12.8940403</pub-id><?supplied-pmid 8940403?><pub-id pub-id-type="pmid">8940403</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anjomshoa</surname><given-names>S.</given-names></name><name><surname>Namazian</surname><given-names>M.</given-names></name><name><surname>Noorbala</surname><given-names>M. R.</given-names></name></person-group> (<year>2016</year>). <article-title>The effect of solvent on tautomerism, acidity and radical stability of curcumin and its derivatives based on thermodynamic quantities</article-title>. <source>J. Solution Chem.</source>
<volume>45</volume>, <fpage>1021</fpage>&#x02013;<lpage>1030</lpage>. <pub-id pub-id-type="doi">10.1007/s10953-016-0481-y</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antico Arciuch</surname><given-names>V. G.</given-names></name><name><surname>Elguero</surname><given-names>M. E.</given-names></name><name><surname>Poderoso</surname><given-names>J. J.</given-names></name><name><surname>Carreras</surname><given-names>M. C.</given-names></name></person-group> (<year>2012</year>). <article-title>Mitochondrial regulation of cell cycle and proliferation</article-title>. <source>Antioxid. Redox Signal.</source>
<volume>16</volume>, <fpage>1150</fpage>&#x02013;<lpage>1180</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2011.4085</pub-id><?supplied-pmid 21967640?><pub-id pub-id-type="pmid">21967640</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aravindan</surname><given-names>N.</given-names></name><name><surname>Madhusoodhanan</surname><given-names>R.</given-names></name><name><surname>Ahmad</surname><given-names>S.</given-names></name><name><surname>Johnson</surname><given-names>D.</given-names></name><name><surname>Herman</surname><given-names>T. S.</given-names></name></person-group> (<year>2008</year>). <article-title>Curcumin inhibits NF&#x003ba;B mediated radioprotection and modulate apoptosis related genes in human neuroblastoma cells</article-title>. <source>Cancer Biol. Ther.</source>
<volume>7</volume>, <fpage>569</fpage>&#x02013;<lpage>576</lpage>. <pub-id pub-id-type="doi">10.4161/cbt.7.4.5534</pub-id><?supplied-pmid 18305409?><pub-id pub-id-type="pmid">18305409</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asl</surname><given-names>M. N.</given-names></name><name><surname>Hosseinzadeh</surname><given-names>H.</given-names></name></person-group> (<year>2008</year>). <article-title>Review of pharmacological effects of <italic>Glycyrrhiza</italic> sp. and its bioactive compounds</article-title>. <source>Phyther. Res.</source>
<volume>22</volume>, <fpage>709</fpage>&#x02013;<lpage>724</lpage>. <pub-id pub-id-type="doi">10.1002/ptr.2362</pub-id><?supplied-pmid 18446848?><pub-id pub-id-type="pmid">18446848</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atanasov</surname><given-names>A. G.</given-names></name><name><surname>Waltenberger</surname><given-names>B.</given-names></name><name><surname>Pferschy-Wenzig</surname><given-names>E.-M.</given-names></name><name><surname>Linder</surname><given-names>T.</given-names></name><name><surname>Wawrosch</surname><given-names>C.</given-names></name><name><surname>Uhrin</surname><given-names>P.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Discovery and resupply of pharmacologically active plant-derived natural products: a review</article-title>. <source>Biotechnol. Adv.</source>
<volume>33</volume>, <fpage>1582</fpage>&#x02013;<lpage>1614</lpage>. <pub-id pub-id-type="doi">10.1016/j.biotechadv.2015.08.001</pub-id><?supplied-pmid 26281720?><pub-id pub-id-type="pmid">26281720</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ayoub</surname><given-names>S.</given-names></name><name><surname>Melzig</surname><given-names>M. F.</given-names></name></person-group> (<year>2006</year>). <article-title>Induction of neutral endopeptidase (NEP) activity of SK-N-SH cells by natural compounds from green tea</article-title>. <source>J. Pharm. Pharmacol.</source>
<volume>58</volume>, <fpage>495</fpage>&#x02013;<lpage>501</lpage>. <pub-id pub-id-type="doi">10.1211/jpp.58.4.0009</pub-id><?supplied-pmid 16597367?><pub-id pub-id-type="pmid">16597367</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ballard</surname><given-names>C.</given-names></name><name><surname>Howard</surname><given-names>R.</given-names></name></person-group> (<year>2006</year>). <article-title>Neuroleptic drugs in dementia: benefits and harm</article-title>. <source>Nat. Rev. Neurosci.</source>
<volume>7</volume>, <fpage>492</fpage>&#x02013;<lpage>500</lpage>. <pub-id pub-id-type="doi">10.1038/nrn1926</pub-id><?supplied-pmid 16715057?><pub-id pub-id-type="pmid">16715057</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baloh</surname><given-names>R. H.</given-names></name></person-group> (<year>2011</year>). <article-title>TDP-43: the relationship between protein aggregation and neurodegeneration in amyotrophic lateral sclerosis and frontotemporal lobar degeneration</article-title>. <source>FEBS J.</source>
<volume>278</volume>, <fpage>3539</fpage>&#x02013;<lpage>3549</lpage>. <pub-id pub-id-type="doi">10.1111/j.1742-4658.2011.08256.x</pub-id><?supplied-pmid 21777387?><pub-id pub-id-type="pmid">21777387</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banasch</surname><given-names>M.</given-names></name><name><surname>Ellrichmann</surname><given-names>M.</given-names></name><name><surname>Tannapfel</surname><given-names>A.</given-names></name><name><surname>Schmidt</surname><given-names>W. E.</given-names></name><name><surname>Goetze</surname><given-names>O.</given-names></name></person-group> (<year>2011</year>). <article-title>The non-invasive (13)C-methionine breath test detects hepatic mitochondrial dysfunction as a marker of disease activity in non-alcoholic steatohepatitis</article-title>. <source>Eur. J. Med. Res.</source>
<volume>16</volume>:<fpage>258</fpage>. <pub-id pub-id-type="doi">10.1186/2047-783X-16-6-258</pub-id><?supplied-pmid 21810560?><pub-id pub-id-type="pmid">21810560</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartus</surname><given-names>R. T.</given-names></name><name><surname>Dean</surname><given-names>R. L.</given-names><suffix>III.</suffix></name><name><surname>Beer</surname><given-names>B.</given-names></name><name><surname>Lippa</surname><given-names>A. S.</given-names></name></person-group> (<year>1982</year>). <article-title>The cholinergic hypothesis of geriatric memory dysfunction</article-title>. <source>Science</source>
<volume>217</volume>, <fpage>408</fpage>&#x02013;<lpage>414</lpage>. <pub-id pub-id-type="doi">10.1126/science.7046051</pub-id><?supplied-pmid 7046051?><pub-id pub-id-type="pmid">7046051</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beal</surname><given-names>M. F.</given-names></name></person-group> (<year>2005</year>). <article-title>Mitochondria take center stage in aging and neurodegeneration</article-title>. <source>Ann. Neurol.</source>
<volume>58</volume>, <fpage>495</fpage>&#x02013;<lpage>505</lpage>. <pub-id pub-id-type="doi">10.1002/ana.20624</pub-id><?supplied-pmid 16178023?><pub-id pub-id-type="pmid">16178023</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belkacemi</surname><given-names>A.</given-names></name><name><surname>Doggui</surname><given-names>S.</given-names></name><name><surname>Dao</surname><given-names>L.</given-names></name><name><surname>Ramassamy</surname><given-names>C.</given-names></name></person-group> (<year>2011</year>). <article-title>Challenges associated with curcumin therapy in Alzheimer disease</article-title>. <source>Expert Rev. Mol. Med.</source>
<volume>13</volume>, <fpage>e34</fpage>. <pub-id pub-id-type="doi">10.1017/S1462399411002055</pub-id><?supplied-pmid 22051121?><pub-id pub-id-type="pmid">22051121</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>S.</given-names></name><name><surname>Grant</surname><given-names>M. M.</given-names></name><name><surname>Aldred</surname><given-names>S.</given-names></name></person-group> (<year>2009</year>). <article-title>Oxidative stress in vascular dementia and Alzheimer's disease: a common pathology</article-title>. <source>J. Alzheimers. Dis.</source>
<volume>17</volume>, <fpage>245</fpage>&#x02013;<lpage>257</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-2009-1041</pub-id><?supplied-pmid 19221412?><pub-id pub-id-type="pmid">19221412</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berridge</surname><given-names>M. J.</given-names></name></person-group> (<year>1995</year>). <article-title>Calcium signalling and cell proliferation</article-title>. <source>Bioessays</source>
<volume>17</volume>, <fpage>491</fpage>&#x02013;<lpage>500</lpage>. <pub-id pub-id-type="doi">10.1002/bies.950170605</pub-id><?supplied-pmid 7575490?><pub-id pub-id-type="pmid">7575490</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berridge</surname><given-names>M. J.</given-names></name></person-group> (<year>2011</year>). <article-title>Calcium signalling and Alzheimer's disease</article-title>. <source>Neurochem. Res.</source>
<volume>36</volume>, <fpage>1149</fpage>&#x02013;<lpage>1156</lpage>. <pub-id pub-id-type="doi">10.1007/s11064-010-0371-4</pub-id><?supplied-pmid 21184278?><pub-id pub-id-type="pmid">21184278</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blennow</surname><given-names>K.</given-names></name><name><surname>de Leon</surname><given-names>M. J.</given-names></name><name><surname>Zetterberg</surname><given-names>H.</given-names></name></person-group> (<year>2006</year>). <article-title>Alzheimer's disease</article-title>. <source>Lancet (London, England)</source>
<volume>368</volume>, <fpage>387</fpage>&#x02013;<lpage>403</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(06)69113-7</pub-id><?supplied-pmid 16876668?><pub-id pub-id-type="pmid">16876668</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Blumenthal</surname><given-names>M.</given-names></name><name><surname>Goldberg</surname><given-names>A.</given-names></name><name><surname>Brinkmann</surname><given-names>J.</given-names></name></person-group> (<year>2000</year>). <source>Herbal Medicine, Expanded Commission E Monographs Cd-Rom.</source>
<publisher-loc>Austin, TX</publisher-loc>: <publisher-name>American Botanical Council/Integrative Medical</publisher-name>.</mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bridi</surname><given-names>R.</given-names></name><name><surname>Crossetti</surname><given-names>F. P.</given-names></name><name><surname>Steffen</surname><given-names>V. M.</given-names></name><name><surname>Henriques</surname><given-names>A. T.</given-names></name></person-group> (<year>2001</year>). <article-title>The antioxidant activity of standardized extract of <italic>Ginkgo biloba</italic> (EGb 761) in rats</article-title>. <source>Phytother. Res.</source>
<volume>15</volume>, <fpage>449</fpage>&#x02013;<lpage>451</lpage>. <pub-id pub-id-type="doi">10.1002/ptr.814</pub-id><?supplied-pmid 11507743?><pub-id pub-id-type="pmid">11507743</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brondino</surname><given-names>N.</given-names></name><name><surname>Re</surname><given-names>S.</given-names></name><name><surname>Boldrini</surname><given-names>A.</given-names></name><name><surname>Cuccomarino</surname><given-names>A.</given-names></name><name><surname>Lanati</surname><given-names>N.</given-names></name><name><surname>Barale</surname><given-names>F.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Curcumin as a therapeutic agent in dementia: a mini systematic review of human studies</article-title>. <source>Sci. World J.</source>
<volume>2014</volume>:<fpage>174282</fpage>. <pub-id pub-id-type="doi">10.1155/2014/174282</pub-id><?supplied-pmid 24578620?><pub-id pub-id-type="pmid">24578620</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brun</surname><given-names>A.</given-names></name></person-group> (<year>1987</year>). <article-title>Frontal lobe degeneration of non-Alzheimer type</article-title>. <source>I. Neuropathology. Arch. Gerontol. Geriatr.</source>
<volume>6</volume>, <fpage>193</fpage>&#x02013;<lpage>208</lpage>. <pub-id pub-id-type="doi">10.1016/0167-4943(87)90021-5</pub-id><?supplied-pmid 3689053?><pub-id pub-id-type="pmid">3689053</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burgess</surname><given-names>L.</given-names></name><name><surname>Page</surname><given-names>S.</given-names></name><name><surname>Hardman</surname><given-names>P.</given-names></name></person-group> (<year>2002</year>). <article-title>Changing attitudes in dementia care and the role of nurses</article-title>. <source>Nurs. Times</source>
<volume>99</volume>, <fpage>18</fpage>&#x02013;<lpage>19</lpage>. <?supplied-pmid 14562428?><pub-id pub-id-type="pmid">14562428</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burte</surname><given-names>F.</given-names></name><name><surname>Carelli</surname><given-names>V.</given-names></name><name><surname>Chinnery</surname><given-names>P. F.</given-names></name><name><surname>Yu-Wai-Man</surname><given-names>P.</given-names></name></person-group> (<year>2015</year>). <article-title>Disturbed mitochondrial dynamics and neurodegenerative disorders</article-title>. <source>Nat. Rev. Neurol.</source>
<volume>11</volume>, <fpage>11</fpage>&#x02013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2014.228</pub-id><?supplied-pmid 25486875?><pub-id pub-id-type="pmid">25486875</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butterfield</surname><given-names>D. A.</given-names></name><name><surname>Swomley</surname><given-names>A. M.</given-names></name><name><surname>Sultana</surname><given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>Amyloid beta-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression</article-title>. <source>Antioxid. Redox Signal.</source>
<volume>19</volume>, <fpage>823</fpage>&#x02013;<lpage>835</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2012.5027</pub-id><?supplied-pmid 23249141?><pub-id pub-id-type="pmid">23249141</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>H.</given-names></name><name><surname>Cong</surname><given-names>W.</given-names></name><name><surname>Ji</surname><given-names>S.</given-names></name><name><surname>Rothman</surname><given-names>S.</given-names></name><name><surname>Maudsley</surname><given-names>S.</given-names></name><name><surname>Martin</surname><given-names>B.</given-names></name></person-group> (<year>2012</year>). <article-title>Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disorders</article-title>. <source>Curr. Alzheimer Res.</source>
<volume>9</volume>, <fpage>5</fpage>&#x02013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.2174/156720512799015064</pub-id><?supplied-pmid 22329649?><pub-id pub-id-type="pmid">22329649</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Callender</surname><given-names>V. D.</given-names></name><name><surname>St Surin-Lord</surname><given-names>S.</given-names></name><name><surname>Davis</surname><given-names>E. C.</given-names></name><name><surname>Maclin</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Postinflammatory hyperpigmentation: etiologic and therapeutic considerations</article-title>. <source>Am. J. Clin. Dermatol.</source>
<volume>12</volume>, <fpage>87</fpage>&#x02013;<lpage>99</lpage>. <pub-id pub-id-type="doi">10.2165/11536930-000000000-00000</pub-id><?supplied-pmid 21348540?><pub-id pub-id-type="pmid">21348540</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>CESA</collab></person-group> (<year>1992</year>). <source>Usos Tradicionales de las Especies Forestales Nativas en el Ecuador</source>. <publisher-loc>Tomo II. CESA</publisher-loc>: <publisher-name>Central Ecuatoriana de Servicios Agr&#x000ed;colas</publisher-name>.</mixed-citation></ref><ref id="B39"><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>CESA</collab></person-group> (<year>1993</year>). <source>Usos Tradicionales de las Especies Forestales Nativas en el Ecuador</source>. <publisher-loc>Tomo III. CESA</publisher-loc>: <publisher-name>Central Ecuatoriana de Servicios Agr&#x000ed;colas</publisher-name>.</mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chacko</surname><given-names>S. M.</given-names></name><name><surname>Thambi</surname><given-names>P. T.</given-names></name><name><surname>Kuttan</surname><given-names>R.</given-names></name><name><surname>Nishigaki</surname><given-names>I.</given-names></name></person-group> (<year>2010</year>). <article-title>Beneficial effects of green tea: a literature review</article-title>. <source>Chin. Med.</source>
<volume>5</volume>:<fpage>13</fpage>. <pub-id pub-id-type="doi">10.1186/1749-8546-5-13</pub-id><?supplied-pmid 20370896?><pub-id pub-id-type="pmid">20370896</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>D. C.</given-names></name></person-group> (<year>2006</year>). <article-title>Mitochondria: dynamic organelles in disease, aging, and development</article-title>. <source>Cell</source>
<volume>125</volume>, <fpage>1241</fpage>&#x02013;<lpage>1252</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2006.06.010</pub-id><?supplied-pmid 16814712?><pub-id pub-id-type="pmid">16814712</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandrasekaran</surname><given-names>K.</given-names></name><name><surname>Mehrabian</surname><given-names>Z.</given-names></name><name><surname>Spinnewyn</surname><given-names>B.</given-names></name><name><surname>Chinopoulos</surname><given-names>C.</given-names></name><name><surname>Drieu</surname><given-names>K.</given-names></name><name><surname>Fiskum</surname><given-names>G.</given-names></name></person-group> (<year>2003</year>). <article-title>Neuroprotective effects of bilobalide, a component of <italic>Ginkgo biloba</italic> extract (EGb 761&#x000ae;) in global brain ischemia and in excitotoxicity-induced neuronal death</article-title>. <source>Pharmacopsychiatry</source>
<volume>36</volume>, <fpage>89</fpage>&#x02013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1055/s-2003-40447</pub-id><pub-id pub-id-type="pmid">12806565</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>H.-M.</given-names></name><name><surname>But</surname><given-names>P. P. H.</given-names></name><name><surname>Yao</surname><given-names>S.-C.</given-names></name></person-group> (<year>1986</year>). <source>Pharmacology and Applications of Chinese Materia Medica</source>. <publisher-loc>Singapore</publisher-loc>: <publisher-name>World Scientific</publisher-name>.</mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>K.-H.</given-names></name><name><surname>Chen</surname><given-names>I.-C.</given-names></name><name><surname>Lin</surname><given-names>H.-Y.</given-names></name><name><surname>Chen</surname><given-names>H.-C.</given-names></name><name><surname>Lin</surname><given-names>C.-H.</given-names></name><name><surname>Lin</surname><given-names>T.-H.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>The aqueous extract of Glycyrrhiza inflata can upregulate unfolded protein response-mediated chaperones to reduce tau misfolding in cell models of Alzheimer's disease</article-title>. <source>Drug Des. Devel. Ther.</source>
<volume>10</volume>, <fpage>885</fpage>&#x02013;<lpage>896</lpage>. <pub-id pub-id-type="doi">10.2147/DDDT.S96454</pub-id><?supplied-pmid 27013866?><pub-id pub-id-type="pmid">27013866</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C.-M.</given-names></name><name><surname>Weng</surname><given-names>Y.-T.</given-names></name><name><surname>Chen</surname><given-names>W.-L.</given-names></name><name><surname>Lin</surname><given-names>T.-H.</given-names></name><name><surname>Chao</surname><given-names>C.-Y.</given-names></name><name><surname>Lin</surname><given-names>C.-H.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Aqueous extract of Glycyrrhiza inflata inhibits aggregation by upregulating PPARGC1A and NFE2L2-ARE pathways in cell models of spinocerebellar ataxia 3</article-title>. <source>Free Radic. Biol. Med.</source>
<volume>71</volume>, <fpage>339</fpage>&#x02013;<lpage>350</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2014.03.023</pub-id><?supplied-pmid 24675225?><pub-id pub-id-type="pmid">24675225</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>F.</given-names></name><name><surname>Eckman</surname><given-names>E. A.</given-names></name><name><surname>Eckman</surname><given-names>C. B.</given-names></name></person-group> (<year>2006</year>). <article-title>Reductions in levels of the Alzheimer's amyloid beta peptide after oral administration of ginsenosides</article-title>. <source>FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol.</source>
<volume>20</volume>, <fpage>1269</fpage>&#x02013;<lpage>1271</lpage>. <pub-id pub-id-type="doi">10.1096/fj.05-5530fje</pub-id><?supplied-pmid 16636099?><pub-id pub-id-type="pmid">16636099</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J. X.</given-names></name><name><surname>Yan</surname><given-names>S. S.</given-names></name></person-group> (<year>2010</year>). <article-title>Role of mitochondrial amyloid-beta in Alzheimer's disease</article-title>. <source>J. Alzheimers. Dis.</source>
<volume>20</volume>(<issue>Suppl. 2</issue>), <fpage>S569</fpage>&#x02013;<lpage>S578</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-2010-100357</pub-id><?supplied-pmid 20463403?><pub-id pub-id-type="pmid">20463403</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Chevallier</surname><given-names>A.</given-names></name></person-group> (<year>1996</year>). <source>The Encyclopedia of Medicinal Plants</source>. <publisher-loc>London</publisher-loc>: <publisher-name>Dorling Kindersley publishers</publisher-name>.</mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chin</surname><given-names>D.</given-names></name><name><surname>Huebbe</surname><given-names>P.</given-names></name><name><surname>Pallauf</surname><given-names>K.</given-names></name><name><surname>Rimbach</surname><given-names>G.</given-names></name></person-group> (<year>2013</year>). <article-title>Neuroprotective properties of curcumin in Alzheimer's disease&#x02013;merits and limitations</article-title>. <source>Curr. Med. Chem.</source>
<volume>20</volume>, <fpage>3955</fpage>&#x02013;<lpage>3985</lpage>. <pub-id pub-id-type="doi">10.2174/09298673113209990210</pub-id><?supplied-pmid 23931272?><pub-id pub-id-type="pmid">23931272</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chrusciel</surname><given-names>M.</given-names></name><name><surname>Varagi&#x00107;</surname><given-names>V.</given-names></name></person-group> (<year>1966</year>). <article-title>The effect of galantamine on the blood pressure of the rat</article-title>. <source>Br. J. Pharmacol.</source>
<volume>26</volume>, <fpage>295</fpage>&#x02013;<lpage>301</lpage>. <pub-id pub-id-type="doi">10.1111/j.1476-5381.1966.tb01908.x</pub-id><?supplied-pmid 4380412?><pub-id pub-id-type="pmid">4380412</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corder</surname><given-names>E. H.</given-names></name><name><surname>Saunders</surname><given-names>A. M.</given-names></name><name><surname>Strittmatter</surname><given-names>W. J.</given-names></name><name><surname>Schmechel</surname><given-names>D. E.</given-names></name><name><surname>Gaskell</surname><given-names>P. C.</given-names></name><name><surname>Small</surname><given-names>G. W.</given-names></name><etal/></person-group>. (<year>1993</year>). <article-title>Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families</article-title>. <source>Science</source>
<volume>261</volume>, <fpage>921</fpage>&#x02013;<lpage>923</lpage>. <?supplied-pmid 8346443?><pub-id pub-id-type="pmid">8346443</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corrada</surname><given-names>M. M.</given-names></name><name><surname>Brookmeyer</surname><given-names>R.</given-names></name><name><surname>Paganini-Hill</surname><given-names>A.</given-names></name><name><surname>Berlau</surname><given-names>D.</given-names></name><name><surname>Kawas</surname><given-names>C. H.</given-names></name></person-group> (<year>2010</year>). <article-title>Dementia incidence continues to increase with age in the oldest old: the 90+ study</article-title>. <source>Ann. Neurol.</source>
<volume>67</volume>, <fpage>114</fpage>&#x02013;<lpage>121</lpage>. <pub-id pub-id-type="doi">10.1002/ana.21915</pub-id><?supplied-pmid 20186856?><pub-id pub-id-type="pmid">20186856</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>K. H. M.</given-names></name><name><surname>Pipingas</surname><given-names>A.</given-names></name><name><surname>Scholey</surname><given-names>A. B.</given-names></name></person-group> (<year>2015</year>). <article-title>Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population</article-title>. <source>J. Psychopharmacol.</source>
<volume>29</volume>, <fpage>642</fpage>&#x02013;<lpage>651</lpage>. <pub-id pub-id-type="doi">10.1177/0269881114552744</pub-id><?supplied-pmid 25277322?><pub-id pub-id-type="pmid">25277322</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cummings</surname><given-names>J.</given-names></name><name><surname>Aisen</surname><given-names>P. S.</given-names></name><name><surname>DuBois</surname><given-names>B.</given-names></name><name><surname>Fr&#x000f6;lich</surname><given-names>L.</given-names></name><name><surname>Jack</surname><given-names>C. R.</given-names></name><name><surname>Jones</surname><given-names>R. W.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Drug development in Alzheimer's disease: the path to 2025</article-title>. <source>Alzheimer's Res. Ther.</source>
<volume>8</volume>:<fpage>39</fpage>. <pub-id pub-id-type="doi">10.1186/s13195-016-0207-9</pub-id><?supplied-pmid 27646601?><pub-id pub-id-type="pmid">27646601</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>D.-F.</given-names></name><name><surname>Chiao</surname><given-names>Y. A.</given-names></name><name><surname>Marcinek</surname><given-names>D. J.</given-names></name><name><surname>Szeto</surname><given-names>H. H.</given-names></name><name><surname>Rabinovitch</surname><given-names>P. S.</given-names></name></person-group> (<year>2014</year>). <article-title>Mitochondrial oxidative stress in aging and healthspan</article-title>. <source>Longev. Heal.</source>
<volume>3</volume>:<fpage>6</fpage>. <pub-id pub-id-type="doi">10.1186/2046-2395-3-6</pub-id><?supplied-pmid 24860647?><pub-id pub-id-type="pmid">24860647</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Damasio</surname><given-names>A. R.</given-names></name><name><surname>Gabrowski</surname><given-names>T. J.</given-names></name></person-group> (<year>2004</year>). <article-title>Definition, clinical features and neuroanatomical basis of dementia</article-title>, in <source>The Neuropathology of Dementia</source>, eds <person-group person-group-type="editor"><name><surname>Esiri</surname><given-names>M. M.</given-names></name><name><surname>Lee</surname><given-names>V. M.-Y.</given-names></name><name><surname>Trojanowski</surname><given-names>J. Q.</given-names></name></person-group> (<publisher-loc>Cambridge</publisher-loc>: <publisher-name>Cambridge University Press</publisher-name>), <fpage>1</fpage>&#x02013;<lpage>34</lpage>.</mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dandekar</surname><given-names>A.</given-names></name><name><surname>Mendez</surname><given-names>R.</given-names></name><name><surname>Zhang</surname><given-names>K.</given-names></name></person-group> (<year>2015</year>). <article-title>Cross talk between ER stress, oxidative stress, and inflammation in health and disease</article-title>. <source>Methods Mol. Biol.</source>
<volume>1292</volume>, <fpage>205</fpage>&#x02013;<lpage>214</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4939-2522-3_15</pub-id><?supplied-pmid 25804758?><pub-id pub-id-type="pmid">25804758</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danysz</surname><given-names>W.</given-names></name><name><surname>Parsons</surname><given-names>C. G.</given-names></name></person-group> (<year>2003</year>). <article-title>The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence</article-title>. <source>Int. J. Geriatr. Psychiatry</source>
<volume>18</volume>, <fpage>S23</fpage>&#x02013;<lpage>S32</lpage>. <pub-id pub-id-type="doi">10.1002/gps.938</pub-id><?supplied-pmid 12973747?><pub-id pub-id-type="pmid">12973747</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daverey</surname><given-names>A.</given-names></name><name><surname>Agrawal</surname><given-names>S. K.</given-names></name></person-group> (<year>2016</year>). <article-title>Curcumin alleviates oxidative stress and mitochondrial dysfunction in astrocytes</article-title>. <source>Neuroscience</source>
<volume>333</volume>, <fpage>92</fpage>&#x02013;<lpage>103</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2016.07.012</pub-id><?supplied-pmid 27423629?><pub-id pub-id-type="pmid">27423629</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x000e1;vila</surname><given-names>D.</given-names></name><name><surname>Fern&#x000e1;ndez</surname><given-names>S.</given-names></name><name><surname>Torres-Alem&#x000e1;n</surname><given-names>I.</given-names></name></person-group> (<year>2016</year>). <article-title>Astrocyte resilience to oxidative stress induced by insulin-like growth factor I (IGF-I) involves preserved AKT (protein kinase B) activity</article-title>. <source>J. Biol. Chem.</source>
<volume>291</volume>, <fpage>12039</fpage>. <pub-id pub-id-type="doi">10.1074/jbc.A115.695478</pub-id><?supplied-pmid 26631726?><pub-id pub-id-type="pmid">27261528</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>de Barradas</surname><given-names>J. P.</given-names></name></person-group> (<year>1957</year>). <source>Plantas M&#x000e1;gicas Americanas</source>. <publisher-name>Consejo Superior de Investigaciones Cient&#x000ed;ficas, Instituto &#x0201c;Bernardino de Sahag&#x000fa;n.&#x0201d;</publisher-name></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Mejia</surname><given-names>E. G.</given-names></name><name><surname>Ramirez-Mares</surname><given-names>M. V.</given-names></name><name><surname>Puangpraphant</surname><given-names>S.</given-names></name></person-group> (<year>2009</year>). <article-title>Bioactive components of tea: cancer, inflammation and behavior</article-title>. <source>Brain. Behav. Immun.</source>
<volume>23</volume>, <fpage>721</fpage>&#x02013;<lpage>731</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2009.02.013</pub-id><?supplied-pmid 19258034?><pub-id pub-id-type="pmid">19258034</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhingra</surname><given-names>D.</given-names></name><name><surname>Parle</surname><given-names>M.</given-names></name><name><surname>Kulkarni</surname><given-names>S. K.</given-names></name></person-group> (<year>2004</year>). <article-title>Memory enhancing activity of Glycyrrhiza glabra in mice</article-title>. <source>J. Ethnopharmacol.</source>
<volume>91</volume>, <fpage>361</fpage>&#x02013;<lpage>365</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2004.01.016</pub-id><?supplied-pmid 15120462?><pub-id pub-id-type="pmid">15120462</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dkhar</surname><given-names>P.</given-names></name><name><surname>Sharma</surname><given-names>R.</given-names></name></person-group> (<year>2010</year>). <article-title>Effect of dimethylsulphoxide and curcumin on protein carbonyls and reactive oxygen species of cerebral hemispheres of mice as a function of age</article-title>. <source>Int. J. Dev. Neurosci.</source>
<volume>28</volume>, <fpage>351</fpage>&#x02013;<lpage>357</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijdevneu.2010.04.005</pub-id><?supplied-pmid 20403421?><pub-id pub-id-type="pmid">20403421</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doggui</surname><given-names>S.</given-names></name><name><surname>Belkacemi</surname><given-names>A.</given-names></name><name><surname>Paka</surname><given-names>G. D.</given-names></name><name><surname>Perrotte</surname><given-names>M.</given-names></name><name><surname>Pi</surname><given-names>R.</given-names></name><name><surname>Ramassamy</surname><given-names>C.</given-names></name></person-group> (<year>2013</year>). <article-title>Curcumin protects neuronal-like cells against acrolein by restoring Akt and redox signaling pathways</article-title>. <source>Mol. Nutr. Food Res.</source>
<volume>57</volume>, <fpage>1660</fpage>&#x02013;<lpage>1670</lpage>. <pub-id pub-id-type="doi">10.1002/mnfr.201300130</pub-id><?supplied-pmid 23901044?><pub-id pub-id-type="pmid">23901044</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dolgin</surname><given-names>E.</given-names></name></person-group> (<year>2016</year>). <article-title>How to defeat dementia</article-title>. <source>Nature</source>
<volume>539</volume>, <fpage>156</fpage>&#x02013;<lpage>158</lpage>. <pub-id pub-id-type="doi">10.1038/539156a</pub-id><?supplied-pmid 27830826?><pub-id pub-id-type="pmid">27830826</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Domor&#x000e1;kov&#x000e1;</surname><given-names>I.</given-names></name><name><surname>Burda</surname><given-names>J.</given-names></name><name><surname>Mech&#x000ed;rov&#x000e1;</surname><given-names>E.</given-names></name><name><surname>Ferikov&#x000e1;</surname><given-names>M.</given-names></name></person-group> (<year>2006</year>). <article-title>Mapping of rat hippocampal neurons with NeuN after ischemia/reperfusion and <italic>Ginkgo biloba</italic> extract (EGb 761) pretreatment</article-title>. <source>Cell. Mol. Neurobiol.</source>
<volume>26</volume>, <fpage>1191</fpage>&#x02013;<lpage>1202</lpage>. <pub-id pub-id-type="doi">10.1007/s10571-006-9080-6</pub-id><?supplied-pmid 16758319?><pub-id pub-id-type="pmid">16758319</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>S.</given-names></name><name><surname>Zeng</surname><given-names>Q.</given-names></name><name><surname>Mitchell</surname><given-names>E. S.</given-names></name><name><surname>Xiu</surname><given-names>J.</given-names></name><name><surname>Duan</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Curcumin enhances neurogenesis and cognition in aged rats: implications for transcriptional interactions related to growth and synaptic plasticity</article-title>. <source>PLoS ONE</source>
<volume>7</volume>:<fpage>e31211</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0031211</pub-id><?supplied-pmid 22359574?><pub-id pub-id-type="pmid">22359574</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doody</surname><given-names>R. S.</given-names></name><name><surname>Stevens</surname><given-names>J. C.</given-names></name><name><surname>Beck</surname><given-names>C.</given-names></name><name><surname>Dubinsky</surname><given-names>R. M.</given-names></name><name><surname>Kaye</surname><given-names>J. A.</given-names></name><name><surname>Gwyther</surname><given-names>L.</given-names></name><etal/></person-group>. (<year>2001</year>). <article-title>Practice parameter: management of dementia (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology</article-title>. <source>Neurology</source>
<volume>56</volume>, <fpage>1154</fpage>&#x02013;<lpage>1166</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.56.9.1154</pub-id><?supplied-pmid 11342679?><pub-id pub-id-type="pmid">11342679</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dragicevic</surname><given-names>N.</given-names></name><name><surname>Smith</surname><given-names>A.</given-names></name><name><surname>Lin</surname><given-names>X.</given-names></name><name><surname>Yuan</surname><given-names>F.</given-names></name><name><surname>Copes</surname><given-names>N.</given-names></name><name><surname>Delic</surname><given-names>V.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Green tea epigallocatechin-3-gallate (EGCG) and other flavonoids reduce Alzheimer's amyloid-induced mitochondrial dysfunction</article-title>. <source>J. Alzheimers. Dis.</source>
<volume>26</volume>, <fpage>507</fpage>&#x02013;<lpage>521</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-2011-101629</pub-id><?supplied-pmid 21694462?><pub-id pub-id-type="pmid">21694462</pub-id></mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dringen</surname><given-names>R.</given-names></name></person-group> (<year>2000</year>). <article-title>Metabolism and functions of glutathione in brain</article-title>. <source>Prog. Neurobiol.</source>
<volume>62</volume>, <fpage>649</fpage>&#x02013;<lpage>671</lpage>. <pub-id pub-id-type="doi">10.1016/S0301-0082(99)00060-X</pub-id><?supplied-pmid 10880854?><pub-id pub-id-type="pmid">10880854</pub-id></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Duke</surname><given-names>J. A.</given-names></name><name><surname>Ayensu</surname><given-names>E. S.</given-names></name></person-group> (<year>1985</year>). <source>Medicinal Plants of China</source>. <publisher-loc>Algonac</publisher-loc>: <publisher-name>Reference Publications</publisher-name>.</mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eckert</surname><given-names>A.</given-names></name><name><surname>Keil</surname><given-names>U.</given-names></name><name><surname>Scherping</surname><given-names>I.</given-names></name><name><surname>Hauptmann</surname><given-names>S.</given-names></name><name><surname>Muller</surname><given-names>W. E.</given-names></name></person-group> (<year>2005</year>). <article-title>Stabilization of mitochondrial membrane potential and improvement of neuronal energy metabolism by <italic>Ginkgo biloba</italic> extract EGb 761</article-title>. <source>Ann. N.Y. Acad. Sci.</source>
<volume>1056</volume>, <fpage>474</fpage>&#x02013;<lpage>485</lpage>. <pub-id pub-id-type="doi">10.1196/annals.1352.023</pub-id><?supplied-pmid 16387710?><pub-id pub-id-type="pmid">16387710</pub-id></mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eckert</surname><given-names>G. P.</given-names></name><name><surname>Schiborr</surname><given-names>C.</given-names></name><name><surname>Hagl</surname><given-names>S.</given-names></name><name><surname>Abdel-Kader</surname><given-names>R.</given-names></name><name><surname>Muller</surname><given-names>W. E.</given-names></name><name><surname>Rimbach</surname><given-names>G.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Curcumin prevents mitochondrial dysfunction in the brain of the senescence-accelerated mouse-prone 8</article-title>. <source>Neurochem. Int.</source>
<volume>62</volume>, <fpage>595</fpage>&#x02013;<lpage>602</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuint.2013.02.014</pub-id><?supplied-pmid 23422877?><pub-id pub-id-type="pmid">23422877</pub-id></mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egashira</surname><given-names>N.</given-names></name><name><surname>Hayakawa</surname><given-names>K.</given-names></name><name><surname>Osajima</surname><given-names>M.</given-names></name><name><surname>Mishima</surname><given-names>K.</given-names></name><name><surname>Iwasaki</surname><given-names>K.</given-names></name><name><surname>Oishi</surname><given-names>R.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>Involvement of GABA(A) receptors in the neuroprotective effect of theanine on focal cerebral ischemia in mice</article-title>. <source>J. Pharmacol. Sci.</source>
<volume>105</volume>, <fpage>211</fpage>&#x02013;<lpage>214</lpage>. <pub-id pub-id-type="doi">10.1254/jphs.SCZ070901</pub-id><?supplied-pmid 17928735?><pub-id pub-id-type="pmid">17928735</pub-id></mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egashira</surname><given-names>N.</given-names></name><name><surname>Ishigami</surname><given-names>N.</given-names></name><name><surname>Pu</surname><given-names>F.</given-names></name><name><surname>Mishima</surname><given-names>K.</given-names></name><name><surname>Iwasaki</surname><given-names>K.</given-names></name><name><surname>Orito</surname><given-names>K.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>Theanine prevents memory impairment induced by repeated cerebral ischemia in rats</article-title>. <source>Phytother. Res.</source>
<volume>22</volume>, <fpage>65</fpage>&#x02013;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1002/ptr.2261</pub-id><?supplied-pmid 17705146?><pub-id pub-id-type="pmid">17705146</pub-id></mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ezoulin</surname><given-names>M. J. M.</given-names></name><name><surname>Ombetta</surname><given-names>J.-E.</given-names></name><name><surname>Dutertre-Catella</surname><given-names>H.</given-names></name><name><surname>Warnet</surname><given-names>J.-M.</given-names></name><name><surname>Massicot</surname><given-names>F.</given-names></name></person-group> (<year>2008</year>). <article-title>Antioxidative properties of galantamine on neuronal damage induced by hydrogen peroxide in SK-N-SH cells</article-title>. <source>Neurotoxicology</source>
<volume>29</volume>, <fpage>270</fpage>&#x02013;<lpage>277</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuro.2007.11.004</pub-id><?supplied-pmid 18191456?><pub-id pub-id-type="pmid">18191456</pub-id></mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farkas</surname><given-names>E.</given-names></name><name><surname>Luiten</surname><given-names>P. G.</given-names></name></person-group> (<year>2001</year>). <article-title>Cerebral microvascular pathology in aging and Alzheimer's disease</article-title>. <source>Prog. Neurobiol.</source>
<volume>64</volume>, <fpage>575</fpage>&#x02013;<lpage>611</lpage>. <pub-id pub-id-type="doi">10.1016/S0301-0082(00)00068-X</pub-id><?supplied-pmid 11311463?><pub-id pub-id-type="pmid">11311463</pub-id></mixed-citation></ref><ref id="B79"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Fatumbi</surname><given-names>P. V. P.</given-names></name></person-group> (<year>1995</year>). <source>Ew&#x000e9;: The Use of Plants in Yoruba Society</source>. <publisher-loc>Salvador</publisher-loc>: <publisher-name>Oderbrecht</publisher-name>.</mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Favaloro</surname><given-names>B.</given-names></name><name><surname>Allocati</surname><given-names>N.</given-names></name><name><surname>Graziano</surname><given-names>V.</given-names></name><name><surname>Di Ilio</surname><given-names>C.</given-names></name><name><surname>De Laurenzi</surname><given-names>V.</given-names></name></person-group> (<year>2012</year>). <article-title>Role of Apoptosis in disease</article-title>. <source>Aging (Albany NY)</source>
<volume>4</volume>, <fpage>330</fpage>&#x02013;<lpage>349</lpage>. <pub-id pub-id-type="doi">10.18632/aging.100459</pub-id><?supplied-pmid 22683550?><pub-id pub-id-type="pmid">22683550</pub-id></mixed-citation></ref><ref id="B81"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Finkler</surname><given-names>K.</given-names></name></person-group> (<year>1985</year>). <source>Spiritualist Healers in Mexico: Successes and Failures of Alternative Therapeutics</source>. <publisher-loc>Salem, WI</publisher-loc>: <publisher-name>Praeger Publishers</publisher-name>.</mixed-citation></ref><ref id="B82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>C.</given-names></name><name><surname>Crugel</surname><given-names>M.</given-names></name><name><surname>Maidment</surname><given-names>I.</given-names></name><name><surname>Auestad</surname><given-names>B. H.</given-names></name><name><surname>Coulton</surname><given-names>S.</given-names></name><name><surname>Treloar</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Efficacy of memantine for agitation in Alzheimer's dementia: a randomised double-blind placebo controlled trial</article-title>. <source>PLoS ONE</source>
<volume>7</volume>:<fpage>e35185</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0035185</pub-id><?supplied-pmid 22567095?><pub-id pub-id-type="pmid">22567095</pub-id></mixed-citation></ref><ref id="B83"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franzblau</surname><given-names>M.</given-names></name><name><surname>Gonzales-Portillo</surname><given-names>C.</given-names></name><name><surname>Gonzales-Portillo</surname><given-names>G. S.</given-names></name><name><surname>Diamandis</surname><given-names>T.</given-names></name><name><surname>Borlongan</surname><given-names>M. C.</given-names></name><name><surname>Tajiri</surname><given-names>N.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Vascular damage: a persisting pathology common to Alzheimer's disease and traumatic brain injury</article-title>. <source>Med. Hypotheses</source>
<volume>81</volume>, <fpage>842</fpage>&#x02013;<lpage>845</lpage>. <pub-id pub-id-type="doi">10.1016/j.mehy.2013.09.012</pub-id><?supplied-pmid 24074832?><pub-id pub-id-type="pmid">24074832</pub-id></mixed-citation></ref><ref id="B84"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Fuchs</surname><given-names>L.</given-names></name></person-group> (<year>1543</year>). <source>Kr&#x000e4;uterbuch. Michael Isingrin</source>. <publisher-loc>Basel</publisher-loc>.</mixed-citation></ref><ref id="B85"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>H.-M.</given-names></name><name><surname>Zhou</surname><given-names>H.</given-names></name><name><surname>Hong</surname><given-names>J.-S.</given-names></name></person-group> (<year>2014</year>). <article-title>Oxidative stress, neuroinflammation, and neurodegeneration</article-title>, in <source>Neuroinflammation, and Neurodegeneration</source>, eds <person-group person-group-type="editor"><name><surname>Peterson</surname><given-names>P. K.</given-names></name><name><surname>Toborek</surname><given-names>M.</given-names></name></person-group> (<publisher-loc>New York, NY</publisher-loc>: <publisher-name>Springer New York</publisher-name>), <fpage>81</fpage>&#x02013;<lpage>104</lpage>.</mixed-citation></ref><ref id="B86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gate</surname><given-names>D.</given-names></name><name><surname>Rezai-Zadeh</surname><given-names>K.</given-names></name><name><surname>Jodry</surname><given-names>D.</given-names></name><name><surname>Rentsendorj</surname><given-names>A.</given-names></name><name><surname>Town</surname><given-names>T.</given-names></name></person-group> (<year>2010</year>). <article-title>Macrophages in Alzheimer's disease: the blood-borne identity</article-title>. <source>J. Neural Transm.</source>
<volume>117</volume>, <fpage>961</fpage>&#x02013;<lpage>970</lpage>. <pub-id pub-id-type="doi">10.1007/s00702-010-0422-7</pub-id><?supplied-pmid 20517700?><pub-id pub-id-type="pmid">20517700</pub-id></mixed-citation></ref><ref id="B87"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geeganage</surname><given-names>C.</given-names></name><name><surname>Wilcox</surname><given-names>R.</given-names></name><name><surname>Bath</surname><given-names>P. M. W.</given-names></name></person-group> (<year>2010</year>). <article-title>Triple antiplatelet therapy for preventing vascular events: a systematic review and meta-analysis</article-title>. <source>BMC Med.</source>
<volume>8</volume>:<fpage>36</fpage>. <pub-id pub-id-type="doi">10.1186/1741-7015-8-36</pub-id><?supplied-pmid 20553581?><pub-id pub-id-type="pmid">20553581</pub-id></mixed-citation></ref><ref id="B88"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giacobini</surname><given-names>E.</given-names></name></person-group> (<year>2004</year>). <article-title>Cholinesterase inhibitors: new roles and therapeutic alternatives</article-title>. <source>Pharmacol. Res.</source>
<volume>50</volume>, <fpage>433</fpage>&#x02013;<lpage>440</lpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2003.11.017</pub-id><?supplied-pmid 15304240?><pub-id pub-id-type="pmid">15304240</pub-id></mixed-citation></ref><ref id="B89"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giri</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Lu</surname><given-names>Y.</given-names></name></person-group> (<year>2016</year>). <article-title>Genes associated with Alzheimer's disease: an overview and current status</article-title>. <source>Clin. Interv. Aging</source>
<volume>11</volume>, <fpage>665</fpage>&#x02013;<lpage>681</lpage>. <pub-id pub-id-type="doi">10.2147/CIA.S105769</pub-id><?supplied-pmid 27274215?><pub-id pub-id-type="pmid">27274215</pub-id></mixed-citation></ref><ref id="B90"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goenka</surname><given-names>P.</given-names></name><name><surname>Sarawgi</surname><given-names>A.</given-names></name><name><surname>Karun</surname><given-names>V.</given-names></name><name><surname>Nigam</surname><given-names>A. G.</given-names></name><name><surname>Dutta</surname><given-names>S.</given-names></name><name><surname>Marwah</surname><given-names>N.</given-names></name></person-group> (<year>2013</year>). <article-title>Camellia sinensis (Tea): implications and role in preventing dental decay</article-title>. <source>Pharmacogn. Rev.</source>
<volume>7</volume>, <fpage>152</fpage>&#x02013;<lpage>156</lpage>. <pub-id pub-id-type="doi">10.4103/0973-7847.120515</pub-id><?supplied-pmid 24347923?><pub-id pub-id-type="pmid">24347923</pub-id></mixed-citation></ref><ref id="B91"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>G&#x000f3;mez-S&#x000e1;mano</surname><given-names>M. &#x000c1;.</given-names></name><name><surname>Grajales-G&#x000f3;mez</surname><given-names>M.</given-names></name><name><surname>Zuarth-V&#x000e1;zquez</surname><given-names>J. M.</given-names></name><name><surname>Navarro-Flores</surname><given-names>M. F.</given-names></name><name><surname>Mart&#x000ed;nez-Saavedra</surname><given-names>M.</given-names></name><name><surname>Ju&#x000e1;rez-Le&#x000f3;n</surname><given-names>&#x000d3;. A.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Fibroblast growth factor 21 and its novel association with oxidative stress</article-title>. <source>Redox Biol.</source>
<volume>11</volume>, <fpage>335</fpage>&#x02013;<lpage>341</lpage>. <pub-id pub-id-type="doi">10.1016/j.redox.2016.12.024</pub-id><?supplied-pmid 28039838?><pub-id pub-id-type="pmid">28039838</pub-id></mixed-citation></ref><ref id="B92"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gonz&#x000e1;lez Ayala</surname><given-names>J. C.</given-names></name></person-group> (<year>1994</year>). <source>Bot&#x000e1;nica Medicinal Popular: Etnobot&#x000e1;nica Medicinal de El Salvador</source>. <publisher-name>Jard&#x000ed;n Bot&#x000e0;nico La Laguna</publisher-name>.</mixed-citation></ref><ref id="B93"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grand</surname><given-names>J. H.</given-names></name><name><surname>Caspar</surname><given-names>S.</given-names></name><name><surname>Macdonald</surname><given-names>S. W.</given-names></name></person-group> (<year>2011</year>). <article-title>Clinical features and multidisciplinary approaches to dementia care</article-title>. <source>J Multidiscip Heal.</source>
<volume>2011</volume>, <fpage>125</fpage>&#x02013;<lpage>147</lpage>. <pub-id pub-id-type="doi">10.2147/JMDH.S17773</pub-id></mixed-citation></ref><ref id="B94"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guan</surname><given-names>R.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Fan</surname><given-names>G.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Zhou</surname><given-names>W.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Draft genome of the living fossil <italic>Ginkgo biloba</italic></article-title>. <source>Gigascience</source>
<volume>5</volume>, <fpage>49</fpage>. <pub-id pub-id-type="doi">10.1186/s13742-016-0154-1</pub-id><?supplied-pmid 27871309?><pub-id pub-id-type="pmid">27871309</pub-id></mixed-citation></ref><ref id="B95"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gurib-Fakim</surname><given-names>A.</given-names></name></person-group> (<year>2006</year>). <article-title>Medicinal plants: traditions of yesterday and drugs of tomorrow</article-title>. <source>Mol. Aspects Med.</source>
<volume>27</volume>, <fpage>1</fpage>&#x02013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/j.mam.2005.07.008</pub-id><?supplied-pmid 16105678?><pub-id pub-id-type="pmid">16105678</pub-id></mixed-citation></ref><ref id="B96"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hajnoczky</surname><given-names>G.</given-names></name><name><surname>Davies</surname><given-names>E.</given-names></name><name><surname>Madesh</surname><given-names>M.</given-names></name></person-group> (<year>2003</year>). <article-title>Calcium signaling and apoptosis</article-title>. <source>Biochem. Biophys. Res. Commun.</source>
<volume>304</volume>, <fpage>445</fpage>&#x02013;<lpage>454</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-291X(03)00616-8</pub-id><?supplied-pmid 12729578?><pub-id pub-id-type="pmid">12729578</pub-id></mixed-citation></ref><ref id="B97"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardy</surname><given-names>J. A.</given-names></name><name><surname>Higgins</surname><given-names>G. A.</given-names></name></person-group> (<year>1992</year>). <article-title>Alzheimer's disease: the amyloid cascade hypothesis</article-title>. <source>Science</source> (<volume>256</volume>, <fpage>184</fpage>. <?supplied-pmid 1566067?><pub-id pub-id-type="pmid">1566067</pub-id></mixed-citation></ref><ref id="B98"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haskell</surname><given-names>C. F.</given-names></name><name><surname>Kennedy</surname><given-names>D. O.</given-names></name><name><surname>Milne</surname><given-names>A. L.</given-names></name><name><surname>Wesnes</surname><given-names>K. A.</given-names></name><name><surname>Scholey</surname><given-names>A. B.</given-names></name></person-group> (<year>2008</year>). <article-title>The effects of L-theanine, caffeine and their combination on cognition and mood</article-title>. <source>Biol. Psychol.</source>
<volume>77</volume>, <fpage>113</fpage>&#x02013;<lpage>122</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsycho.2007.09.008</pub-id><?supplied-pmid 18006208?><pub-id pub-id-type="pmid">18006208</pub-id></mixed-citation></ref><ref id="B99"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heim</surname><given-names>C.</given-names></name><name><surname>Khan</surname><given-names>M. A.</given-names></name><name><surname>Motsch</surname><given-names>B.</given-names></name><name><surname>Gocht</surname><given-names>A.</given-names></name><name><surname>Ramsperger-Gleixner</surname><given-names>M.</given-names></name><name><surname>Stamminger</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>microvascular integrity can be preserved by anti-platelet therapy and in combination with mTOR inhibitor</article-title>. <source>J. Hear. Lung Transplant.</source>
<volume>36</volume>, <fpage>S376</fpage>
<pub-id pub-id-type="doi">10.1016/j.healun.2017.01.1069</pub-id></mixed-citation></ref><ref id="B100"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hikino</surname><given-names>H.</given-names></name></person-group> (<year>1985</year>). <article-title>Recent research on oriental medicinal plants</article-title>. <source>Econ. Med. Plant. Res.</source>
<volume>1</volume>, <fpage>53</fpage>&#x02013;<lpage>85</lpage>.</mixed-citation></ref><ref id="B101"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoppe</surname><given-names>J. B.</given-names></name><name><surname>Coradini</surname><given-names>K.</given-names></name><name><surname>Frozza</surname><given-names>R. L.</given-names></name><name><surname>Oliveira</surname><given-names>C. M.</given-names></name><name><surname>Meneghetti</surname><given-names>A. B.</given-names></name><name><surname>Bernardi</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2013a</year>). <article-title>Free and nanoencapsulated curcumin suppress beta-amyloid-induced cognitive impairments in rats: involvement of BDNF and Akt/GSK-3beta signaling pathway</article-title>. <source>Neurobiol. Learn. Mem.</source>
<volume>106</volume>, <fpage>134</fpage>&#x02013;<lpage>144</lpage>. <pub-id pub-id-type="doi">10.1016/j.nlm.2013.08.001</pub-id><?supplied-pmid 23954730?><pub-id pub-id-type="pmid">23954730</pub-id></mixed-citation></ref><ref id="B102"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoppe</surname><given-names>J. B.</given-names></name><name><surname>Haag</surname><given-names>M.</given-names></name><name><surname>Whalley</surname><given-names>B. J.</given-names></name><name><surname>Salbego</surname><given-names>C. G.</given-names></name><name><surname>Cimarosti</surname><given-names>H.</given-names></name></person-group> (<year>2013b</year>). <article-title>Curcumin protects organotypic hippocampal slice cultures from Abeta1-42-induced synaptic toxicity</article-title>. <source>Toxicol. In Vitro</source>
<volume>27</volume>, <fpage>2325</fpage>&#x02013;<lpage>2330</lpage>. <pub-id pub-id-type="doi">10.1016/j.tiv.2013.10.002</pub-id><?supplied-pmid 24134851?><pub-id pub-id-type="pmid">24134851</pub-id></mixed-citation></ref><ref id="B103"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howard</surname><given-names>R. J.</given-names></name><name><surname>Juszczak</surname><given-names>E.</given-names></name><name><surname>Ballard</surname><given-names>C. G.</given-names></name><name><surname>Bentham</surname><given-names>P.</given-names></name><name><surname>Brown</surname><given-names>R. G.</given-names></name><name><surname>Bullock</surname><given-names>R.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>Donepezil for the treatment of agitation in Alzheimer's disease</article-title>. <source>N. Engl. J. Med.</source>
<volume>357</volume>, <fpage>1382</fpage>&#x02013;<lpage>1392</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa066583</pub-id><?supplied-pmid 17914039?><pub-id pub-id-type="pmid">17914039</pub-id></mixed-citation></ref><ref id="B104"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howes</surname><given-names>M.-J. R.</given-names></name><name><surname>Houghton</surname><given-names>P. J.</given-names></name></person-group> (<year>2003</year>). <article-title>Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function</article-title>. <source>Pharmacol. Biochem. Behav.</source>
<volume>75</volume>, <fpage>513</fpage>&#x02013;<lpage>527</lpage>. <pub-id pub-id-type="doi">10.1016/S0091-3057(03)00128-X</pub-id><?supplied-pmid 12895669?><pub-id pub-id-type="pmid">12895669</pub-id></mixed-citation></ref><ref id="B105"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howes</surname><given-names>M.-J. R.</given-names></name><name><surname>Perry</surname><given-names>E.</given-names></name></person-group> (<year>2011</year>). <article-title>The role of phytochemicals in the treatment and prevention of dementia</article-title>. <source>Drugs Aging</source>
<volume>28</volume>, <fpage>439</fpage>&#x02013;<lpage>468</lpage>. <pub-id pub-id-type="doi">10.2165/11591310-000000000-00000</pub-id><?supplied-pmid 21639405?><pub-id pub-id-type="pmid">21639405</pub-id></mixed-citation></ref><ref id="B106"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howes</surname><given-names>M. R.</given-names></name><name><surname>Perry</surname><given-names>N. S. L.</given-names></name><name><surname>Houghton</surname><given-names>P. J.</given-names></name></person-group> (<year>2003</year>). <article-title>Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders</article-title>. <source>Phyther. Res.</source>
<volume>17</volume>, <fpage>1</fpage>&#x02013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1002/ptr.1280</pub-id><?supplied-pmid 12557240?><pub-id pub-id-type="pmid">12557240</pub-id></mixed-citation></ref><ref id="B107"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>H.-C.</given-names></name><name><surname>Tang</surname><given-names>D.</given-names></name><name><surname>Xu</surname><given-names>K.</given-names></name><name><surname>Jiang</surname><given-names>Z.-F.</given-names></name></person-group> (<year>2014</year>). <article-title>Curcumin attenuates amyloid-beta-induced tau hyperphosphorylation in human neuroblastoma SH-SY5Y cells involving PTEN/Akt/GSK-3beta signaling pathway</article-title>. <source>J. Recept. Signal Transduct. Res.</source>
<volume>34</volume>, <fpage>26</fpage>&#x02013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.3109/10799893.2013.848891</pub-id><?supplied-pmid 24188406?><pub-id pub-id-type="pmid">24188406</pub-id></mixed-citation></ref><ref id="B108"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>H&#x000fc;gel</surname><given-names>H. M.</given-names></name><name><surname>Jackson</surname><given-names>N.</given-names></name></person-group> (<year>2015</year>). <article-title>Polyphenols for the prevention and treatment of dementia diseases</article-title>. <source>Neural Regen. Res.</source>
<volume>10</volume>, <fpage>1756</fpage>&#x02013;<lpage>1758</lpage>. <pub-id pub-id-type="doi">10.4103/1673-5374.169609</pub-id><?supplied-pmid 26807106?><pub-id pub-id-type="pmid">26807106</pub-id></mixed-citation></ref><ref id="B109"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huminiecki</surname><given-names>L.</given-names></name><name><surname>Horbanczuk</surname><given-names>J.</given-names></name><name><surname>Atanasov</surname><given-names>A. G.</given-names></name></person-group> (<year>2017</year>). <article-title>The functional genomic studies of curcumin</article-title>. <source>Semin. Cancer Biol.</source>
<volume>46</volume>, <fpage>107</fpage>&#x02013;<lpage>118</lpage>. <pub-id pub-id-type="doi">10.1016/j.semcancer.2017.04.002</pub-id><?supplied-pmid 28392463?><pub-id pub-id-type="pmid">28392463</pub-id></mixed-citation></ref><ref id="B110"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hung</surname><given-names>C. H.-L.</given-names></name><name><surname>Cheng</surname><given-names>S. S.-Y.</given-names></name><name><surname>Cheung</surname><given-names>Y.-T.</given-names></name><name><surname>Wuwongse</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>N. Q.</given-names></name><name><surname>Ho</surname><given-names>Y.-S.</given-names></name><etal/></person-group>. (<year>2018</year>). <article-title>A reciprocal relationship between reactive oxygen species and mitochondrial dynamics in neurodegeneration</article-title>. <source>Redox Biol.</source>
<volume>14</volume>, <fpage>7</fpage>&#x02013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/j.redox.2017.08.010</pub-id><?supplied-pmid 28837882?><pub-id pub-id-type="pmid">28837882</pub-id></mixed-citation></ref><ref id="B111"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hurd</surname><given-names>M. D.</given-names></name><name><surname>Martorell</surname><given-names>P.</given-names></name><name><surname>Langa</surname><given-names>K. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Monetary costs of dementia in the United States</article-title>. <source>N. Engl. J. Med.</source>
<volume>369</volume>, <fpage>489</fpage>&#x02013;<lpage>490</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMc1305541</pub-id><?supplied-pmid 23902508?><pub-id pub-id-type="pmid">23902508</pub-id></mixed-citation></ref><ref id="B112"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iadecola</surname><given-names>C.</given-names></name></person-group> (<year>2013</year>). <article-title>The pathobiology of vascular dementia</article-title>. <source>Neuron</source>
<volume>80</volume>, <fpage>844</fpage>&#x02013;<lpage>866</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2013.10.008</pub-id><?supplied-pmid 24267647?><pub-id pub-id-type="pmid">24267647</pub-id></mixed-citation></ref><ref id="B113"><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>IARC Working Group</collab></person-group> (<year>2016</year>). <source>Some Drugs and Herbal Products.</source>
<publisher-loc>Lyon</publisher-loc>: <publisher-name>Ginkgo Biloba. International Agency for Research and Cancer (IARC) Monographs, WHO</publisher-name>.</mixed-citation></ref><ref id="B114"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ibrahim</surname><given-names>F.</given-names></name><name><surname>Knight</surname><given-names>S. R.</given-names></name><name><surname>Cramer</surname><given-names>R. L.</given-names></name></person-group> (<year>2012</year>). <article-title>Addressing the controversial use of antipsychotic drugs for behavioral and psychological symptoms of dementia</article-title>. <source>J. Pharm. Technol.</source>
<volume>28</volume>, <fpage>3</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1177/875512251202800102</pub-id></mixed-citation></ref><ref id="B115"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ihl</surname><given-names>R.</given-names></name><name><surname>Tribanek</surname><given-names>M.</given-names></name><name><surname>Bachinskaya</surname><given-names>N.</given-names></name></person-group> (<year>2012</year>). <article-title>Efficacy and tolerability of a once daily formulation of <italic>Ginkgo biloba</italic> extract EGb 761(R) in Alzheimer's disease and vascular dementia: results from a randomised controlled trial</article-title>. <source>Pharmacopsychiatry</source>
<volume>45</volume>, <fpage>41</fpage>&#x02013;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1055/s-0031-1291217</pub-id><?supplied-pmid 22086747?><pub-id pub-id-type="pmid">22086747</pub-id></mixed-citation></ref><ref id="B116"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikarashi</surname><given-names>Y.</given-names></name><name><surname>Mizoguchi</surname><given-names>K.</given-names></name></person-group> (<year>2016</year>). <article-title>Neuropharmacological efficacy of the traditional Japanese Kampo medicine yokukansan and its active ingredients</article-title>. <source>Pharmacol. Ther.</source>
<volume>166</volume>, <fpage>84</fpage>&#x02013;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1016/j.pharmthera.2016.06.018</pub-id><?supplied-pmid 27373856?><pub-id pub-id-type="pmid">27373856</pub-id></mixed-citation></ref><ref id="B117"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iqbal</surname><given-names>K.</given-names></name><name><surname>Liu</surname><given-names>F.</given-names></name><name><surname>Gong</surname><given-names>C.-X.</given-names></name></person-group> (<year>2016</year>). <article-title>Tau and neurodegenerative disease: the story so far</article-title>. <source>Nat. Rev. Neurol.</source>
<volume>12</volume>, <fpage>15</fpage>&#x02013;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2015.225</pub-id><?supplied-pmid 26635213?><pub-id pub-id-type="pmid">26635213</pub-id></mixed-citation></ref><ref id="B118"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iqbal</surname><given-names>K.</given-names></name><name><surname>Liu</surname><given-names>F.</given-names></name><name><surname>Gong</surname><given-names>C.-X.</given-names></name><name><surname>Grundke-Iqbal</surname><given-names>I.</given-names></name></person-group> (<year>2010</year>). <article-title>Tau in Alzheimer disease and related tauopathies</article-title>. <source>Curr. Alzheimer Res.</source>
<volume>7</volume>, <fpage>656</fpage>&#x02013;<lpage>664</lpage>. <pub-id pub-id-type="doi">10.2174/156720510793611592</pub-id><?supplied-pmid 20678074?><pub-id pub-id-type="pmid">20678074</pub-id></mixed-citation></ref><ref id="B119"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isah</surname><given-names>T.</given-names></name></person-group> (<year>2015</year>). <article-title>Rethinking <italic>Ginkgo biloba</italic> L.: medicinal uses and conservation</article-title>. <source>Pharmacogn. Rev.</source>
<volume>9</volume>, <fpage>140</fpage>&#x02013;<lpage>148</lpage>. <pub-id pub-id-type="doi">10.4103/0973-7847.162137</pub-id><?supplied-pmid 26392712?><pub-id pub-id-type="pmid">26392712</pub-id></mixed-citation></ref><ref id="B120"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Izzo</surname><given-names>A. A.</given-names></name></person-group> (<year>2012</year>). <article-title>Interactions between herbs and conventional drugs: overview of the clinical data</article-title>. <source>Med. Princ. Pract.</source>
<volume>21</volume>, <fpage>404</fpage>&#x02013;<lpage>428</lpage>. <pub-id pub-id-type="doi">10.1159/000334488</pub-id><?supplied-pmid 22236736?><pub-id pub-id-type="pmid">22236736</pub-id></mixed-citation></ref><ref id="B121"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jahanshahi</surname><given-names>M.</given-names></name><name><surname>Nickmahzar</surname><given-names>E. G.</given-names></name><name><surname>Babakordi</surname><given-names>F.</given-names></name></person-group> (<year>2013</year>). <article-title>Effect of Gingko biloba extract on scopolamine-induced apoptosis in the hippocampus of rats</article-title>. <source>Anat. Sci. Int.</source>
<volume>88</volume>, <fpage>217</fpage>&#x02013;<lpage>222</lpage>. <pub-id pub-id-type="doi">10.1007/s12565-013-0188-8</pub-id><?supplied-pmid 23828103?><pub-id pub-id-type="pmid">23828103</pub-id></mixed-citation></ref><ref id="B122"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jahanshahi</surname><given-names>M.</given-names></name><name><surname>Nikmahzar</surname><given-names>E.</given-names></name><name><surname>Yadollahi</surname><given-names>N.</given-names></name><name><surname>Ramazani</surname><given-names>K.</given-names></name></person-group> (<year>2012</year>). <article-title>Protective effects of <italic>Ginkgo biloba</italic> extract (EGB 761) on astrocytes of rat hippocampus after exposure with scopolamine</article-title>. <source>Anat. Cell Biol.</source>
<volume>45</volume>, <fpage>92</fpage>&#x02013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.5115/acb.2012.45.2.92</pub-id><?supplied-pmid 22822463?><pub-id pub-id-type="pmid">22822463</pub-id></mixed-citation></ref><ref id="B123"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jelenkovic</surname><given-names>A.</given-names></name><name><surname>Jovanovic</surname><given-names>M. D.</given-names></name><name><surname>Stevanovic</surname><given-names>I.</given-names></name><name><surname>Petronijevic</surname><given-names>N.</given-names></name><name><surname>Bokonjic</surname><given-names>D.</given-names></name><name><surname>Zivkovic</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Influence of the green tea leaf extract on neurotoxicity of aluminium chloride in rats</article-title>. <source>Phytother. Res.</source>
<volume>28</volume>, <fpage>82</fpage>&#x02013;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1002/ptr.4962</pub-id><?supplied-pmid 23494944?><pub-id pub-id-type="pmid">23494944</pub-id></mixed-citation></ref><ref id="B124"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ju</surname><given-names>H. S.</given-names></name><name><surname>Li</surname><given-names>X. J.</given-names></name><name><surname>Zhao</surname><given-names>B. L.</given-names></name><name><surname>Han</surname><given-names>Z. W.</given-names></name><name><surname>Xin</surname><given-names>W. J.</given-names></name></person-group> (<year>1989</year>). <article-title>Effects of glycyrrhiza flavonoid on lipid peroxidation and active oxygen radicals</article-title>. <source>Yao Xue Xue Bao</source>
<volume>24</volume>, <fpage>807</fpage>&#x02013;<lpage>812</lpage>. <?supplied-pmid 2618676?><pub-id pub-id-type="pmid">2618676</pub-id></mixed-citation></ref><ref id="B125"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanno</surname><given-names>H.</given-names></name><name><surname>Kawakami</surname><given-names>Z.</given-names></name><name><surname>Tabuchi</surname><given-names>M.</given-names></name><name><surname>Mizoguchi</surname><given-names>K.</given-names></name><name><surname>Ikarashi</surname><given-names>Y.</given-names></name><name><surname>Kase</surname><given-names>Y.</given-names></name></person-group> (<year>2015</year>). <article-title>Protective effects of glycycoumarin and procyanidin B1, active components of traditional Japanese medicine yokukansan, on amyloid beta oligomer-induced neuronal death</article-title>. <source>J. Ethnopharmacol.</source>
<volume>159</volume>, <fpage>122</fpage>&#x02013;<lpage>128</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2014.10.058</pub-id><?supplied-pmid 25446602?><pub-id pub-id-type="pmid">25446602</pub-id></mixed-citation></ref><ref id="B126"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanowski</surname><given-names>S.</given-names></name><name><surname>Herrmann</surname><given-names>W. M.</given-names></name><name><surname>Stephan</surname><given-names>K.</given-names></name><name><surname>Wierich</surname><given-names>W.</given-names></name><name><surname>Horr</surname><given-names>R.</given-names></name></person-group> (<year>1996</year>). <article-title>Proof of efficacy of the <italic>Ginkgo biloba</italic> special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia</article-title>. <source>Pharmacopsychiatry</source>
<volume>29</volume>, <fpage>47</fpage>&#x02013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1055/s-2007-979544</pub-id><?supplied-pmid 8741021?><pub-id pub-id-type="pmid">8741021</pub-id></mixed-citation></ref><ref id="B127"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katsel</surname><given-names>P.</given-names></name><name><surname>Tan</surname><given-names>W.</given-names></name><name><surname>Fam</surname><given-names>P.</given-names></name><name><surname>Purohit</surname><given-names>D. P.</given-names></name><name><surname>Haroutunian</surname><given-names>V.</given-names></name></person-group> (<year>2013</year>). <article-title>Cell cycle checkpoint abnormalities during dementia: a plausible association with the loss of protection against oxidative stress in Alzheimer's disease [corrected]</article-title>. <source>PLoS ONE</source>
<volume>8</volume>:<fpage>e68361</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0068361</pub-id><?supplied-pmid 23861893?><pub-id pub-id-type="pmid">23861893</pub-id></mixed-citation></ref><ref id="B128"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname><given-names>U.</given-names></name><name><surname>Banerjee</surname><given-names>P.</given-names></name><name><surname>Bir</surname><given-names>A.</given-names></name><name><surname>Sinha</surname><given-names>M.</given-names></name><name><surname>Biswas</surname><given-names>A.</given-names></name><name><surname>Chakrabarti</surname><given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>Reactive oxygen species, redox signaling and neuroinflammation in Alzheimer's disease: the NF-kappaB connection</article-title>. <source>Curr. Top. Med. Chem.</source>
<volume>15</volume>, <fpage>446</fpage>&#x02013;<lpage>457</lpage>. <pub-id pub-id-type="doi">10.2174/1568026615666150114160543</pub-id><?supplied-pmid 25620241?><pub-id pub-id-type="pmid">25620241</pub-id></mixed-citation></ref><ref id="B129"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kihara</surname><given-names>T.</given-names></name><name><surname>Shimohama</surname><given-names>S.</given-names></name></person-group> (<year>2004</year>). <article-title>Alzheimer's disease and acetylcholine receptors</article-title>. <source>Acta Neurobiol. Exp. (Wars).</source>
<volume>64</volume>, <fpage>99</fpage>&#x02013;<lpage>105</lpage>. <?supplied-pmid 15190684?><pub-id pub-id-type="pmid">15190684</pub-id></mixed-citation></ref><ref id="B130"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J. M.</given-names></name><name><surname>Ryou</surname><given-names>S. H.</given-names></name><name><surname>Kang</surname><given-names>Y. H.</given-names></name><name><surname>Kang</surname><given-names>J. S.</given-names></name></person-group> (<year>2011</year>). <article-title>Effect of <italic>Ginkgo biloba</italic> leaf powder and extract on plasma and liver lipids, platelet aggregation and erythrocyte Na+ efflux in rats fed hypercholesterolemic diet</article-title>. <source>FASEB J.</source>
<volume>25</volume>, <fpage>980</fpage>&#x02013;<lpage>988</lpage>.</mixed-citation></ref><ref id="B131"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Shim</surname><given-names>J.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Cho</surname><given-names>W.-H.</given-names></name><name><surname>Hong</surname><given-names>E.</given-names></name><name><surname>Lee</surname><given-names>J. H.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Rg3-enriched ginseng extract ameliorates scopolamine-induced learning deficits in mice</article-title>. <source>BMC Complement. Altern. Med.</source>
<volume>16</volume>:<fpage>66</fpage>. <pub-id pub-id-type="doi">10.1186/s12906-016-1050-z</pub-id><?supplied-pmid 26887326?><pub-id pub-id-type="pmid">26887326</pub-id></mixed-citation></ref><ref id="B132"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>M.-S.</given-names></name><name><surname>Lee</surname><given-names>J.-I.</given-names></name><name><surname>Lee</surname><given-names>W.-Y.</given-names></name><name><surname>Kim</surname><given-names>S.-E.</given-names></name></person-group> (<year>2004</year>). <article-title>Neuroprotective effect of <italic>Ginkgo biloba</italic> L. extract in a rat model of Parkinson's disease</article-title>. <source>Phytother. Res.</source>
<volume>18</volume>, <fpage>663</fpage>&#x02013;<lpage>666</lpage>. <pub-id pub-id-type="doi">10.1002/ptr.1486</pub-id><?supplied-pmid 15472919?><pub-id pub-id-type="pmid">15472919</pub-id></mixed-citation></ref><ref id="B133"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>T. I.</given-names></name><name><surname>Lee</surname><given-names>Y. K.</given-names></name><name><surname>Park</surname><given-names>S. G.</given-names></name><name><surname>Choi</surname><given-names>I. S.</given-names></name><name><surname>Ban</surname><given-names>J. O.</given-names></name><name><surname>Park</surname><given-names>H. K.</given-names></name><etal/></person-group>. (<year>2009</year>). <article-title>l-Theanine, an amino acid in green tea, attenuates beta-amyloid-induced cognitive dysfunction and neurotoxicity: reduction in oxidative damage and inactivation of ERK/p38 kinase and NF-kappaB pathways</article-title>. <source>Free Radic. Biol. Med.</source>
<volume>47</volume>, <fpage>1601</fpage>&#x02013;<lpage>1610</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2009.09.008</pub-id><?supplied-pmid 19766184?><pub-id pub-id-type="pmid">19766184</pub-id></mixed-citation></ref><ref id="B134"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>Y. C.</given-names></name><name><surname>Kim</surname><given-names>S. R.</given-names></name><name><surname>Markelonis</surname><given-names>G. J.</given-names></name><name><surname>Oh</surname><given-names>T. H.</given-names></name></person-group> (<year>1998</year>). <article-title>Ginsenosides Rb1 and Rg3 protect cultured rat cortical cells from glutamate-induced neurodegeneration</article-title>. <source>J. Neurosci. Res.</source>
<volume>53</volume>, <fpage>426</fpage>&#x02013;<lpage>432</lpage>. <?supplied-pmid 9710262?><pub-id pub-id-type="pmid">9710262</pub-id></mixed-citation></ref><ref id="B135"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>K.</given-names></name><name><surname>Ozeki</surname><given-names>M.</given-names></name><name><surname>Juneja</surname><given-names>L. R.</given-names></name><name><surname>Ohira</surname><given-names>H.</given-names></name></person-group> (<year>2007</year>). <article-title>L-Theanine reduces psychological and physiological stress responses</article-title>. <source>Biol. Psychol.</source>
<volume>74</volume>, <fpage>39</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsycho.2006.06.006</pub-id><?supplied-pmid 16930802?><pub-id pub-id-type="pmid">16930802</pub-id></mixed-citation></ref><ref id="B136"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Knapp</surname><given-names>M.</given-names></name><name><surname>Prince</surname><given-names>M.</given-names></name><name><surname>Albanese</surname><given-names>E.</given-names></name><name><surname>Banerjee</surname><given-names>S.</given-names></name><name><surname>Dhanasiri</surname><given-names>S.</given-names></name><name><surname>Fernandez</surname><given-names>J. L.</given-names></name></person-group> (<year>2007</year>). <source>Dementia UK: The Full Report</source>. <publisher-loc>London</publisher-loc>: <publisher-name>Alzheimer's Society</publisher-name>.</mixed-citation></ref><ref id="B137"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koola</surname><given-names>M. M.</given-names></name><name><surname>Buchanan</surname><given-names>R. W.</given-names></name><name><surname>Pillai</surname><given-names>A.</given-names></name><name><surname>Aitchison</surname><given-names>K. J.</given-names></name><name><surname>Weinberger</surname><given-names>D. R.</given-names></name><name><surname>Aaronson</surname><given-names>S. T.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Potential role of the combination of galantamine and memantine to improve cognition in schizophrenia</article-title>. <source>Schizophr. Res.</source>
<volume>157</volume>, <fpage>84</fpage>&#x02013;<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1016/j.schres.2014.04.037</pub-id><?supplied-pmid 24878431?><pub-id pub-id-type="pmid">24878431</pub-id></mixed-citation></ref><ref id="B138"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Prakash</surname><given-names>A.</given-names></name><name><surname>Pahwa</surname><given-names>D.</given-names></name></person-group> (<year>2011</year>). <article-title>Galantamine potentiates the protective effect of rofecoxib and caffeic acid against intrahippocampal Kainic acid-induced cognitive dysfunction in rat</article-title>. <source>Brain Res. Bull.</source>
<volume>85</volume>, <fpage>158</fpage>&#x02013;<lpage>168</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainresbull.2011.03.010</pub-id><?supplied-pmid 21439356?><pub-id pub-id-type="pmid">21439356</pub-id></mixed-citation></ref><ref id="B139"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Singh</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>). <article-title>A review on mitochondrial restorative mechanism of antioxidants in Alzheimer's disease and other neurological conditions</article-title>. <source>Front. Pharmacol.</source>
<volume>6</volume>:<fpage>206</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2015.00206</pub-id><?supplied-pmid 26441662?><pub-id pub-id-type="pmid">26441662</pub-id></mixed-citation></ref><ref id="B140"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LeBlanc</surname><given-names>A. C.</given-names></name></person-group> (<year>2005</year>). <article-title>The role of apoptotic pathways in Alzheimer's disease neurodegeneration and cell death</article-title>. <source>Curr. Alzheimer Res.</source>
<volume>2</volume>, <fpage>389</fpage>&#x02013;<lpage>402</lpage>. <pub-id pub-id-type="doi">10.2174/156720505774330573</pub-id><?supplied-pmid 16248844?><pub-id pub-id-type="pmid">16248844</pub-id></mixed-citation></ref><ref id="B141"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Kim</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>T.</given-names></name><name><surname>Hwang</surname><given-names>Y. J.</given-names></name><name><surname>Hyeon</surname><given-names>S. J.</given-names></name><name><surname>Im</surname><given-names>H.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>SIRT3 deregulation is linked to mitochondrial dysfunction in Alzheimer's disease</article-title>. <source>Aging Cell</source>. [Epub ahead of print]. <pub-id pub-id-type="doi">10.1111/acel.12679</pub-id><?supplied-pmid 29130578?><pub-id pub-id-type="pmid">29130578</pub-id></mixed-citation></ref><ref id="B142"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>T.-K.</given-names></name><name><surname>Johnke</surname><given-names>R. M.</given-names></name><name><surname>Allison</surname><given-names>R. R.</given-names></name><name><surname>O'Brien</surname><given-names>K. F.</given-names></name><name><surname>Dobbs</surname><given-names>L. J. J.</given-names></name></person-group> (<year>2005</year>). <article-title>Radioprotective potential of ginseng</article-title>. <source>Mutagenesis</source>
<volume>20</volume>, <fpage>237</fpage>&#x02013;<lpage>243</lpage>. <pub-id pub-id-type="doi">10.1093/mutage/gei041</pub-id><?supplied-pmid 15956041?><pub-id pub-id-type="pmid">15956041</pub-id></mixed-citation></ref><ref id="B143"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Chu</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Yin</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name></person-group> (<year>2012</year>). <article-title>Ginsenoside Rg1 attenuates tau phosphorylation in SK-N-SH induced by Abeta-stimulated THP-1 supernatant and the involvement of p38 pathway activation</article-title>. <source>Life Sci.</source>
<volume>91</volume>, <fpage>809</fpage>&#x02013;<lpage>815</lpage>. <pub-id pub-id-type="doi">10.1016/j.lfs.2012.08.028</pub-id><?supplied-pmid 22982182?><pub-id pub-id-type="pmid">22982182</pub-id></mixed-citation></ref><ref id="B144"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lilienfeld</surname><given-names>S.</given-names></name></person-group> (<year>2002</year>). <article-title>Galantamine&#x02013;a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease</article-title>. <source>CNS Drug Rev.</source>
<volume>8</volume>, <fpage>159</fpage>&#x02013;<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1111/j.1527-3458.2002.tb00221.x</pub-id><?supplied-pmid 12177686?><pub-id pub-id-type="pmid">12177686</pub-id></mixed-citation></ref><ref id="B145"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>S. L.</given-names></name><name><surname>Rodriguez-Ortiz</surname><given-names>C. J.</given-names></name><name><surname>Kitazawa</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>Infection, systemic inflammation, and Alzheimer's disease</article-title>. <source>Microbes Infect.</source>
<volume>17</volume>, <fpage>549</fpage>&#x02013;<lpage>556</lpage>. <pub-id pub-id-type="doi">10.1016/j.micinf.2015.04.004</pub-id><?supplied-pmid 25912134?><pub-id pub-id-type="pmid">25912134</pub-id></mixed-citation></ref><ref id="B146"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>M. T.</given-names></name><name><surname>Beal</surname><given-names>M. F.</given-names></name></person-group> (<year>2006</year>). <article-title>Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases</article-title>. <source>Nature</source>
<volume>443</volume>, <fpage>787</fpage>&#x02013;<lpage>795</lpage>. <pub-id pub-id-type="doi">10.1038/nature05292</pub-id><?supplied-pmid 17051205?><pub-id pub-id-type="pmid">17051205</pub-id></mixed-citation></ref><ref id="B147"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>C.-C.</given-names></name><name><surname>Liu</surname><given-names>C.-C.</given-names></name><name><surname>Kanekiyo</surname><given-names>T.</given-names></name><name><surname>Xu</surname><given-names>H.</given-names></name><name><surname>Bu</surname><given-names>G.</given-names></name></person-group> (<year>2013</year>). <article-title>Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy</article-title>. <source>Nat. Rev. Neurol.</source>
<volume>9</volume>, <fpage>106</fpage>&#x02013;<lpage>118</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2012.263</pub-id><?supplied-pmid 23296339?><pub-id pub-id-type="pmid">23296339</pub-id></mixed-citation></ref><ref id="B148"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Xu</surname><given-names>K.</given-names></name><name><surname>Yan</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Zheng</surname><given-names>X.</given-names></name></person-group> (<year>2010</year>). <article-title>Protective effects of galantamine against A&#x003b2;-induced PC12 cell apoptosis by preventing mitochondrial dysfunction and endoplasmic reticulum stress</article-title>. <source>Neurochem. Int.</source>
<volume>57</volume>, <fpage>588</fpage>&#x02013;<lpage>599</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuint.2010.07.007</pub-id><?supplied-pmid 20655346?><pub-id pub-id-type="pmid">20655346</pub-id></mixed-citation></ref><ref id="B149"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>F.</given-names></name><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Hao</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>P.</given-names></name></person-group> (<year>2015</year>). <article-title>A strategy for the identification of combinatorial bioactive compounds contributing to the holistic effect of herbal medicines</article-title>. <source>Sci. Rep.</source>
<volume>5</volume>:<fpage>12361</fpage>. <pub-id pub-id-type="doi">10.1038/srep12361</pub-id><?supplied-pmid 26198093?><pub-id pub-id-type="pmid">26198093</pub-id></mixed-citation></ref><ref id="B150"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lonicerus</surname><given-names>A.</given-names></name></person-group> (<year>1679</year>). <source>Kr&#x000e4;uterbuch, Matthias Wagner</source>. <publisher-loc>Ulm</publisher-loc>.</mixed-citation></ref><ref id="B151"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loy</surname><given-names>C.</given-names></name><name><surname>Schneider</surname><given-names>L.</given-names></name></person-group> (<year>2006</year>). <article-title>Galantamine for Alzheimer's disease and mild cognitive impairment</article-title>. <source>Cochrane database Syst. Rev.</source>
<volume>25</volume>:<fpage>CD001747</fpage>
<pub-id pub-id-type="doi">10.1002/14651858.CD001747.pub3</pub-id></mixed-citation></ref><ref id="B152"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Luengo-Fernandez</surname><given-names>R.</given-names></name><name><surname>Leal</surname><given-names>J.</given-names></name><name><surname>Gray</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>). <source>Dementia 2010: The Economic Burden of Dementia and Associated Research Funding in the United Kingdom</source>. <publisher-loc>Oxford</publisher-loc>: <publisher-name>Cambridge Alzheimer's Research Trust</publisher-name>.</mixed-citation></ref><ref id="B153"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>B.</given-names></name><name><surname>Meng</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Sun</surname><given-names>J.</given-names></name><name><surname>Ren</surname><given-names>X.</given-names></name><name><surname>Qin</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Notoginsenoside R1 attenuates amyloid-beta-induced damage in neurons by inhibiting reactive oxygen species and modulating MAPK activation</article-title>. <source>Int. Immunopharmacol.</source>
<volume>22</volume>, <fpage>151</fpage>&#x02013;<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2014.06.018</pub-id><?supplied-pmid 24975829?><pub-id pub-id-type="pmid">24975829</pub-id></mixed-citation></ref><ref id="B154"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahley</surname><given-names>R. W.</given-names></name><name><surname>Rall</surname><given-names>S. C.</given-names><suffix>Jr.</suffix></name></person-group> (<year>2000</year>). <article-title>Apolipoprotein E: far more than a lipid transport protein</article-title>. <source>Annu. Rev. Genomics Hum. Genet.</source>
<volume>1</volume>, <fpage>507</fpage>&#x02013;<lpage>537</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.genom.1.1.507</pub-id><?supplied-pmid 11701639?><pub-id pub-id-type="pmid">11701639</pub-id></mixed-citation></ref><ref id="B155"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahmood</surname><given-names>T.</given-names></name><name><surname>Akhtar</surname><given-names>N.</given-names></name><name><surname>Khan</surname><given-names>B. A.</given-names></name></person-group> (<year>2010</year>). <article-title>The morphology, characteristics, and medicinal properties of Camellia sinensis tea</article-title>. <source>J. Med. Plants Res.</source>
<volume>4</volume>, <fpage>2028</fpage>&#x02013;<lpage>2033</lpage>. <pub-id pub-id-type="doi">10.5897/JMPR10.010</pub-id></mixed-citation></ref><ref id="B156"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandel</surname><given-names>S. A.</given-names></name><name><surname>Amit</surname><given-names>T.</given-names></name><name><surname>Weinreb</surname><given-names>O.</given-names></name><name><surname>Youdim</surname><given-names>M. B. H.</given-names></name></person-group> (<year>2011</year>). <article-title>Understanding the broad-spectrum neuroprotective action profile of green tea polyphenols in aging and neurodegenerative diseases</article-title>. <source>J. Alzheimers. Dis.</source>
<volume>25</volume>, <fpage>187</fpage>&#x02013;<lpage>208</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-2011-101803</pub-id><?supplied-pmid 21368374?><pub-id pub-id-type="pmid">21368374</pub-id></mixed-citation></ref><ref id="B157"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mantle</surname><given-names>D.</given-names></name><name><surname>Pickering</surname><given-names>A. T.</given-names></name><name><surname>Perry</surname><given-names>E. K.</given-names></name></person-group> (<year>2000</year>). <article-title>Medicinal plant extracts for the treatment of dementia</article-title>. <source>CNS Drugs</source>
<volume>13</volume>, <fpage>201</fpage>&#x02013;<lpage>213</lpage>. <pub-id pub-id-type="doi">10.2165/00023210-200013030-00006</pub-id></mixed-citation></ref><ref id="B158"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manyam</surname><given-names>B. V.</given-names></name></person-group> (<year>1999</year>). <article-title>Dementia in ayurveda</article-title>. <source>J. Altern. Complement. Med.</source>
<volume>5</volume>, <fpage>81</fpage>&#x02013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1089/acm.1999.5.81</pub-id><?supplied-pmid 10100034?><pub-id pub-id-type="pmid">10100034</pub-id></mixed-citation></ref><ref id="B159"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKhann</surname><given-names>G. M.</given-names></name><name><surname>Albert</surname><given-names>M. S.</given-names></name><name><surname>Grossman</surname><given-names>M.</given-names></name><name><surname>Miller</surname><given-names>B.</given-names></name><name><surname>Dickson</surname><given-names>D.</given-names></name><name><surname>Trojanowski</surname><given-names>J. Q.</given-names></name></person-group> (<year>2001</year>). <article-title>Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease</article-title>. <source>Arch. Neurol.</source>
<volume>58</volume>, <fpage>1803</fpage>&#x02013;<lpage>1809</lpage>. <pub-id pub-id-type="doi">10.1001/archneur.58.11.1803</pub-id><?supplied-pmid 11708987?><pub-id pub-id-type="pmid">11708987</pub-id></mixed-citation></ref><ref id="B160"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Mehan</surname><given-names>S.</given-names></name><name><surname>Sharma</surname><given-names>D.</given-names></name><name><surname>Sharma</surname><given-names>G.</given-names></name><name><surname>Arora</surname><given-names>R.</given-names></name><name><surname>Sehgal</surname><given-names>V.</given-names></name></person-group> (<year>2012</year>). <source>Dementia-A Complete Literature Review on Various Mechanisms Involves in Pathogenesis and an Intracerebroventricular Streptozotocin Induced Alzheimer's Disease</source>. <publisher-name>INTECH Open Access Publisher</publisher-name> Available online at: <ext-link ext-link-type="uri" xlink:href="http://www.intechopen.com/books/inflammatory-diseases-immunopathology-clinical-and-pharmacologicalbases/alzheimer-s-disease-an-updated-review-on-pathogenesis-and-intracerebroventricular-streptozotocin-ind">http://www.intechopen.com/books/inflammatory-diseases-immunopathology-clinical-and-pharmacologicalbases/alzheimer-s-disease-an-updated-review-on-pathogenesis-and-intracerebroventricular-streptozotocin-ind</ext-link></mixed-citation></ref><ref id="B161"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miao</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>S.</given-names></name><name><surname>Gao</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>R.</given-names></name><name><surname>Wu</surname><given-names>Q.</given-names></name><name><surname>Wu</surname><given-names>H.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Curcumin pretreatment attenuates inflammation and mitochondrial dysfunction in experimental stroke: the possible role of Sirt1 signaling</article-title>. <source>Brain Res. Bull.</source>
<volume>121</volume>, <fpage>9</fpage>&#x02013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainresbull.2015.11.019</pub-id><?supplied-pmid 26639783?><pub-id pub-id-type="pmid">26639783</pub-id></mixed-citation></ref><ref id="B162"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Mills</surname><given-names>S. Y.</given-names></name></person-group> (<year>1991</year>). <source>Out of the Earth: The Essential Book of Herbal Medicine</source>. <publisher-loc>London</publisher-loc>: <publisher-name>Viking</publisher-name>.</mixed-citation></ref><ref id="B163"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>S.</given-names></name><name><surname>Palanivelu</surname><given-names>K.</given-names></name></person-group> (<year>2008</year>). <article-title>The effect of curcumin (turmeric) on Alzheimer's disease: an overview</article-title>. <source>Ann. Indian Acad. Neurol.</source>
<volume>11</volume>, <fpage>13</fpage>&#x02013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.4103/0972-2327.40220</pub-id><?supplied-pmid 19966973?><pub-id pub-id-type="pmid">19966973</pub-id></mixed-citation></ref><ref id="B164"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Misra</surname><given-names>R.</given-names></name></person-group> (<year>1998</year>). <article-title>Modern drug development from traditional medicinal plants using radioligand receptor-binding assays</article-title>. <source>Med. Res. Rev.</source>
<volume>18</volume>, <fpage>383</fpage>&#x02013;<lpage>402</lpage>. <?supplied-pmid 9828039?><pub-id pub-id-type="pmid">9828039</pub-id></mixed-citation></ref><ref id="B165"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monsch</surname><given-names>A. U.</given-names></name><name><surname>Giannakopoulos</surname><given-names>P.</given-names></name></person-group> (<year>2004</year>). <article-title>Effects of galantamine on behavioural and psychological disturbances and caregiver burden in patients with Alzheimer's disease</article-title>. <source>Curr. Med. Res. Opin.</source>
<volume>20</volume>, <fpage>931</fpage>&#x02013;<lpage>938</lpage>. <pub-id pub-id-type="doi">10.1185/030079904125003890</pub-id><?supplied-pmid 15200752?><pub-id pub-id-type="pmid">15200752</pub-id></mixed-citation></ref><ref id="B166"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreira</surname><given-names>P. I.</given-names></name><name><surname>Carvalho</surname><given-names>C.</given-names></name><name><surname>Zhu</surname><given-names>X.</given-names></name><name><surname>Smith</surname><given-names>M. A.</given-names></name><name><surname>Perry</surname><given-names>G.</given-names></name></person-group> (<year>2010</year>). <article-title>Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology</article-title>. <source>Biochim. Biophys. Acta</source>
<volume>1802</volume>, <fpage>2</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbadis.2009.10.006</pub-id><?supplied-pmid 19853658?><pub-id pub-id-type="pmid">19853658</pub-id></mixed-citation></ref><ref id="B167"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>M&#x000fc;ller-Ebeling</surname><given-names>C.</given-names></name><name><surname>R&#x000e4;tsch</surname><given-names>C.</given-names></name></person-group> (<year>1989</year>). <source>Heilpflanzen der Seychellen.VWB-Verlag f&#x000fc;r Wissenschaft und Bildung</source>. <publisher-loc>Berlin</publisher-loc>.</mixed-citation></ref><ref id="B168"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nah</surname><given-names>S.-Y.</given-names></name></person-group> (<year>2014</year>). <article-title>Ginseng ginsenoside pharmacology in the nervous system: involvement in the regulation of ion channels and receptors</article-title>. <source>Front. Physiol.</source>
<volume>5</volume>:<fpage>98</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2014.00098</pub-id><?supplied-pmid 24678300?><pub-id pub-id-type="pmid">24678300</pub-id></mixed-citation></ref><ref id="B169"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Namanja</surname><given-names>H. A.</given-names></name><name><surname>Emmert</surname><given-names>D.</given-names></name><name><surname>Pires</surname><given-names>M. M.</given-names></name><name><surname>Hrycyna</surname><given-names>C. A.</given-names></name><name><surname>Chmielewski</surname><given-names>J.</given-names></name></person-group> (<year>2009</year>). <article-title>Inhibition of human P-glycoprotein transport and substrate binding using a galantamine dimer</article-title>. <source>Biochem. Biophys. Res. Commun.</source>
<volume>388</volume>, <fpage>672</fpage>&#x02013;<lpage>676</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2009.08.056</pub-id><?supplied-pmid 19683513?><pub-id pub-id-type="pmid">19683513</pub-id></mixed-citation></ref><ref id="B170"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Napryeyenko</surname><given-names>O.</given-names></name><name><surname>Sonnik</surname><given-names>G.</given-names></name><name><surname>Tartakovsky</surname><given-names>I.</given-names></name></person-group> (<year>2009</year>). <article-title>Efficacy and tolerability of <italic>Ginkgo biloba</italic> extract EGb 761 by type of dementia: analyses of a randomised controlled trial</article-title>. <source>J. Neurol. Sci.</source>
<volume>283</volume>, <fpage>224</fpage>&#x02013;<lpage>229</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2009.02.353</pub-id><?supplied-pmid 19286192?><pub-id pub-id-type="pmid">19286192</pub-id></mixed-citation></ref><ref id="B171"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narlawar</surname><given-names>R.</given-names></name><name><surname>Pickhardt</surname><given-names>M.</given-names></name><name><surname>Leuchtenberger</surname><given-names>S.</given-names></name><name><surname>Baumann</surname><given-names>K.</given-names></name><name><surname>Krause</surname><given-names>S.</given-names></name><name><surname>Dyrks</surname><given-names>T.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>Curcumin-derived pyrazoles and isoxazoles: swiss army knives or blunt tools for Alzheimer's disease?</article-title>
<source>ChemMedChem</source>
<volume>3</volume>, <fpage>165</fpage>&#x02013;<lpage>172</lpage>. <pub-id pub-id-type="doi">10.1002/cmdc.200700218</pub-id><?supplied-pmid 17943713?><pub-id pub-id-type="pmid">17943713</pub-id></mixed-citation></ref><ref id="B172"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navia</surname><given-names>B. A.</given-names></name><name><surname>Rostasy</surname><given-names>K.</given-names></name></person-group> (<year>2005</year>). <article-title>The AIDS dementia complex: clinical and basic neuroscience with implications for novel molecular therapies</article-title>. <source>Neurotox. Res.</source>
<volume>8</volume>, <fpage>3</fpage>&#x02013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1007/BF03033817</pub-id><?supplied-pmid 16260383?><pub-id pub-id-type="pmid">16260383</pub-id></mixed-citation></ref><ref id="B173"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>T.-P.</given-names></name><name><surname>Chiam</surname><given-names>P.-C.</given-names></name><name><surname>Lee</surname><given-names>T.</given-names></name><name><surname>Chua</surname><given-names>H.-C.</given-names></name><name><surname>Lim</surname><given-names>L.</given-names></name><name><surname>Kua</surname><given-names>E.-H.</given-names></name></person-group> (<year>2006</year>). <article-title>Curry consumption and cognitive function in the elderly</article-title>. <source>Am. J. Epidemiol.</source>
<volume>164</volume>, <fpage>898</fpage>&#x02013;<lpage>906</lpage>. <pub-id pub-id-type="doi">10.1093/aje/kwj267</pub-id><?supplied-pmid 16870699?><pub-id pub-id-type="pmid">16870699</pub-id></mixed-citation></ref><ref id="B174"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>Y. P.</given-names></name><name><surname>Or</surname><given-names>T. C. T.</given-names></name><name><surname>Ip</surname><given-names>N. Y.</given-names></name></person-group> (<year>2015</year>). <article-title>Plant alkaloids as drug leads for Alzheimer's disease</article-title>. <source>Neurochem. Int.</source>
<volume>89</volume>, <fpage>260</fpage>&#x02013;<lpage>270</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuint.2015.07.018</pub-id><?supplied-pmid 26220901?><pub-id pub-id-type="pmid">26220901</pub-id></mixed-citation></ref><ref id="B175"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ngan</surname><given-names>F.</given-names></name><name><surname>Shaw</surname><given-names>P.</given-names></name><name><surname>But</surname><given-names>P.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name></person-group> (<year>1999</year>). <article-title>Molecular authentication of Panax species</article-title>. <source>Phytochemistry</source>
<volume>50</volume>, <fpage>787</fpage>&#x02013;<lpage>791</lpage>. <pub-id pub-id-type="doi">10.1016/S0031-9422(98)00606-2</pub-id><?supplied-pmid 10192964?><pub-id pub-id-type="pmid">10192964</pub-id></mixed-citation></ref><ref id="B176"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niikura</surname><given-names>T.</given-names></name><name><surname>Tajima</surname><given-names>H.</given-names></name><name><surname>Kita</surname><given-names>Y.</given-names></name></person-group> (<year>2006</year>). <article-title>Neuronal cell death in Alzheimer's disease and a neuroprotective factor, humanin</article-title>. <source>Curr. Neuropharmacol.</source>
<volume>4</volume>, <fpage>139</fpage>&#x02013;<lpage>147</lpage>. <pub-id pub-id-type="doi">10.2174/157015906776359577</pub-id><?supplied-pmid 18615127?><pub-id pub-id-type="pmid">18615127</pub-id></mixed-citation></ref><ref id="B177"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nimmrich</surname><given-names>V.</given-names></name><name><surname>Eckert</surname><given-names>A.</given-names></name></person-group> (<year>2013</year>). <article-title>Calcium channel blockers and dementia</article-title>. <source>Br. J. Pharmacol.</source>
<volume>169</volume>, <fpage>1203</fpage>&#x02013;<lpage>1210</lpage>. <pub-id pub-id-type="doi">10.1111/bph.12240</pub-id><?supplied-pmid 23638877?><pub-id pub-id-type="pmid">23638877</pub-id></mixed-citation></ref><ref id="B178"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishida</surname><given-names>K.</given-names></name><name><surname>Yasuda</surname><given-names>E.</given-names></name><name><surname>Nagasawa</surname><given-names>K.</given-names></name><name><surname>Fujimoto</surname><given-names>S.</given-names></name></person-group> (<year>2008</year>). <article-title>Altered levels of oxidation and phospholipase C isozyme expression in the brains of theanine-administered rats</article-title>. <source>Biol. Pharm. Bull.</source>
<volume>31</volume>, <fpage>857</fpage>&#x02013;<lpage>860</lpage>. <pub-id pub-id-type="doi">10.1248/bpb.31.857</pub-id><?supplied-pmid 18451507?><pub-id pub-id-type="pmid">18451507</pub-id></mixed-citation></ref><ref id="B179"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishiyama</surname><given-names>N.</given-names></name><name><surname>Chu</surname><given-names>P. J.</given-names></name><name><surname>Saito</surname><given-names>H.</given-names></name></person-group> (<year>1995</year>). <article-title>Beneficial effects of Biota, a traditional Chinese herbal medicine on learning impairment induced by basal forebrain-lesion in mice</article-title>. <source>Biol. Pharm. Bull.</source>
<volume>28</volume>, <fpage>1513</fpage>&#x02013;<lpage>1517</lpage>.</mixed-citation></ref><ref id="B180"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olin</surname><given-names>J.</given-names></name><name><surname>Schneider</surname><given-names>L.</given-names></name></person-group> (<year>2002</year>). <article-title>Galantamine for Alzheimer's disease</article-title>. <source>Cochrane database Syst. Rev.</source>
<volume>3</volume>:<fpage>CD001747</fpage>
<pub-id pub-id-type="doi">10.1002/14651858.CD001747</pub-id></mixed-citation></ref><ref id="B181"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ortiz de Montellano</surname><given-names>B. R.</given-names></name></person-group> (<year>1990</year>). <source>Aztec Medicine, Health and Nutrition</source>. <publisher-loc>New Brunswick</publisher-loc>: <publisher-name>Rutgers University Press</publisher-name>.</mixed-citation></ref><ref id="B182"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Owen</surname><given-names>G. N.</given-names></name><name><surname>Parnell</surname><given-names>H.</given-names></name><name><surname>De Bruin</surname><given-names>E. A.</given-names></name><name><surname>Rycroft</surname><given-names>J. A.</given-names></name></person-group> (<year>2008</year>). <article-title>The combined effects of L-theanine and caffeine on cognitive performance and mood</article-title>. <source>Nutr. Neurosci.</source>
<volume>11</volume>, <fpage>193</fpage>&#x02013;<lpage>198</lpage>. <pub-id pub-id-type="doi">10.1179/147683008X301513</pub-id><?supplied-pmid 18681988?><pub-id pub-id-type="pmid">18681988</pub-id></mixed-citation></ref><ref id="B183"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paganelli</surname><given-names>R. A.</given-names></name><name><surname>Benetoli</surname><given-names>A.</given-names></name><name><surname>Milani</surname><given-names>H.</given-names></name></person-group> (<year>2006</year>). <article-title>Sustained neuroprotection and facilitation of behavioral recovery by the <italic>Ginkgo biloba</italic> extract, EGb 761, after transient forebrain ischemia in rats</article-title>. <source>Behav. Brain Res.</source>
<volume>174</volume>, <fpage>70</fpage>&#x02013;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2006.07.005</pub-id><?supplied-pmid 16934342?><pub-id pub-id-type="pmid">16934342</pub-id></mixed-citation></ref><ref id="B184"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parle</surname><given-names>M.</given-names></name><name><surname>Dhingra</surname><given-names>D.</given-names></name><name><surname>Kulkarni</surname><given-names>S. K.</given-names></name></person-group> (<year>2004</year>). <article-title>Memory-strengthening activity of Glycyrrhiza glabra in exteroceptive and interoceptive behavioral models</article-title>. <source>J. Med. Food</source>
<volume>7</volume>, <fpage>462</fpage>&#x02013;<lpage>466</lpage>. <pub-id pub-id-type="doi">10.1089/jmf.2004.7.462</pub-id><?supplied-pmid 15671690?><pub-id pub-id-type="pmid">15671690</pub-id></mixed-citation></ref><ref id="B185"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pasqualetti</surname><given-names>G.</given-names></name><name><surname>Brooks</surname><given-names>D. J.</given-names></name><name><surname>Edison</surname><given-names>P.</given-names></name></person-group> (<year>2015</year>). <article-title>The role of neuroinflammation in dementias</article-title>. <source>Curr. Neurol. Neurosci. Rep.</source>
<volume>15</volume>:<fpage>17</fpage>. <pub-id pub-id-type="doi">10.1007/s11910-015-0531-7</pub-id><?supplied-pmid 25716012?><pub-id pub-id-type="pmid">25716012</pub-id></mixed-citation></ref><ref id="B186"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pastor</surname><given-names>P.</given-names></name><name><surname>Roe</surname><given-names>C. M.</given-names></name><name><surname>Villegas</surname><given-names>A.</given-names></name><name><surname>Bedoya</surname><given-names>G.</given-names></name><name><surname>Chakraverty</surname><given-names>S.</given-names></name><name><surname>Garcia</surname><given-names>G.</given-names></name><etal/></person-group>. (<year>2003</year>). <article-title>Apolipoprotein Eepsilon4 modifies Alzheimer's disease onset in an E280A PS1 kindred</article-title>. <source>Ann. Neurol.</source>
<volume>54</volume>, <fpage>163</fpage>&#x02013;<lpage>169</lpage>. <pub-id pub-id-type="doi">10.1002/ana.10636</pub-id><?supplied-pmid 12891668?><pub-id pub-id-type="pmid">12891668</pub-id></mixed-citation></ref><ref id="B187"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pathak</surname><given-names>L.</given-names></name><name><surname>Agrawal</surname><given-names>Y.</given-names></name><name><surname>Dhir</surname><given-names>A.</given-names></name></person-group> (<year>2013</year>). <article-title>Natural polyphenols in the management of major depression</article-title>. <source>Expert Opin. Investig. Drugs</source>
<volume>22</volume>, <fpage>863</fpage>&#x02013;<lpage>880</lpage>. <pub-id pub-id-type="doi">10.1517/13543784.2013.794783</pub-id><?supplied-pmid 23642183?><pub-id pub-id-type="pmid">23642183</pub-id></mixed-citation></ref><ref id="B188"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname><given-names>E.</given-names></name><name><surname>Howes</surname><given-names>M. R.</given-names></name></person-group> (<year>2011</year>). <article-title>Medicinal plants and dementia therapy: herbal hopes for brain aging?</article-title>
<source>CNS Neurosci. Ther.</source>
<volume>17</volume>, <fpage>683</fpage>&#x02013;<lpage>698</lpage>. <pub-id pub-id-type="doi">10.1111/j.1755-5949.2010.00202.x</pub-id><?supplied-pmid 22070157?><pub-id pub-id-type="pmid">22070157</pub-id></mixed-citation></ref><ref id="B189"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname><given-names>E. K.</given-names></name><name><surname>Pickering</surname><given-names>A. T.</given-names></name><name><surname>Wang</surname><given-names>W. W.</given-names></name><name><surname>Houghton</surname><given-names>P.</given-names></name><name><surname>Perry</surname><given-names>N. S. L.</given-names></name></person-group> (<year>1998</year>). <article-title>Medicinal plants and Alzheimer's disease: integrating ethnobotanical and contemporary scientific evidence</article-title>. <source>J. Altern. Complement. Med.</source>
<volume>4</volume>, <fpage>419</fpage>&#x02013;<lpage>428</lpage>. <?supplied-pmid 9884179?><pub-id pub-id-type="pmid">9884179</pub-id></mixed-citation></ref><ref id="B190"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Pohl</surname><given-names>S.</given-names></name><name><surname>Zobel</surname><given-names>J.</given-names></name><name><surname>Moffat</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Extended boolean retrieval for systematic biomedical reviews</article-title>, in <source>Proceedings of the Thirty-Third Australasian Conferenc on Computer Science - Volume 102</source> ACSC'10. (<publisher-loc>Darlinghurst, NSW</publisher-loc>: <publisher-name>Australian Computer Society, Inc</publisher-name>), <fpage>117</fpage>&#x02013;<lpage>126</lpage>. Available online at: <ext-link ext-link-type="uri" xlink:href="http://dl.acm.org/citation.cfm?id=1862199.1862212">http://dl.acm.org/citation.cfm?id=1862199.1862212</ext-link></mixed-citation></ref><ref id="B191"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Popovich</surname><given-names>D. G.</given-names></name><name><surname>Kitts</surname><given-names>D. D.</given-names></name></person-group> (<year>2004</year>). <article-title>Generation of ginsenosides Rg3 and Rh2 from North American ginseng</article-title>. <source>Phytochemistry</source>
<volume>65</volume>, <fpage>337</fpage>&#x02013;<lpage>344</lpage>. <pub-id pub-id-type="doi">10.1016/j.phytochem.2003.11.020</pub-id><?supplied-pmid 14751305?><pub-id pub-id-type="pmid">14751305</pub-id></mixed-citation></ref><ref id="B192"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Power</surname><given-names>M. C.</given-names></name><name><surname>Adar</surname><given-names>S. D.</given-names></name><name><surname>Yanosky</surname><given-names>J. D.</given-names></name><name><surname>Weuve</surname><given-names>J.</given-names></name></person-group> (<year>2016</year>). <article-title>Exposure to air pollution as a potential contributor to cognitive function, cognitive decline, brain imaging, and dementia: a systematic review of epidemiologic research</article-title>. <source>Neurotoxicology</source>
<volume>56</volume>, <fpage>235</fpage>&#x02013;<lpage>253</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuro.2016.06.004</pub-id><?supplied-pmid 27328897?><pub-id pub-id-type="pmid">27328897</pub-id></mixed-citation></ref><ref id="B193"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Price</surname><given-names>S.</given-names></name><name><surname>Price</surname><given-names>L.</given-names></name></person-group> (<year>1995</year>). <source>Aromatherapy for Health Professionals</source>. <publisher-loc>Edinburgh</publisher-loc>: <publisher-name>Churchill Livingston</publisher-name>.</mixed-citation></ref><ref id="B194"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Prince</surname><given-names>M.</given-names></name><name><surname>Comas-Herrera</surname><given-names>A.</given-names></name><name><surname>Knapp</surname><given-names>M.</given-names></name><name><surname>Guerchet</surname><given-names>M.</given-names></name><name><surname>Karagiannidou</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <source>World Alzheimer Report 2016: Improving Healthcare for People Living with Dementia: Coverage, Quality and Costs Now and in the Future</source>. <publisher-loc>London</publisher-loc>: <publisher-name>Personal Social Services Research Unit; London School of Economics and Political Science</publisher-name>.</mixed-citation></ref><ref id="B195"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiao</surname><given-names>X.</given-names></name><name><surname>Ji</surname><given-names>S.</given-names></name><name><surname>Yu</surname><given-names>S.-W.</given-names></name><name><surname>Lin</surname><given-names>X.-H.</given-names></name><name><surname>Jin</surname><given-names>H.-W.</given-names></name><name><surname>Duan</surname><given-names>Y.-K.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Identification of key licorice constituents which interact with cytochrome P450: evaluation by LC/MS/MS cocktail assay and metabolic profiling</article-title>. <source>AAPS J.</source>
<volume>16</volume>, <fpage>101</fpage>&#x02013;<lpage>113</lpage>. <pub-id pub-id-type="doi">10.1208/s12248-013-9544-9</pub-id><?supplied-pmid 24254844?><pub-id pub-id-type="pmid">24254844</pub-id></mixed-citation></ref><ref id="B196"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>C.</given-names></name><name><surname>Kivipelto</surname><given-names>M.</given-names></name><name><surname>von Strauss</surname><given-names>E.</given-names></name></person-group> (<year>2009</year>). <article-title>Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention</article-title>. <source>Dialogues Clin. Neurosci.</source>
<volume>11</volume>, <fpage>111</fpage>&#x02013;<lpage>128</lpage>. <?supplied-pmid 19585947?><pub-id pub-id-type="pmid">19585947</pub-id></mixed-citation></ref><ref id="B197"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quaglio</surname><given-names>G.</given-names></name><name><surname>Brand</surname><given-names>H.</given-names></name><name><surname>Dario</surname><given-names>C.</given-names></name></person-group> (<year>2016</year>). <article-title>Fighting dementia in Europe: the time to act is now</article-title>. <source>Lancet Neurol.</source>
<volume>15</volume>, <fpage>452</fpage>&#x02013;<lpage>454</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(16)00079-X</pub-id><?supplied-pmid 26987700?><pub-id pub-id-type="pmid">26987700</pub-id></mixed-citation></ref><ref id="B198"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rabinovici</surname><given-names>G. D.</given-names></name><name><surname>Miller</surname><given-names>B. L.</given-names></name></person-group> (<year>2010</year>). <article-title>Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management</article-title>. <source>CNS Drugs</source>
<volume>24</volume>, <fpage>375</fpage>&#x02013;<lpage>398</lpage>. <pub-id pub-id-type="doi">10.2165/11533100-000000000-00000</pub-id><?supplied-pmid 20369906?><pub-id pub-id-type="pmid">20369906</pub-id></mixed-citation></ref><ref id="B199"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raina</surname><given-names>A. K.</given-names></name><name><surname>Zhu</surname><given-names>X.</given-names></name><name><surname>Rottkamp</surname><given-names>C. A.</given-names></name><name><surname>Monteiro</surname><given-names>M.</given-names></name><name><surname>Takeda</surname><given-names>A.</given-names></name><name><surname>Smith</surname><given-names>M. A.</given-names></name></person-group> (<year>2000</year>). <article-title>Cyclin' toward dementia: cell cycle abnormalities and abortive oncogenesis in Alzheimer disease</article-title>. <source>J. Neurosci. Res.</source>
<volume>61</volume>, <fpage>128</fpage>&#x02013;<lpage>133</lpage>. <pub-id pub-id-type="doi">10.1002/1097-4547(20000715)61:2&#x0003c;128::AID-JNR2&#x0003e;3.0.CO;2-H</pub-id><?supplied-pmid 10878584?><pub-id pub-id-type="pmid">10878584</pub-id></mixed-citation></ref><ref id="B200"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramkumar</surname><given-names>M.</given-names></name><name><surname>Rajasankar</surname><given-names>S.</given-names></name><name><surname>Gobi</surname><given-names>V. V.</given-names></name><name><surname>Dhanalakshmi</surname><given-names>C.</given-names></name><name><surname>Manivasagam</surname><given-names>T.</given-names></name><name><surname>Justin Thenmozhi</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Neuroprotective effect of Demethoxycurcumin, a natural derivative of Curcumin on rotenone induced neurotoxicity in SH-SY 5Y Neuroblastoma cells</article-title>. <source>BMC Complement. Altern. Med.</source>
<volume>17</volume>, <fpage>217</fpage>. <pub-id pub-id-type="doi">10.1186/s12906-017-1720-5</pub-id><?supplied-pmid 28420370?><pub-id pub-id-type="pmid">28420370</pub-id></mixed-citation></ref><ref id="B201"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rastogi</surname><given-names>M.</given-names></name><name><surname>Ojha</surname><given-names>R. P.</given-names></name><name><surname>Sagar</surname><given-names>C.</given-names></name><name><surname>Agrawal</surname><given-names>A.</given-names></name><name><surname>Dubey</surname><given-names>G. P.</given-names></name></person-group> (<year>2014</year>). <article-title>Protective effect of curcuminoids on age-related mitochondrial impairment in female Wistar rat brain</article-title>. <source>Biogerontology</source>
<volume>15</volume>, <fpage>21</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1007/s10522-013-9466-z</pub-id><?supplied-pmid 24048922?><pub-id pub-id-type="pmid">24048922</pub-id></mixed-citation></ref><ref id="B202"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reddy</surname><given-names>A. P.</given-names></name><name><surname>Reddy</surname><given-names>P. H.</given-names></name></person-group> (<year>2017</year>). <article-title>mitochondria-targeted molecules as potential drugs to treat patients with Alzheimer's disease</article-title>. <source>Prog. Mol. Biol. Transl. Sci.</source>
<volume>146</volume>, <fpage>173</fpage>&#x02013;<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1016/bs.pmbts.2016.12.010</pub-id><?supplied-pmid 28253985?><pub-id pub-id-type="pmid">28253985</pub-id></mixed-citation></ref><ref id="B203"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rezai-Zadeh</surname><given-names>K.</given-names></name><name><surname>Arendash</surname><given-names>G. W.</given-names></name><name><surname>Hou</surname><given-names>H.</given-names></name><name><surname>Fernandez</surname><given-names>F.</given-names></name><name><surname>Jensen</surname><given-names>M.</given-names></name><name><surname>Runfeldt</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice</article-title>. <source>Brain Res.</source>
<volume>1214</volume>, <fpage>177</fpage>&#x02013;<lpage>187</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2008.02.107</pub-id><?supplied-pmid 18457818?><pub-id pub-id-type="pmid">18457818</pub-id></mixed-citation></ref><ref id="B204"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhein</surname><given-names>V.</given-names></name><name><surname>Giese</surname><given-names>M.</given-names></name><name><surname>Baysang</surname><given-names>G.</given-names></name><name><surname>Meier</surname><given-names>F.</given-names></name><name><surname>Rao</surname><given-names>S.</given-names></name><name><surname>Schulz</surname><given-names>K. L.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title><italic>Ginkgo biloba</italic> extract ameliorates oxidative phosphorylation performance and rescues abeta-induced failure</article-title>. <source>PLoS ONE</source>
<volume>5</volume>:<fpage>e12359</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0012359</pub-id><?supplied-pmid 20808761?><pub-id pub-id-type="pmid">20808761</pub-id></mixed-citation></ref><ref id="B205"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ribeiro</surname><given-names>M. L.</given-names></name><name><surname>Moreira</surname><given-names>L. M.</given-names></name><name><surname>Arcari</surname><given-names>D. P.</given-names></name><name><surname>Dos Santos</surname><given-names>L. F.</given-names></name><name><surname>Marques</surname><given-names>A. C.</given-names></name><name><surname>Pedrazzoli</surname><given-names>J. J.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Protective effects of chronic treatment with a standardized extract of <italic>Ginkgo biloba</italic> L. in the prefrontal cortex and dorsal hippocampus of middle-aged rats</article-title>. <source>Behav. Brain Res.</source>
<volume>313</volume>, <fpage>144</fpage>&#x02013;<lpage>150</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2016.06.029</pub-id><?supplied-pmid 27424157?><pub-id pub-id-type="pmid">27424157</pub-id></mixed-citation></ref><ref id="B206"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ridley</surname><given-names>N. J.</given-names></name><name><surname>Draper</surname><given-names>B.</given-names></name><name><surname>Withall</surname><given-names>A.</given-names></name></person-group> (<year>2013</year>). <article-title>Alcohol-related dementia: an update of the evidence</article-title>. <source>Alzheimers. Res. Ther.</source>
<volume>5</volume>, <fpage>3</fpage>. <pub-id pub-id-type="doi">10.1186/alzrt157</pub-id><?supplied-pmid 23347747?><pub-id pub-id-type="pmid">23347747</pub-id></mixed-citation></ref><ref id="B207"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivas-Arancibia</surname><given-names>S.</given-names></name><name><surname>Hern&#x000e1;ndez-Zimbr&#x000f3;n</surname><given-names>L. F.</given-names></name><name><surname>Rodr&#x000ed;guez-Mart&#x000ed;nez</surname><given-names>E.</given-names></name><name><surname>Borgonio-P&#x000e9;rez</surname><given-names>G.</given-names></name><name><surname>Velumani</surname><given-names>V.</given-names></name><name><surname>Dur&#x000e1;n-Bedolla</surname><given-names>J.</given-names></name></person-group> (<year>2013</year>). <article-title>Chronic exposure to low doses of ozone produces a state of oxidative stress and blood-brain barrier damage in the hippocampus of rat</article-title>. <source>Adv. Biosci. Biotechnol.</source>
<volume>4</volume>:<fpage>24</fpage>
<pub-id pub-id-type="doi">10.4236/abb.2013.411A2004</pub-id></mixed-citation></ref><ref id="B208"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Roeder</surname><given-names>B.A.</given-names></name></person-group> (<year>1988</year>). <source>Chicano Folk Medicine from Los Angeles</source>. <publisher-loc>Berkeley; Los Angeles: CA</publisher-loc>: <publisher-name>University of California Press</publisher-name>.</mixed-citation></ref><ref id="B209"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romero</surname><given-names>A.</given-names></name><name><surname>Egea</surname><given-names>J.</given-names></name><name><surname>Garcia</surname><given-names>A. G.</given-names></name><name><surname>Lopez</surname><given-names>M. G.</given-names></name></person-group> (<year>2010</year>). <article-title>Synergistic neuroprotective effect of combined low concentrations of galantamine and melatonin against oxidative stress in SH-SY5Y neuroblastoma cells</article-title>. <source>J. Pineal Res.</source>
<volume>49</volume>, <fpage>141</fpage>&#x02013;<lpage>148</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-079X.2010.00778.x</pub-id><?supplied-pmid 20536682?><pub-id pub-id-type="pmid">20536682</pub-id></mixed-citation></ref><ref id="B210"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>I. A.</given-names></name></person-group> (<year>2001</year>). <source>Medicinal Plants of the World: Chemical Constituents, Traditional and Modern Medicinal Uses</source>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Humana Press</publisher-name>.</mixed-citation></ref><ref id="B211"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruttkay-Nedecky</surname><given-names>B.</given-names></name><name><surname>Nejdl</surname><given-names>L.</given-names></name><name><surname>Gumulec</surname><given-names>J.</given-names></name><name><surname>Zitka</surname><given-names>O.</given-names></name><name><surname>Masarik</surname><given-names>M.</given-names></name><name><surname>Eckschlager</surname><given-names>T.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>The role of metallothionein in oxidative stress</article-title>. <source>Int. J. Mol. Sci.</source>
<volume>14</volume>, <fpage>6044</fpage>&#x02013;<lpage>6066</lpage>. <pub-id pub-id-type="doi">10.3390/ijms14036044</pub-id><?supplied-pmid 23502468?><pub-id pub-id-type="pmid">23502468</pub-id></mixed-citation></ref><ref id="B212"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saharan</surname><given-names>S.</given-names></name><name><surname>Mandal</surname><given-names>P. K.</given-names></name></person-group> (<year>2014</year>). <article-title>The emerging role of glutathione in Alzheimer's disease</article-title>. <source>J. Alzheimers. Dis.</source>
<volume>40</volume>, <fpage>519</fpage>&#x02013;<lpage>529</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-132483</pub-id><?supplied-pmid 24496077?><pub-id pub-id-type="pmid">24496077</pub-id></mixed-citation></ref><ref id="B213"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sahne</surname><given-names>F.</given-names></name><name><surname>Mohammadi</surname><given-names>M.</given-names></name><name><surname>Najafpour</surname><given-names>G. D.</given-names></name><name><surname>Moghadamnia</surname><given-names>A. A.</given-names></name></person-group> (<year>2017</year>). <article-title>Enzyme-assisted ionic liquid extraction of bioactive compound from turmeric (<italic>Curcuma longa</italic> L.): isolation, purification and analysis of curcumin</article-title>. <source>Ind. Crops Prod.</source>
<volume>95</volume>, <fpage>686</fpage>&#x02013;<lpage>694</lpage>. <pub-id pub-id-type="doi">10.1016/j.indcrop.2016.11.037</pub-id></mixed-citation></ref><ref id="B214"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sama</surname><given-names>D. M.</given-names></name><name><surname>Norris</surname><given-names>C. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Calcium dysregulation and neuroinflammation: discrete and integrated mechanisms for age-related synaptic dysfunction</article-title>. <source>Ageing Res. Rev.</source>
<volume>12</volume>, <fpage>982</fpage>&#x02013;<lpage>995</lpage>. <pub-id pub-id-type="doi">10.1016/j.arr.2013.05.008</pub-id><?supplied-pmid 23751484?><pub-id pub-id-type="pmid">23751484</pub-id></mixed-citation></ref><ref id="B215"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savelev</surname><given-names>S. U.</given-names></name><name><surname>Okello</surname><given-names>E. J.</given-names></name><name><surname>Perry</surname><given-names>E. K.</given-names></name></person-group> (<year>2004</year>). <article-title>Butyryl-and acetyl-cholinesterase inhibitory activities in essential oils of Salvia species and their constituents</article-title>. <source>Phyther. Res.</source>
<volume>18</volume>, <fpage>315</fpage>&#x02013;<lpage>324</lpage>. <pub-id pub-id-type="doi">10.1002/ptr.1451</pub-id><?supplied-pmid 15162368?><pub-id pub-id-type="pmid">15162368</pub-id></mixed-citation></ref><ref id="B216"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schultes</surname><given-names>R. E.</given-names></name></person-group> (<year>1993</year>). <article-title>Plants in treating senile dementia in the Northwest Amazon</article-title>. <source>J. Ethnopharmacol.</source>
<volume>38</volume>, <fpage>121</fpage>&#x02013;<lpage>128</lpage>. <pub-id pub-id-type="doi">10.1016/0378-8741(93)90007-R</pub-id><?supplied-pmid 8510460?><pub-id pub-id-type="pmid">8510459</pub-id></mixed-citation></ref><ref id="B217"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Schultes</surname><given-names>R. E.</given-names></name></person-group> (<year>1994</year>). <source>Amazonian Ethnobotany and the Search for New Drugs BT - Ciba Foundation Symposium 185.</source>
<publisher-loc>Chichester</publisher-loc>: <publisher-name>Wiley</publisher-name>.</mixed-citation></ref><ref id="B218"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulz</surname><given-names>R.</given-names></name><name><surname>McGinnis</surname><given-names>K. A.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Martire</surname><given-names>L. M.</given-names></name><name><surname>Hebert</surname><given-names>R. S.</given-names></name><name><surname>Beach</surname><given-names>S. R.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>Dementia patient suffering and caregiver depression</article-title>. <source>Alzheimer Dis. Assoc. Disord.</source>
<volume>22</volume>, <fpage>170</fpage>&#x02013;<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1097/WAD.0b013e31816653cc</pub-id><?supplied-pmid 18525290?><pub-id pub-id-type="pmid">18525290</pub-id></mixed-citation></ref><ref id="B219"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwarzkopf</surname><given-names>T. M.</given-names></name><name><surname>Koch</surname><given-names>K. A.</given-names></name><name><surname>Klein</surname><given-names>J.</given-names></name></person-group> (<year>2013</year>). <article-title>Neurodegeneration after transient brain ischemia in aged mice: beneficial effects of bilobalide</article-title>. <source>Brain Res.</source>
<volume>1529</volume>, <fpage>178</fpage>&#x02013;<lpage>187</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2013.07.003</pub-id><?supplied-pmid 23850645?><pub-id pub-id-type="pmid">23850645</pub-id></mixed-citation></ref><ref id="B220"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Schweitzer de Palacios</surname><given-names>D.</given-names></name></person-group> (<year>1994</year>). <source>Cambiashun. Las pr&#x000e1;cticas m&#x000e9;dicas tradicionales y sus expertos en San Miguel del Com&#x000fa;n, una comuna ind</source>&#x000ed;<italic>gena en los alrededores de Quito</italic>
<publisher-loc>Berlin</publisher-loc>: <publisher-name>Holos-Verlag; Free University of Berlin</publisher-name>.</mixed-citation></ref><ref id="B221"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sfikas</surname><given-names>G.</given-names></name></person-group> (<year>1980</year>). <source>Heilpflanzen Griechenlands. P. Efstathiadis &#x00026; S&#x000f6;hne AG</source>. <publisher-loc>Athen</publisher-loc>.</mixed-citation></ref><ref id="B222"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shankar</surname><given-names>G. M.</given-names></name><name><surname>Walsh</surname><given-names>D. M.</given-names></name></person-group> (<year>2009</year>). <article-title>Alzheimer's disease: synaptic dysfunction and A&#x003b2;</article-title>. <source>Mol. Neurodegener.</source>
<volume>4</volume>:<fpage>48</fpage>. <pub-id pub-id-type="doi">10.1186/1750-1326-4-48</pub-id><?supplied-pmid 19930651?><pub-id pub-id-type="pmid">19930651</pub-id></mixed-citation></ref><ref id="B223"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sirirugsa</surname><given-names>P.</given-names></name><name><surname>Larsen</surname><given-names>K.</given-names></name><name><surname>Maknoi</surname><given-names>C.</given-names></name></person-group> (<year>2007</year>). <article-title>The genus <italic>Curcuma</italic> L.(zingiberaceae): distribution and classification with reference to species diversity in Thailand</article-title>. <source>Gard. Bull. Singapore</source>
<volume>59</volume>, <fpage>203</fpage>&#x02013;<lpage>320</lpage>.</mixed-citation></ref><ref id="B224"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solfrizzi</surname><given-names>V.</given-names></name><name><surname>Panza</surname><given-names>F.</given-names></name></person-group> (<year>2015</year>). <article-title>Plant-based nutraceutical interventions against cognitive impairment and dementia: meta-analytic evidence of efficacy of a standardized Gingko biloba extract</article-title>. <source>J. Alzheimers. Dis.</source>
<volume>43</volume>, <fpage>605</fpage>&#x02013;<lpage>611</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-141887</pub-id><?supplied-pmid 25352453?><pub-id pub-id-type="pmid">25352453</pub-id></mixed-citation></ref><ref id="B225"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>L.</given-names></name><name><surname>Xu</surname><given-names>M.-B.</given-names></name><name><surname>Zhou</surname><given-names>X.-L.</given-names></name><name><surname>Zhang</surname><given-names>D.-P.</given-names></name><name><surname>Zhang</surname><given-names>S.-L.</given-names></name><name><surname>Zheng</surname><given-names>G.-Q.</given-names></name></person-group> (<year>2017</year>). <article-title>A Preclinical systematic review of ginsenoside-Rg1 in experimental Parkinson's disease</article-title>. <source>Oxid. Med. Cell. Longev.</source>
<volume>2017</volume>:<fpage>2163053</fpage>. <pub-id pub-id-type="doi">10.1155/2017/2163053</pub-id><?supplied-pmid 28386306?><pub-id pub-id-type="pmid">28386306</pub-id></mixed-citation></ref><ref id="B226"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spano</surname><given-names>M.</given-names></name><name><surname>Signorelli</surname><given-names>M.</given-names></name><name><surname>Vitaliani</surname><given-names>R.</given-names></name><name><surname>Aguglia</surname><given-names>E.</given-names></name><name><surname>Giometto</surname><given-names>B.</given-names></name></person-group> (<year>2015</year>). <article-title>The possible involvement of mitochondrial dysfunctions in Lewy body dementia: a systematic review</article-title>. <source>Funct. Neurol.</source>
<volume>30</volume>, <fpage>151</fpage>&#x02013;<lpage>158</lpage>. <pub-id pub-id-type="doi">10.11138/FNeur/2015.30.3.151</pub-id><?supplied-pmid 26346695?><pub-id pub-id-type="pmid">26346695</pub-id></mixed-citation></ref><ref id="B227"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stackman</surname><given-names>R. W.</given-names></name><name><surname>Eckenstein</surname><given-names>F.</given-names></name><name><surname>Frei</surname><given-names>B.</given-names></name><name><surname>Kulhanek</surname><given-names>D.</given-names></name><name><surname>Nowlin</surname><given-names>J.</given-names></name><name><surname>Quinn</surname><given-names>J. F.</given-names></name></person-group> (<year>2003</year>). <article-title>Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic <italic>Ginkgo biloba</italic> treatment</article-title>. <source>Exp. Neurol.</source>
<volume>184</volume>, <fpage>510</fpage>&#x02013;<lpage>520</lpage>. <pub-id pub-id-type="doi">10.1016/S0014-4886(03)00399-6</pub-id><?supplied-pmid 14637120?><pub-id pub-id-type="pmid">14637120</pub-id></mixed-citation></ref><ref id="B228"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stafford</surname><given-names>G. I.</given-names></name><name><surname>Pedersen</surname><given-names>M. E.</given-names></name><name><surname>van Staden</surname><given-names>J.</given-names></name><name><surname>J&#x000e4;ger</surname><given-names>A. K.</given-names></name></person-group> (<year>2008</year>). <article-title>Review on plants with CNS-effects used in traditional South African medicine against mental diseases</article-title>. <source>J. Ethnopharmacol.</source>
<volume>119</volume>, <fpage>513</fpage>&#x02013;<lpage>537</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2008.08.010</pub-id><?supplied-pmid 18775771?><pub-id pub-id-type="pmid">18775771</pub-id></mixed-citation></ref><ref id="B229"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>M.</given-names></name><name><surname>Ye</surname><given-names>Y.</given-names></name><name><surname>Xiao</surname><given-names>L.</given-names></name><name><surname>Duan</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name></person-group> (<year>2017</year>). <article-title>Anticancer effects of ginsenoside Rg3 (Review)</article-title>. <source>Int. J. Mol. Med.</source>
<volume>39</volume>, <fpage>507</fpage>&#x02013;<lpage>518</lpage>. <pub-id pub-id-type="doi">10.3892/ijmm.2017.2857</pub-id><?supplied-pmid 28098857?><pub-id pub-id-type="pmid">28098857</pub-id></mixed-citation></ref><ref id="B230"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>C.-Z.</given-names></name><name><surname>Tong</surname><given-names>R.</given-names></name><name><surname>Li</surname><given-names>X.-L.</given-names></name><name><surname>Fishbein</surname><given-names>A.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Effects of steaming the root of Panax notoginseng on chemical composition and anticancer activities</article-title>. <source>Food Chem.</source>
<volume>118</volume>, <fpage>307</fpage>&#x02013;<lpage>314</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodchem.2009.04.122</pub-id></mixed-citation></ref><ref id="B231"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Z.-K.</given-names></name><name><surname>Yang</surname><given-names>H.-Q.</given-names></name><name><surname>Chen</surname><given-names>S.-D.</given-names></name></person-group> (<year>2013</year>). <article-title>Traditional Chinese medicine: a promising candidate for the treatment of Alzheimer's disease</article-title>. <source>Transl. Neurodegener.</source>
<volume>2</volume>:<fpage>6</fpage>. <pub-id pub-id-type="doi">10.1186/2047-9158-2-6</pub-id><?supplied-pmid 23445907?><pub-id pub-id-type="pmid">23445907</pub-id></mixed-citation></ref><ref id="B232"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swerdlow</surname><given-names>R. H.</given-names></name><name><surname>Burns</surname><given-names>J. M.</given-names></name><name><surname>Khan</surname><given-names>S. M.</given-names></name></person-group> (<year>2010</year>). <article-title>The Alzheimer's disease mitochondrial cascade hypothesis</article-title>. <source>J. Alzheimers. Dis.</source>
<volume>20</volume>(<issue>Suppl. 2</issue>), <fpage>S265</fpage>&#x02013;<lpage>S279</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-2010-100339</pub-id><?supplied-pmid 20442494?><pub-id pub-id-type="pmid">20442494</pub-id></mixed-citation></ref><ref id="B233"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swerdlow</surname><given-names>R. H.</given-names></name><name><surname>Koppel</surname><given-names>S.</given-names></name><name><surname>Weidling</surname><given-names>I.</given-names></name><name><surname>Hayley</surname><given-names>C.</given-names></name><name><surname>Ji</surname><given-names>Y.</given-names></name><name><surname>Wilkins</surname><given-names>H. M.</given-names></name></person-group> (<year>2017</year>). <article-title>mitochondria, cybrids, aging, and Alzheimer's disease</article-title>. <source>Prog. Mol. Biol. Transl. Sci.</source>
<volume>146</volume>, <fpage>259</fpage>&#x02013;<lpage>302</lpage>. <pub-id pub-id-type="doi">10.1016/bs.pmbts.2016.12.017</pub-id><?supplied-pmid 28253988?><pub-id pub-id-type="pmid">28253988</pub-id></mixed-citation></ref><ref id="B234"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Tabernaemontanus</surname><given-names>D. I. T.</given-names></name></person-group> (<year>1987</year>). <source>Kr&#x000e4;uterbuch, Johann Ludwig K&#x000f6;nig/Johann Brandm&#x000fc;ller</source>. <publisher-loc>Basel</publisher-loc>.</mixed-citation></ref><ref id="B235"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takuma</surname><given-names>K.</given-names></name><name><surname>Hoshina</surname><given-names>Y.</given-names></name><name><surname>Arai</surname><given-names>S.</given-names></name><name><surname>Himeno</surname><given-names>Y.</given-names></name><name><surname>Matsuo</surname><given-names>A.</given-names></name><name><surname>Funatsu</surname><given-names>Y.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title><italic>Ginkgo biloba</italic> extract EGb 761 attenuates hippocampal neuronal loss and cognitive dysfunction resulting from chronic restraint stress in ovariectomized rats</article-title>. <source>Neuroscience</source>
<volume>149</volume>, <fpage>256</fpage>&#x02013;<lpage>262</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2007.07.042</pub-id><?supplied-pmid 17869007?><pub-id pub-id-type="pmid">17869007</pub-id></mixed-citation></ref><ref id="B236"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>A.</given-names></name><name><surname>Arai</surname><given-names>Y.</given-names></name><name><surname>Kim</surname><given-names>S.-N.</given-names></name><name><surname>Ham</surname><given-names>J.</given-names></name><name><surname>Usuki</surname><given-names>T.</given-names></name></person-group> (<year>2011</year>). <article-title>Synthesis and biological evaluation of bilobol and adipostatin A</article-title>. <source>J. Asian Nat. Prod. Res.</source>
<volume>13</volume>, <fpage>290</fpage>&#x02013;<lpage>296</lpage>. <pub-id pub-id-type="doi">10.1080/10286020.2011.554828</pub-id><?supplied-pmid 21462031?><pub-id pub-id-type="pmid">21462031</pub-id></mixed-citation></ref><ref id="B237"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>L.</given-names></name></person-group> (<year>1998</year>). <source>Herbal Secrets of the Rainforest: The Healing Power of over 50 Medicinal Plants You Should Know About</source>. <publisher-loc>Rocklin, CA</publisher-loc>: <publisher-name>Prima Publishing</publisher-name>.</mixed-citation></ref><ref id="B238"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tayyem</surname><given-names>R. F.</given-names></name><name><surname>Heath</surname><given-names>D. D.</given-names></name><name><surname>Al-Delaimy</surname><given-names>W. K.</given-names></name><name><surname>Rock</surname><given-names>C. L.</given-names></name></person-group> (<year>2006</year>). <article-title>Curcumin content of turmeric and curry powders</article-title>. <source>Nutr. Cancer</source>
<volume>55</volume>, <fpage>126</fpage>&#x02013;<lpage>131</lpage>. <pub-id pub-id-type="doi">10.1207/s15327914nc5502_2</pub-id><?supplied-pmid 17044766?><pub-id pub-id-type="pmid">17044766</pub-id></mixed-citation></ref><ref id="B239"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tewari</surname><given-names>D.</given-names></name><name><surname>Mocan</surname><given-names>A.</given-names></name><name><surname>Parvanov</surname><given-names>E. D.</given-names></name><name><surname>Sah</surname><given-names>A. N.</given-names></name><name><surname>Nabavi</surname><given-names>S. M.</given-names></name><name><surname>Huminiecki</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Ethnopharmacological approaches for therapy of jaundice: Part II. Highly used plant species from Acanthaceae, Euphorbiaceae, Asteraceae, Combretaceae, and Fabaceae families</article-title>. <source>Front. Pharmacol.</source>
<volume>8</volume>:<fpage>519</fpage>
<pub-id pub-id-type="doi">10.3389/fphar.2017.00518</pub-id><pub-id pub-id-type="pmid">28848436</pub-id></mixed-citation></ref><ref id="B240"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>G.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Xu</surname><given-names>B.</given-names></name></person-group> (<year>2009</year>). <article-title>20(S)-ginsenoside Rg3, a neuroprotective agent, inhibits mitochondrial permeability transition pores in rat brain</article-title>. <source>Phytother. Res.</source>
<volume>23</volume>, <fpage>486</fpage>&#x02013;<lpage>491</lpage>. <pub-id pub-id-type="doi">10.1002/ptr.2653</pub-id><?supplied-pmid 19003949?><pub-id pub-id-type="pmid">19003949</pub-id></mixed-citation></ref><ref id="B241"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tripathi</surname><given-names>M.</given-names></name><name><surname>Vibha</surname><given-names>D.</given-names></name></person-group> (<year>2009</year>). <article-title>Reversible dementias</article-title>. <source>Indian J. Psychiatry</source>
<volume>51</volume>, <fpage>S52</fpage>. <?supplied-pmid 21416018?><pub-id pub-id-type="pmid">21416018</pub-id></mixed-citation></ref><ref id="B242"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsvetkova</surname><given-names>D.</given-names></name><name><surname>Obreshkova</surname><given-names>D.</given-names></name><name><surname>Zheleva-Dimitrova</surname><given-names>D.</given-names></name><name><surname>Saso</surname><given-names>L.</given-names></name></person-group> (<year>2013</year>). <article-title>Antioxidant activity of galantamine and some of its derivatives</article-title>. <source>Curr. Med. Chem.</source>
<volume>20</volume>, <fpage>4595</fpage>&#x02013;<lpage>4608</lpage>. <pub-id pub-id-type="doi">10.2174/09298673113209990148</pub-id><?supplied-pmid 23834167?><pub-id pub-id-type="pmid">23834167</pub-id></mixed-citation></ref><ref id="B243"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tzvetkov</surname><given-names>N. T.</given-names></name><name><surname>Antonov</surname><given-names>L.</given-names></name></person-group> (<year>2017</year>). <article-title>Subnanomolar indazole-5-carboxamide inhibitors of monoamine oxidase B (MAO-B) continued: indications of iron binding, experimental evidence for optimised solubility and brain penetration</article-title>. <source>J. Enzyme Inhib. Med. Chem.</source>
<volume>32</volume>, <fpage>960</fpage>&#x02013;<lpage>967</lpage>. <pub-id pub-id-type="doi">10.1080/14756366.2017.1344980</pub-id><?supplied-pmid 28726524?><pub-id pub-id-type="pmid">28726524</pub-id></mixed-citation></ref><ref id="B244"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Horssen</surname><given-names>J.</given-names></name><name><surname>van Schaik</surname><given-names>P.</given-names></name><name><surname>Witte</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Inflammation and mitochondrial dysfunction: a vicious circle in neurodegenerative disorders?</article-title>
<source>Neurosci. Lett.</source> [Epub ahead of print]. <pub-id pub-id-type="doi">10.1016/j.neulet.2017.06.050</pub-id><?supplied-pmid 28668382?><pub-id pub-id-type="pmid">28668382</pub-id></mixed-citation></ref><ref id="B245"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waldemar</surname><given-names>G.</given-names></name><name><surname>Dubois</surname><given-names>B.</given-names></name><name><surname>Emre</surname><given-names>M.</given-names></name><name><surname>Georges</surname><given-names>J.</given-names></name><name><surname>McKeith</surname><given-names>I. G.</given-names></name><name><surname>Rossor</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline</article-title>. <source>Eur. J. Neurol.</source>
<volume>14</volume>, <fpage>e1</fpage>&#x02013;<lpage>e26</lpage>. <pub-id pub-id-type="doi">10.1111/j.1468-1331.2006.01605.x</pub-id><?supplied-pmid 17222085?><pub-id pub-id-type="pmid">17222085</pub-id></mixed-citation></ref><ref id="B246"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walsh</surname><given-names>C.</given-names></name><name><surname>Barrow</surname><given-names>S.</given-names></name><name><surname>Voronina</surname><given-names>S.</given-names></name><name><surname>Chvanov</surname><given-names>M.</given-names></name><name><surname>Petersen</surname><given-names>O. H.</given-names></name><name><surname>Tepikin</surname><given-names>A.</given-names></name></person-group> (<year>2009</year>). <article-title>Modulation of calcium signalling by mitochondria</article-title>. <source>Biochim. Biophys. Acta</source>
<volume>1787</volume>, <fpage>1374</fpage>&#x02013;<lpage>1382</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbabio.2009.01.007</pub-id><?supplied-pmid 19344663?><pub-id pub-id-type="pmid">19344663</pub-id></mixed-citation></ref><ref id="B247"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waltenberger</surname><given-names>B.</given-names></name><name><surname>Mocan</surname><given-names>A.</given-names></name><name><surname>Smejkal</surname><given-names>K.</given-names></name><name><surname>Heiss</surname><given-names>E. H.</given-names></name><name><surname>Atanasov</surname><given-names>A. G.</given-names></name></person-group> (<year>2016</year>). <article-title>Natural Products to counteract the epidemic of cardiovascular and metabolic disorders</article-title>. <source>Molecules</source>
<volume>21</volume>, <fpage>1</fpage>&#x02013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.3390/molecules21060807</pub-id><?supplied-pmid 27338339?><pub-id pub-id-type="pmid">27338339</pub-id></mixed-citation></ref><ref id="B248"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wan</surname><given-names>W.</given-names></name><name><surname>Cao</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Kalionis</surname><given-names>B.</given-names></name><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Tai</surname><given-names>X.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>EGb761 provides a protective effect against A&#x003b2;(1-42) oligomer-induced cell damage and blood-brain barrier disruption in an <italic>in vitro</italic> bEnd.3 endothelial model</article-title>. <source>PLoS ONE</source>
<volume>9</volume>:<fpage>e113126</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0113126</pub-id><?supplied-pmid 25426944?><pub-id pub-id-type="pmid">25426944</pub-id></mixed-citation></ref><ref id="B249"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>B.</given-names></name></person-group> (<year>2016</year>). <article-title><italic>Ginkgo biloba</italic> extract attenuates oxidative stress and apoptosis in mouse cochlear neural stem cells</article-title>. <source>Phytother. Res.</source>
<volume>30</volume>, <fpage>774</fpage>&#x02013;<lpage>780</lpage>. <pub-id pub-id-type="doi">10.1002/ptr.5572</pub-id><?supplied-pmid 26799058?><pub-id pub-id-type="pmid">26799058</pub-id></mixed-citation></ref><ref id="B250"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Youle</surname><given-names>R. J.</given-names></name></person-group> (<year>2009</year>). <article-title>The Role of Mitochondria in Apoptosis</article-title>. <source>Annu. Rev. Genet.</source>
<volume>43</volume>, <fpage>95</fpage>&#x02013;<lpage>118</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-genet-102108-134850</pub-id><?supplied-pmid 19659442?><pub-id pub-id-type="pmid">19659442</pub-id></mixed-citation></ref><ref id="B251"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D.-S.</given-names></name><name><surname>Dickson</surname><given-names>D. W.</given-names></name><name><surname>Malter</surname><given-names>J. S.</given-names></name></person-group> (<year>2006</year>). <article-title>beta-Amyloid degradation and Alzheimer's disease</article-title>. <source>J. Biomed. Biotechnol.</source>
<volume>2006</volume>:<fpage>58406</fpage>. <pub-id pub-id-type="doi">10.1155/JBB/2006/58406</pub-id><?supplied-pmid 17047308?><pub-id pub-id-type="pmid">17047308</pub-id></mixed-citation></ref><ref id="B252"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>P.</given-names></name><name><surname>Su</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Ren</surname><given-names>Y.</given-names></name><name><surname>Sun</surname><given-names>H.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Mechanisms and effects of curcumin on spatial learning and memory improvement in APPswe/PS1dE9 mice</article-title>. <source>J. Neurosci. Res.</source>
<volume>92</volume>, <fpage>218</fpage>&#x02013;<lpage>231</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.23322</pub-id><?supplied-pmid 24273069?><pub-id pub-id-type="pmid">24273069</pub-id></mixed-citation></ref><ref id="B253"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.-H.</given-names></name><name><surname>Du</surname><given-names>G.-H.</given-names></name></person-group> (<year>2009</year>). <article-title>Ginsenoside Rg1 inhibits beta-secretase activity <italic>in vitro</italic> and protects against Abeta-induced cytotoxicity in PC12 cells</article-title>. <source>J. Asian Nat. Prod. Res.</source>
<volume>11</volume>, <fpage>604</fpage>&#x02013;<lpage>612</lpage>. <pub-id pub-id-type="doi">10.1080/10286020902843152</pub-id><?supplied-pmid 20183297?><pub-id pub-id-type="pmid">20183297</pub-id></mixed-citation></ref><ref id="B254"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Huang</surname><given-names>L.</given-names></name><name><surname>Tang</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name></person-group> (<year>2010</year>). <article-title>Retrospect and prospect of active principles from Chinese herbs in the treatment of dementia</article-title>. <source>Acta Pharmacol. Sin.</source>
<volume>31</volume>, <fpage>649</fpage>&#x02013;<lpage>664</lpage>. <pub-id pub-id-type="doi">10.1038/aps.2010.46</pub-id><?supplied-pmid 20523337?><pub-id pub-id-type="pmid">20523337</pub-id></mixed-citation></ref><ref id="B255"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>G.</given-names></name><name><surname>Gong</surname><given-names>J.</given-names></name><name><surname>Lu</surname><given-names>F.</given-names></name><name><surname>Diao</surname><given-names>Q.</given-names></name><name><surname>Sun</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Ginseng for Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials</article-title>. <source>Curr. Top. Med. Chem.</source>
<volume>16</volume>, <fpage>529</fpage>&#x02013;<lpage>536</lpage>. <pub-id pub-id-type="doi">10.2174/1568026615666150813143753</pub-id><?supplied-pmid 26268331?><pub-id pub-id-type="pmid">26268331</pub-id></mixed-citation></ref><ref id="B256"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weksler</surname><given-names>M. E.</given-names></name><name><surname>Szabo</surname><given-names>P.</given-names></name><name><surname>Relkin</surname><given-names>N. R.</given-names></name><name><surname>Reidenberg</surname><given-names>M. M.</given-names></name><name><surname>Weksler</surname><given-names>B. B.</given-names></name><name><surname>Coppus</surname><given-names>A. M. W.</given-names></name></person-group> (<year>2013</year>). <article-title>Alzheimer's disease and Down's syndrome: treating two paths to dementia</article-title>. <source>Autoimmun. Rev.</source>
<volume>12</volume>, <fpage>670</fpage>&#x02013;<lpage>673</lpage>. <pub-id pub-id-type="doi">10.1016/j.autrev.2012.10.013</pub-id><?supplied-pmid 23201920?><pub-id pub-id-type="pmid">23201920</pub-id></mixed-citation></ref><ref id="B257"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winblad</surname><given-names>B.</given-names></name><name><surname>Amouyel</surname><given-names>P.</given-names></name><name><surname>Andrieu</surname><given-names>S.</given-names></name><name><surname>Ballard</surname><given-names>C.</given-names></name><name><surname>Brayne</surname><given-names>C.</given-names></name><name><surname>Brodaty</surname><given-names>H.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Defeating Alzheimer's disease and other dementias: a priority for European science and society</article-title>. <source>Lancet Neurol.</source>
<volume>15</volume>, <fpage>455</fpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(16)00062-4</pub-id><?supplied-pmid 26987701?><pub-id pub-id-type="pmid">26987701</pub-id></mixed-citation></ref><ref id="B258"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Wolters</surname><given-names>B.</given-names></name></person-group> (<year>1994</year>). <source>Drogen, Pfeilgift und Indianermedizin: Arzneipflanzen aus S&#x000fc;damerika</source>. <publisher-loc>Greifenberg</publisher-loc>: <publisher-name>Urs Freud Verlag GmbH</publisher-name>.</mixed-citation></ref><ref id="B259"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiong</surname><given-names>Z.</given-names></name><name><surname>Hongmei</surname><given-names>Z.</given-names></name><name><surname>Lu</surname><given-names>S.</given-names></name><name><surname>Yu</surname><given-names>L.</given-names></name></person-group> (<year>2011</year>). <article-title>Curcumin mediates presenilin-1 activity to reduce beta-amyloid production in a model of Alzheimer's Disease</article-title>. <source>Pharmacol. Rep.</source>
<volume>63</volume>, <fpage>1101</fpage>&#x02013;<lpage>1108</lpage>. <pub-id pub-id-type="doi">10.1016/S1734-1140(11)70629-6</pub-id><?supplied-pmid 22180352?><pub-id pub-id-type="pmid">22180352</pub-id></mixed-citation></ref><ref id="B260"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>T.</given-names></name><name><surname>Terashima</surname><given-names>T.</given-names></name><name><surname>Honma</surname><given-names>H.</given-names></name><name><surname>Nagata</surname><given-names>S.</given-names></name><name><surname>Okubo</surname><given-names>T.</given-names></name><name><surname>Juneja</surname><given-names>L. R.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>Effects of theanine, a unique amino acid in tea leaves, on memory in a rat behavioral test</article-title>. <source>Biosci. Biotechnol. Biochem.</source>
<volume>72</volume>, <fpage>1356</fpage>&#x02013;<lpage>1359</lpage>. <pub-id pub-id-type="doi">10.1271/bbb.70669</pub-id><?supplied-pmid 18460792?><pub-id pub-id-type="pmid">18460792</pub-id></mixed-citation></ref><ref id="B261"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>D.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Yan</surname><given-names>H.</given-names></name></person-group> (<year>2016</year>). <article-title>Pesticide exposure and risk of Alzheimer's disease: a systematic review and meta-analysis</article-title>. <source>Sci. Rep.</source>
<volume>6</volume>:<fpage>32222</fpage>. <pub-id pub-id-type="doi">10.1038/srep32222</pub-id><?supplied-pmid 27581992?><pub-id pub-id-type="pmid">27581992</pub-id></mixed-citation></ref><ref id="B262"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>F.-L.</given-names></name><name><surname>Zheng</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>F.-D.</given-names></name></person-group> (<year>2008</year>). <article-title>Effects of <italic>Ginkgo biloba</italic> extract EGb761 on expression of RAGE and LRP-1 in cerebral microvascular endothelial cells under chronic hypoxia and hypoglycemia</article-title>. <source>Acta Neuropathol.</source>
<volume>116</volume>, <fpage>529</fpage>&#x02013;<lpage>535</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-008-0435-6</pub-id><?supplied-pmid 18830615?><pub-id pub-id-type="pmid">18830615</pub-id></mixed-citation></ref><ref id="B263"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>J.</given-names></name><name><surname>Hu</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>A.</given-names></name><name><surname>He</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Wei</surname><given-names>H.</given-names></name></person-group> (<year>2017</year>). <article-title>Design, synthesis, and evaluation of multitarget-directed ligands against Alzheimer's disease based on the fusion of donepezil and curcumin</article-title>. <source>Bioorg. Med. Chem.</source>
<volume>25</volume>, <fpage>2946</fpage>&#x02013;<lpage>2955</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmc.2017.02.048</pub-id><?supplied-pmid 28454848?><pub-id pub-id-type="pmid">28454848</pub-id></mixed-citation></ref><ref id="B264"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yanagisawa</surname><given-names>D.</given-names></name><name><surname>Taguchi</surname><given-names>H.</given-names></name><name><surname>Yamamoto</surname><given-names>A.</given-names></name><name><surname>Shirai</surname><given-names>N.</given-names></name><name><surname>Hirao</surname><given-names>K.</given-names></name><name><surname>Tooyama</surname><given-names>I.</given-names></name></person-group> (<year>2011</year>). <article-title>Curcuminoid binds to amyloid-beta1-42 oligomer and fibril</article-title>. <source>J. Alzheimers. Dis.</source>
<volume>24</volume>(<issue>Suppl. 2</issue>), <fpage>33</fpage>&#x02013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-2011-102100</pub-id><?supplied-pmid 21335654?><pub-id pub-id-type="pmid">21335654</pub-id></mixed-citation></ref><ref id="B265"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>E.-J.</given-names></name><name><surname>Min</surname><given-names>J. S.</given-names></name><name><surname>Ku</surname><given-names>H.-Y.</given-names></name><name><surname>Choi</surname><given-names>H.-S.</given-names></name><name><surname>Park</surname><given-names>M.</given-names></name><name><surname>Kim</surname><given-names>M. K.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Isoliquiritigenin isolated from Glycyrrhiza uralensis protects neuronal cells against glutamate-induced mitochondrial dysfunction</article-title>. <source>Biochem. Biophys. Res. Commun.</source>
<volume>421</volume>, <fpage>658</fpage>&#x02013;<lpage>664</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2012.04.053</pub-id><?supplied-pmid 22538371?><pub-id pub-id-type="pmid">22538371</pub-id></mixed-citation></ref><ref id="B266"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Hao</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Xia</surname><given-names>W.</given-names></name><name><surname>Dong</surname><given-names>X.</given-names></name><name><surname>Hu</surname><given-names>X.</given-names></name><etal/></person-group>. (<year>2009</year>). <article-title>Ginsenoside Rg3 promotes beta-amyloid peptide degradation by enhancing gene expression of neprilysin</article-title>. <source>J. Pharm. Pharmacol.</source>
<volume>61</volume>, <fpage>375</fpage>&#x02013;<lpage>380</lpage>. <pub-id pub-id-type="doi">10.1211/jpp.61.03.0013</pub-id><?supplied-pmid 19222911?><pub-id pub-id-type="pmid">19222911</pub-id></mixed-citation></ref><ref id="B267"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name></person-group> (<year>2012</year>). <article-title>Curcumin protects against intracellular amyloid toxicity in rat primary neurons</article-title>. <source>Int. J. Clin. Exp. Med.</source>
<volume>5</volume>, <fpage>44</fpage>&#x02013;<lpage>49</lpage>. <?supplied-pmid 22328947?><pub-id pub-id-type="pmid">22328947</pub-id></mixed-citation></ref><ref id="B268"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>R.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Kong</surname><given-names>X.</given-names></name><name><surname>Han</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>Q.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Ginsenoside Rd attenuates mitochondrial dysfunction and sequential apoptosis after transient focal ischemia</article-title>. <source>Neuroscience</source>
<volume>178</volume>, <fpage>169</fpage>&#x02013;<lpage>180</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2011.01.007</pub-id><?supplied-pmid 21219973?><pub-id pub-id-type="pmid">21219973</pub-id></mixed-citation></ref><ref id="B269"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yim</surname><given-names>S. B.</given-names></name><name><surname>Park</surname><given-names>S. E.</given-names></name><name><surname>Lee</surname><given-names>C. S.</given-names></name></person-group> (<year>2007</year>). <article-title>Protective effect of glycyrrhizin on 1-methyl-4-phenylpyridinium-induced mitochondrial damage and cell death in differentiated PC12 cells</article-title>. <source>J. Pharmacol. Exp. Ther.</source>
<volume>321</volume>, <fpage>816</fpage>&#x02013;<lpage>822</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.107.119602</pub-id><?supplied-pmid 17314199?><pub-id pub-id-type="pmid">17314199</pub-id></mixed-citation></ref><ref id="B270"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>S. Y.</given-names></name><name><surname>Kim</surname><given-names>H. J.</given-names></name><name><surname>Kim</surname><given-names>H.-J.</given-names></name></person-group> (<year>2013</year>). <article-title>A comparative study of the effects of whole red ginseng extract and polysaccharide and saponin fractions on influenza A (H1N1) virus infection</article-title>. <source>Biol. Pharm. Bull.</source>
<volume>36</volume>, <fpage>1002</fpage>&#x02013;<lpage>1007</lpage>. <pub-id pub-id-type="doi">10.1248/bpb.b13-00123</pub-id><?supplied-pmid 23727921?><pub-id pub-id-type="pmid">23727921</pub-id></mixed-citation></ref><ref id="B271"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yokota</surname><given-names>T.</given-names></name><name><surname>Nishio</surname><given-names>H.</given-names></name><name><surname>Kubota</surname><given-names>Y.</given-names></name><name><surname>Mizoguchi</surname><given-names>M.</given-names></name></person-group> (<year>1998</year>). <article-title>The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation</article-title>. <source>Pigment cell Res.</source>
<volume>11</volume>, <fpage>355</fpage>&#x02013;<lpage>361</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0749.1998.tb00494.x</pub-id><?supplied-pmid 9870547?><pub-id pub-id-type="pmid">9870547</pub-id></mixed-citation></ref><ref id="B272"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yun</surname><given-names>T. K.</given-names></name></person-group> (<year>2001</year>). <article-title>Brief introduction of Panax ginseng C.A. Meyer</article-title>. <source>J. Korean Med. Sci.</source>
<volume>16</volume>(<issue>Suppl.</issue>) <fpage>S3</fpage>&#x02013;<lpage>S5</lpage>. <pub-id pub-id-type="doi">10.3346/jkms.2001.16.S.S3</pub-id><?supplied-pmid 11748372?><pub-id pub-id-type="pmid">11748372</pub-id></mixed-citation></ref><ref id="B273"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Fang</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Lian</surname><given-names>Y.</given-names></name><name><surname>Xie</surname><given-names>N.</given-names></name><name><surname>Wu</surname><given-names>T.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Curcumin improves amyloid beta-peptide (1-42) induced spatial memory deficits through BDNF-ERK signaling pathway</article-title>. <source>PLoS ONE</source>
<volume>10</volume>:<fpage>e0131525</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0131525</pub-id><?supplied-pmid 26114940?><pub-id pub-id-type="pmid">26114940</pub-id></mixed-citation></ref><ref id="B274"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Fiala</surname><given-names>M.</given-names></name><name><surname>Cashman</surname><given-names>J.</given-names></name><name><surname>Sayre</surname><given-names>J.</given-names></name><name><surname>Espinosa</surname><given-names>A.</given-names></name><name><surname>Mahanian</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2006</year>). <article-title>Curcuminoids enhance amyloid-beta uptake by macrophages of Alzheimer's disease patients</article-title>. <source>J. Alzheimers. Dis.</source>
<volume>10</volume>, <fpage>1</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-2006-10101</pub-id><?supplied-pmid 16988474?><pub-id pub-id-type="pmid">16988474</pub-id></mixed-citation></ref><ref id="B275"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>J.-S.</given-names></name><name><surname>Wang</surname><given-names>J.-F.</given-names></name><name><surname>He</surname><given-names>B.-R.</given-names></name><name><surname>Cui</surname><given-names>Y.-S.</given-names></name><name><surname>Fang</surname><given-names>X.-Y.</given-names></name><name><surname>Ni</surname><given-names>J.-L.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Ginsenoside Rd attenuates mitochondrial permeability transition and cytochrome c release in isolated spinal cord mitochondria: involvement of kinase-mediated pathways</article-title>. <source>Int. J. Mol. Sci.</source>
<volume>15</volume>, <fpage>9859</fpage>&#x02013;<lpage>9877</lpage>. <pub-id pub-id-type="doi">10.3390/ijms15069859</pub-id><?supplied-pmid 24897022?><pub-id pub-id-type="pmid">24897022</pub-id></mixed-citation></ref><ref id="B276"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>S.</given-names></name><name><surname>Lim</surname><given-names>L. Y.</given-names></name><name><surname>Chowbay</surname><given-names>B.</given-names></name></person-group> (<year>2004</year>). <article-title>Herbal modulation of P-glycoprotein</article-title>. <source>Drug Metab. Rev.</source>
<volume>36</volume>, <fpage>57</fpage>&#x02013;<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1081/DMR-120028427</pub-id><?supplied-pmid 15072439?><pub-id pub-id-type="pmid">15072439</pub-id></mixed-citation></ref><ref id="B277"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>X.</given-names></name><name><surname>Cui</surname><given-names>G.</given-names></name><name><surname>Tseng</surname><given-names>H. H. L.</given-names></name><name><surname>Lee</surname><given-names>S. M.-Y.</given-names></name><name><surname>Leung</surname><given-names>G. P. H.</given-names></name><name><surname>Chan</surname><given-names>S. W.</given-names></name><etal/></person-group>. (<year>2016a</year>). <article-title>Vascular contributions to cognitive impairment and treatments with traditional chinese medicine</article-title>. <source>Evid. Based. Complement. Alternat. Med.</source>
<volume>2016</volume>, <fpage>9627258</fpage>. <pub-id pub-id-type="doi">10.1155/2016/9627258</pub-id><?supplied-pmid 28042305?><pub-id pub-id-type="pmid">28042305</pub-id></mixed-citation></ref><ref id="B278"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>X.</given-names></name><name><surname>Seto</surname><given-names>S. W.</given-names></name><name><surname>Chang</surname><given-names>D.</given-names></name><name><surname>Kiat</surname><given-names>H.</given-names></name><name><surname>Razmovski-Naumovski</surname><given-names>V.</given-names></name><name><surname>Chan</surname><given-names>K.</given-names></name><etal/></person-group>. (<year>2016b</year>). <article-title>Synergistic effects of chinese herbal medicine: a comprehensive review of methodology and current research</article-title>. <source>Front. Pharmacol.</source>
<volume>7</volume>:<fpage>201</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2016.00201</pub-id><?supplied-pmid 27462269?><pub-id pub-id-type="pmid">27462269</pub-id></mixed-citation></ref><ref id="B279"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>H.-Y.</given-names></name><name><surname>Wu</surname><given-names>B.</given-names></name><name><surname>Cheng</surname><given-names>C.-Y.</given-names></name><name><surname>Xiao</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>Z.-Z.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Ginkgolide K attenuates neuronal injury after ischemic stroke by inhibiting mitochondrial fission and GSK-3beta-dependent increases in mitochondrial membrane permeability</article-title>. <source>Oncotarget</source>
<volume>8</volume>, <fpage>44682</fpage>&#x02013;<lpage>44693</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.17967</pub-id><?supplied-pmid 28591721?><pub-id pub-id-type="pmid">28591721</pub-id></mixed-citation></ref><ref id="B280"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Ye</surname><given-names>D.</given-names></name><name><surname>Guan</surname><given-names>D.</given-names></name><name><surname>Ye</surname><given-names>L.</given-names></name><name><surname>Jin</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Diammonium glycyrrhizinate upregulates PGC-1&#x003b1; and protects against A&#x003b2; 1&#x02013;42-induced neurotoxicity</article-title>. <source>PLoS ONE</source>
<volume>7</volume>:<fpage>e35823</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0035823</pub-id><?supplied-pmid 22540007?><pub-id pub-id-type="pmid">22540007</pub-id></mixed-citation></ref><ref id="B281"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>X.</given-names></name><name><surname>Perry</surname><given-names>G.</given-names></name><name><surname>Smith</surname><given-names>M. A.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name></person-group> (<year>2013</year>). <article-title>Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease</article-title>. <source>J. Alzheimers. Dis.</source>
<volume>33</volume>(<issue>Suppl. 1</issue>), <fpage>S253</fpage>&#x02013;<lpage>S262</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-2012-129005</pub-id><?supplied-pmid 22531428?><pub-id pub-id-type="pmid">22531428</pub-id></mixed-citation></ref><ref id="B282"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zlokovic</surname><given-names>B. V.</given-names></name></person-group> (<year>2011</year>). <article-title>Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders</article-title>. <source>Nat. Rev. Neurosci.</source>
<volume>12</volume>, <fpage>723</fpage>&#x02013;<lpage>738</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3114</pub-id><?supplied-pmid 22048062?><pub-id pub-id-type="pmid">22048062</pub-id></mixed-citation></ref><ref id="B283"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zupancic</surname><given-names>M.</given-names></name><name><surname>Mahajan</surname><given-names>A.</given-names></name><name><surname>Handa</surname><given-names>K.</given-names></name></person-group> (<year>2011</year>). <article-title>Dementia with lewy bodies: diagnosis and management for primary care providers</article-title>. <source>Prim. Care Companion CNS Disord.</source> 13:PCC.11r01190. <?supplied-pmid 22295275?><pub-id pub-id-type="pmid">22295275</pub-id></mixed-citation></ref></ref-list></back></article>